HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 9.4 X64_SR12 18JUN21:06:47:1818JUN21:06:47:18 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SE SASDATA 9.4 X64_SR12 18JUN21:06:47:1818JUN21:06:47:18 Subject Elements HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000001400000000000000000000 STUDYID Study Identifier DOMAIN Domain Abbreviation USUBJID Unique Subject Identifier SUBJID Subject Identifier for the Study )SESEQ Sequence Number 2ETCD Element Code :(ELEMENT Description of Element BSEUPDES Description of Unplanned Element j TAETORD Planned Order of Element within Arm € EPOCH Epoch ˆSESTDTC Start Date/Time of Element œSEENDTC End Date/Time of Element ¬ SESTDY Study Day of Start of Observation ¼SEENDY Study Day of End of Observation Ä HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 mRNA-1273-P201SEmRNA-1273-P201-US201-1001US2011001ASCREEN Screening ASCREENING 2020-05-26 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1003US2011003ASCREEN Screening ASCREENING 2020-05-26 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1004US2011004ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T13:36Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1004US2011004A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T13:362020-06-29T11:18ABmRNA-1273-P201SEmRNA-1273-P201-US201-1004US2011004A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-29T11:182020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1004US2011004A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-03-09 B9C mRNA-1273-P201SEmRNA-1273-P201-US201-1005US2011005ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1006US2011006ASCREEN Screening ASCREENING 2020-05-26 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1007US2011007ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T14:47Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1007US2011007A PBO Placebo A BLINDED TREATMENT 2020-06-01T14:472020-06-29T13:29ABmRNA-1273-P201SEmRNA-1273-P201-US201-1007US2011007A0PBO Placebo A0BLINDED TREATMENT 2020-06-29T13:292020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1007US2011007A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-03-10 B9C°mRNA-1273-P201SEmRNA-1273-P201-US201-1008US2011008ASCREEN Screening ASCREENING 2020-05-26 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1009US2011009ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T16:15Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1009US2011009A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T16:152020-06-29T16:20ABmRNA-1273-P201SEmRNA-1273-P201-US201-1009US2011009A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-29T16:202020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1009US2011009A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-01-06 B9BÜmRNA-1273-P201SEmRNA-1273-P201-US201-1011US2011011ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T15:41Á0AmRNA-1273-P201SEmRNA-1273-P201-US201-1011US2011011A PBO Placebo A BLINDED TREATMENT 2020-05-29T15:412020-06-26T10:29ABmRNA-1273-P201SEmRNA-1273-P201-US201-1011US2011011A0PBO Placebo A0BLINDED TREATMENT 2020-06-26T10:292020-07-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1011US2011011A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-24 2021-03-04 B9C€mRNA-1273-P201SEmRNA-1273-P201-US201-1012US2011012ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T14:06Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1012US2011012A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T14:062020-06-30T15:28ABmRNA-1273-P201SEmRNA-1273-P201-US201-1012US2011012A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T15:282020-07-31 BB=mRNA-1273-P201SEmRNA-1273-P201-US201-1012US2011012A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-03-09 B=C mRNA-1273-P201SEmRNA-1273-P201-US201-1014US2011014ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T12:57Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1014US2011014A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T12:572020-06-29T08:38ABmRNA-1273-P201SEmRNA-1273-P201-US201-1014US2011014A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T08:382020-07-29 BB;mRNA-1273-P201SEmRNA-1273-P201-US201-1014US2011014A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-03-22 B;CpmRNA-1273-P201SEmRNA-1273-P201-US201-1015US2011015ASCREEN Screening ASCREENING 2020-05-26 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1018US2011018ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T17:09Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1018US2011018A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T17:092020-06-30T18:01ABmRNA-1273-P201SEmRNA-1273-P201-US201-1018US2011018A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-30T18:012020-07-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US201-1018US2011018A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-03-11 B:CÀmRNA-1273-P201SEmRNA-1273-P201-US201-1019US2011019ASCREEN Screening ASCREENING 2020-05-26 2020-06-02T15:03ÁpAmRNA-1273-P201SEmRNA-1273-P201-US201-1019US2011019A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T15:032020-07-02T11:22ABmRNA-1273-P201SEmRNA-1273-P201-US201-1019US2011019A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-02T11:222020-07-30 BB;mRNA-1273-P201SEmRNA-1273-P201-US201-1019US2011019A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-03-10 B;C mRNA-1273-P201SEmRNA-1273-P201-US201-1020US2011020ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T15:19Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1020US2011020A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T15:192020-07-01T15:41ABmRNA-1273-P201SEmRNA-1273-P201-US201-1020US2011020A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-01T15:412020-07-29 BB;mRNA-1273-P201SEmRNA-1273-P201-US201-1020US2011020A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-03-11 B;CÀmRNA-1273-P201SEmRNA-1273-P201-US201-1021US2011021ASCREEN Screening ASCREENING 2020-05-26 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1022US2011022ASCREEN Screening ASCREENING 2020-05-26 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1023US2011023ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T16:38Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1023US2011023A PBO Placebo A BLINDED TREATMENT 2020-06-02T16:382020-07-02T17:42ABmRNA-1273-P201SEmRNA-1273-P201-US201-1023US2011023A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T17:422020-07-30 BB;mRNA-1273-P201SEmRNA-1273-P201-US201-1023US2011023A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-10 B;BþmRNA-1273-P201SEmRNA-1273-P201-US201-1024US2011024ASCREEN Screening ASCREENING 2020-05-27 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1027US2011027ASCREEN Screening ASCREENING 2020-05-27 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1028US2011028ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T11:11ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1028US2011028A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T11:112020-06-29T09:06ABmRNA-1273-P201SEmRNA-1273-P201-US201-1028US2011028A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-29T09:062020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1028US2011028A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-03-15 B9CmRNA-1273-P201SEmRNA-1273-P201-US201-1029US2011029ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T17:37ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1029US2011029A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T17:372020-06-29T16:42ABmRNA-1273-P201SEmRNA-1273-P201-US201-1029US2011029A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T16:422020-07-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US201-1029US2011029A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-03-10 B:C°mRNA-1273-P201SEmRNA-1273-P201-US201-1030US2011030ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T10:48Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1030US2011030A PBO Placebo A BLINDED TREATMENT 2020-06-02T10:482020-06-30T09:14ABmRNA-1273-P201SEmRNA-1273-P201-US201-1030US2011030A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T09:142020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1030US2011030A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-03-03 B9C0mRNA-1273-P201SEmRNA-1273-P201-US201-1032US2011032ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T13:37Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1032US2011032A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T13:372020-07-01T13:04ABmRNA-1273-P201SEmRNA-1273-P201-US201-1032US2011032A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-01T13:042020-07-29 BB:mRNA-1273-P201SEmRNA-1273-P201-US201-1032US2011032A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-03-10 B:C mRNA-1273-P201SEmRNA-1273-P201-US201-1033US2011033ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1034US2011034ASCREEN Screening ASCREENING 2020-05-27 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1035US2011035ASCREEN Screening ASCREENING 2020-05-27 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1037US2011037ASCREEN Screening ASCREENING 2020-05-27 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1039US2011039ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T16:43ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1039US2011039A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T16:432020-06-29T14:02ABmRNA-1273-P201SEmRNA-1273-P201-US201-1039US2011039A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-29T14:022020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1039US2011039A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-03-15 B9CmRNA-1273-P201SEmRNA-1273-P201-US201-1040US2011040ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T15:50ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1040US2011040A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T15:502020-06-29T10:51ABmRNA-1273-P201SEmRNA-1273-P201-US201-1040US2011040A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T10:512020-07-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US201-1040US2011040A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-01-26 B:BðmRNA-1273-P201SEmRNA-1273-P201-US201-1041US2011041ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T10:46Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1041US2011041A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T10:462020-06-30T12:58ABmRNA-1273-P201SEmRNA-1273-P201-US201-1041US2011041A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-30T12:582020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1041US2011041A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-03-09 B9CmRNA-1273-P201SEmRNA-1273-P201-US201-1042US2011042ASCREEN Screening ASCREENING 2020-05-27 2020-06-08T10:01ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US201-1042US2011042A PBO Placebo A BLINDED TREATMENT 2020-06-08T10:012020-07-06T16:07ABmRNA-1273-P201SEmRNA-1273-P201-US201-1042US2011042A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T16:072020-08-04 BB:mRNA-1273-P201SEmRNA-1273-P201-US201-1042US2011042A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-03-15 B:CmRNA-1273-P201SEmRNA-1273-P201-US201-1043US2011043ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T09:07ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1043US2011043A PBO Placebo A BLINDED TREATMENT 2020-06-01T09:072020-06-29T10:00ABmRNA-1273-P201SEmRNA-1273-P201-US201-1043US2011043A0PBO Placebo A0BLINDED TREATMENT 2020-06-29T10:002020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1043US2011043A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-03-10 B9C°mRNA-1273-P201SEmRNA-1273-P201-US201-1045US2011045ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1046US2011046ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T17:27Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1046US2011046A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T17:272020-07-01T14:47ABmRNA-1273-P201SEmRNA-1273-P201-US201-1046US2011046A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T14:472020-07-29 BB:mRNA-1273-P201SEmRNA-1273-P201-US201-1046US2011046A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-03-10 B:C mRNA-1273-P201SEmRNA-1273-P201-US201-1048US2011048ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T10:47ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1048US2011048A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T10:472020-06-29T10:28ABmRNA-1273-P201SEmRNA-1273-P201-US201-1048US2011048A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T10:282020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1048US2011048A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-03-10 B9C°mRNA-1273-P201SEmRNA-1273-P201-US201-1049US2011049ASCREEN Screening ASCREENING 2020-05-27 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1050US2011050ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T09:50ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1050US2011050A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T09:502020-06-29T09:34ABmRNA-1273-P201SEmRNA-1273-P201-US201-1050US2011050A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-29T09:342020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1050US2011050A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-03-10 B9C°mRNA-1273-P201SEmRNA-1273-P201-US201-1051US2011051ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T16:12Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1051US2011051A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T16:122020-07-06T13:46AB#mRNA-1273-P201SEmRNA-1273-P201-US201-1051US2011051A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-06T13:462020-08-04 B#B@mRNA-1273-P201SEmRNA-1273-P201-US201-1051US2011051A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-03-10 B@C mRNA-1273-P201SEmRNA-1273-P201-US201-1052US2011052ASCREEN Screening ASCREENING 2020-05-27 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1053US2011053ASCREEN Screening ASCREENING 2020-05-27 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1054US2011054ASCREEN Screening ASCREENING 2020-05-28 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1055US2011055ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T17:03ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1055US2011055A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T17:032020-06-30T16:10ABmRNA-1273-P201SEmRNA-1273-P201-US201-1055US2011055A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T16:102020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1055US2011055A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-01-08 B9BÝmRNA-1273-P201SEmRNA-1273-P201-US201-1056US2011056ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T17:52ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1056US2011056A PBO Placebo A BLINDED TREATMENT 2020-06-02T17:522020-06-30T17:08ABmRNA-1273-P201SEmRNA-1273-P201-US201-1056US2011056A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T17:082020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1056US2011056A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-03-10 B9C mRNA-1273-P201SEmRNA-1273-P201-US201-1057US2011057ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T14:34ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1057US2011057A PBO Placebo A BLINDED TREATMENT 2020-06-02T14:342020-06-30T08:44ABmRNA-1273-P201SEmRNA-1273-P201-US201-1057US2011057A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T08:442020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1057US2011057A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-03-17 B9CmRNA-1273-P201SEmRNA-1273-P201-US201-1059US2011059ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T09:27ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1059US2011059A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T09:272020-06-30T10:18ABmRNA-1273-P201SEmRNA-1273-P201-US201-1059US2011059A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-30T10:182020-07-29 BB:mRNA-1273-P201SEmRNA-1273-P201-US201-1059US2011059A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-03-12 B:CÀmRNA-1273-P201SEmRNA-1273-P201-US201-1060US2011060ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T12:40ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1060US2011060A PBO Placebo A BLINDED TREATMENT 2020-06-02T12:402020-06-30T16:39ABmRNA-1273-P201SEmRNA-1273-P201-US201-1060US2011060A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T16:392020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1060US2011060A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-03-10 B9C mRNA-1273-P201SEmRNA-1273-P201-US201-1061US2011061ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T17:40Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1061US2011061A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T17:402020-07-02T16:48ABmRNA-1273-P201SEmRNA-1273-P201-US201-1061US2011061A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-02T16:482020-08-03 BB>mRNA-1273-P201SEmRNA-1273-P201-US201-1061US2011061A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-03-10 B>CmRNA-1273-P201SEmRNA-1273-P201-US201-1062US2011062ASCREEN Screening ASCREENING 2020-05-28 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1063US2011063ASCREEN Screening ASCREENING 2020-05-28 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1064US2011064ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T12:23ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1064US2011064A PBO Placebo A BLINDED TREATMENT 2020-06-02T12:232020-07-01T13:53ABmRNA-1273-P201SEmRNA-1273-P201-US201-1064US2011064A0PBO Placebo A0BLINDED TREATMENT 2020-07-01T13:532020-07-30 BB;mRNA-1273-P201SEmRNA-1273-P201-US201-1064US2011064A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-03-17 B;CmRNA-1273-P201SEmRNA-1273-P201-US201-1065US2011065ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T13:09ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1065US2011065A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T13:092020-06-30T14:30ABmRNA-1273-P201SEmRNA-1273-P201-US201-1065US2011065A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-30T14:302020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1065US2011065A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-03-09 B9CmRNA-1273-P201SEmRNA-1273-P201-US201-1066US2011066ASCREEN Screening ASCREENING 2020-05-28 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1067US2011067ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T13:35Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1067US2011067A PBO Placebo A BLINDED TREATMENT 2020-06-03T13:352020-07-07T09:13AB#mRNA-1273-P201SEmRNA-1273-P201-US201-1067US2011067A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T09:132020-08-06 B#BAmRNA-1273-P201SEmRNA-1273-P201-US201-1067US2011067A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-03-11 BAC mRNA-1273-P201SEmRNA-1273-P201-US201-1068US2011068ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T08:38ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1068US2011068A PBO Placebo A BLINDED TREATMENT 2020-06-02T08:382020-06-30T09:41ABmRNA-1273-P201SEmRNA-1273-P201-US201-1068US2011068A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T09:412020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1068US2011068A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-03-10 B9C mRNA-1273-P201SEmRNA-1273-P201-US201-1069US2011069ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T09:53ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1069US2011069A PBO Placebo A BLINDED TREATMENT 2020-06-02T09:532020-06-30T14:01ABmRNA-1273-P201SEmRNA-1273-P201-US201-1069US2011069A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T14:012020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1069US2011069A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-03-10 B9C mRNA-1273-P201SEmRNA-1273-P201-US201-1070US2011070ASCREEN Screening ASCREENING 2020-05-28 2020-06-05T08:58Á€AmRNA-1273-P201SEmRNA-1273-P201-US201-1070US2011070A PBO Placebo A BLINDED TREATMENT 2020-06-05T08:582020-07-06T12:25AB mRNA-1273-P201SEmRNA-1273-P201-US201-1070US2011070A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T12:252020-08-06 B B?mRNA-1273-P201SEmRNA-1273-P201-US201-1070US2011070A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2020-08-06 B?B?mRNA-1273-P201SEmRNA-1273-P201-US201-1071US2011071ASCREEN Screening ASCREENING 2020-05-28 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1072US2011072ASCREEN Screening ASCREENING 2020-05-28 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1074US2011074ASCREEN Screening ASCREENING 2020-05-28 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1075US2011075ASCREEN Screening ASCREENING 2020-05-28 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1076US2011076ASCREEN Screening ASCREENING 2020-05-29 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1077US2011077ASCREEN Screening ASCREENING 2020-05-29 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1078US2011078ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1079US2011079ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1080US2011080ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T11:29ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1080US2011080A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T11:292020-07-01T15:14ABmRNA-1273-P201SEmRNA-1273-P201-US201-1080US2011080A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T15:142020-07-29 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1080US2011080A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-03-11 B9C mRNA-1273-P201SEmRNA-1273-P201-US201-1083US2011083ASCREEN Screening ASCREENING 2020-05-29 2020-06-09 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1084US2011084ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T09:01Á@AmRNA-1273-P201SEmRNA-1273-P201-US201-1084US2011084A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T09:012020-06-30T08:19ABmRNA-1273-P201SEmRNA-1273-P201-US201-1084US2011084A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T08:192020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1084US2011084A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-03-10 B9C mRNA-1273-P201SEmRNA-1273-P201-US201-1085US2011085ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T15:41ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1085US2011085A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T15:412020-07-01T16:54ABmRNA-1273-P201SEmRNA-1273-P201-US201-1085US2011085A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T16:542020-07-29 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1085US2011085A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-03-09 B9C€mRNA-1273-P201SEmRNA-1273-P201-US201-1086US2011086ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T10:20Á@AmRNA-1273-P201SEmRNA-1273-P201-US201-1086US2011086A PBO Placebo A BLINDED TREATMENT 2020-06-02T10:202020-06-30T10:43ABmRNA-1273-P201SEmRNA-1273-P201-US201-1086US2011086A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T10:432020-07-27 BB8mRNA-1273-P201SEmRNA-1273-P201-US201-1086US2011086A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-03-10 B8C mRNA-1273-P201SEmRNA-1273-P201-US201-1087US2011087ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T16:10ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1087US2011087A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T16:102020-07-01T16:12ABmRNA-1273-P201SEmRNA-1273-P201-US201-1087US2011087A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-01T16:122020-07-29 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1087US2011087A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-03-09 B9C€mRNA-1273-P201SEmRNA-1273-P201-US201-1088US2011088ASCREEN Screening ASCREENING 2020-06-01 2020-06-04T08:49Á0AmRNA-1273-P201SEmRNA-1273-P201-US201-1088US2011088A PBO Placebo A BLINDED TREATMENT 2020-06-04T08:492020-07-07T09:38AB"mRNA-1273-P201SEmRNA-1273-P201-US201-1088US2011088A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T09:382020-08-04 B"B>mRNA-1273-P201SEmRNA-1273-P201-US201-1088US2011088A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-03-11 B>CmRNA-1273-P201SEmRNA-1273-P201-US201-1089US2011089ASCREEN Screening ASCREENING 2020-06-01 2020-06-05T09:28Á@AmRNA-1273-P201SEmRNA-1273-P201-US201-1089US2011089A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-05T09:282020-07-10T15:02AB$mRNA-1273-P201SEmRNA-1273-P201-US201-1089US2011089A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-10T15:022020-08-10 B$BCmRNA-1273-P201SEmRNA-1273-P201-US201-1089US2011089A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-03-12 BCCmRNA-1273-P201SEmRNA-1273-P201-US201-1090US2011090ASCREEN Screening ASCREENING 2020-06-01 2020-06-04T10:23Á0AmRNA-1273-P201SEmRNA-1273-P201-US201-1090US2011090A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-04T10:232020-07-02T10:46ABmRNA-1273-P201SEmRNA-1273-P201-US201-1090US2011090A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-02T10:462020-07-30 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1090US2011090A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-03-10 B9C€mRNA-1273-P201SEmRNA-1273-P201-US201-1091US2011091ASCREEN Screening ASCREENING 2020-06-01 2020-06-04T11:26Á0AmRNA-1273-P201SEmRNA-1273-P201-US201-1091US2011091A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-04T11:262020-07-02T13:20ABmRNA-1273-P201SEmRNA-1273-P201-US201-1091US2011091A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-02T13:202020-08-03 BB=mRNA-1273-P201SEmRNA-1273-P201-US201-1091US2011091A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-03-09 B=CpmRNA-1273-P201SEmRNA-1273-P201-US201-1092US2011092ASCREEN Screening ASCREENING 2020-06-02 2020-06-05T14:49Á0AmRNA-1273-P201SEmRNA-1273-P201-US201-1092US2011092A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-05T14:492020-07-07T14:48AB!mRNA-1273-P201SEmRNA-1273-P201-US201-1092US2011092A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T14:482020-08-05 B!B>mRNA-1273-P201SEmRNA-1273-P201-US201-1092US2011092A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-03-10 B>CpmRNA-1273-P201SEmRNA-1273-P201-US201-1093US2011093ASCREEN Screening ASCREENING 2020-06-02 2020-06-08T08:37Á`AmRNA-1273-P201SEmRNA-1273-P201-US201-1093US2011093A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T08:372020-07-06T11:09ABmRNA-1273-P201SEmRNA-1273-P201-US201-1093US2011093A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-06T11:092020-08-03 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1093US2011093A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-03-18 B9CÀmRNA-1273-P201SEmRNA-1273-P201-US201-1094US2011094ASCREEN Screening ASCREENING 2020-06-03 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1095US2011095ASCREEN Screening ASCREENING 2020-06-03 2020-06-05T15:19Á AmRNA-1273-P201SEmRNA-1273-P201-US201-1095US2011095A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-05T15:192020-07-06T16:56AB mRNA-1273-P201SEmRNA-1273-P201-US201-1095US2011095A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-06T16:562020-08-03 B B<mRNA-1273-P201SEmRNA-1273-P201-US201-1095US2011095A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-03-12 B<CmRNA-1273-P201SEmRNA-1273-P201-US201-1096US2011096ASCREEN Screening ASCREENING 2020-06-03 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1097US2011097ASCREEN Screening ASCREENING 2020-06-03 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1098US2011098ASCREEN Screening ASCREENING 2020-06-03 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1099US2011099ASCREEN Screening ASCREENING 2020-06-03 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1100US2011100ASCREEN Screening ASCREENING 2020-06-04 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1101US2011101ASCREEN Screening ASCREENING 2020-06-04 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1102US2011102ASCREEN Screening ASCREENING 2020-06-05 2020-06-08T10:57Á0AmRNA-1273-P201SEmRNA-1273-P201-US201-1102US2011102A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T10:572020-07-06T10:23ABmRNA-1273-P201SEmRNA-1273-P201-US201-1102US2011102A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-06T10:232020-08-04 BB:mRNA-1273-P201SEmRNA-1273-P201-US201-1102US2011102A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-03-09 B:C0mRNA-1273-P201SEmRNA-1273-P201-US201-1103US2011103ASCREEN Screening ASCREENING 2020-06-05 2020-06-08T14:16Á0AmRNA-1273-P201SEmRNA-1273-P201-US201-1103US2011103A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T14:162020-07-07T16:08ABmRNA-1273-P201SEmRNA-1273-P201-US201-1103US2011103A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T16:082020-08-06 BB<mRNA-1273-P201SEmRNA-1273-P201-US201-1103US2011103A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-03-09 B<C0mRNA-1273-P201SEmRNA-1273-P201-US201-1104US2011104ASCREEN Screening ASCREENING 2020-06-08 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1105US2011105ASCREEN Screening ASCREENING 2020-06-08 2020-06-15 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1106US2011106ASCREEN Screening ASCREENING 2020-06-09 2020-06-15 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1107US2011107ASCREEN Screening ASCREENING 2020-06-09 2020-06-15 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1108US2011108ASCREEN Screening ASCREENING 2020-06-09 2020-06-15 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1109US2011109ASCREEN Screening ASCREENING 2020-06-11 2020-06-26T12:17ÁðAmRNA-1273-P201SEmRNA-1273-P201-US201-1109US2011109A PBO Placebo A BLINDED TREATMENT 2020-06-26T12:172020-07-24T11:22ABmRNA-1273-P201SEmRNA-1273-P201-US201-1109US2011109A0PBO Placebo A0BLINDED TREATMENT 2020-07-24T11:222020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1109US2011109A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-03-03 B9BûmRNA-1273-P201SEmRNA-1273-P201-US201-1111US2011111ASCREEN Screening ASCREENING 2020-06-11 2020-06-15 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1112US2011112ASCREEN Screening ASCREENING 2020-06-11 2020-06-15 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1113US2011113ASCREEN Screening ASCREENING 2020-06-12 2020-07-02T11:50ÂAmRNA-1273-P201SEmRNA-1273-P201-US201-1113US2011113A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-02T11:502020-07-30T12:31ABmRNA-1273-P201SEmRNA-1273-P201-US201-1113US2011113A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-30T12:312020-08-31 BB=mRNA-1273-P201SEmRNA-1273-P201-US201-1113US2011113A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-25 B=BïmRNA-1273-P201SEmRNA-1273-P201-US201-1114US2011114ASCREEN Screening ASCREENING 2020-06-12 2020-06-26T11:51ÁàAmRNA-1273-P201SEmRNA-1273-P201-US201-1114US2011114A PBO Placebo A BLINDED TREATMENT 2020-06-26T11:512020-07-24T10:52ABmRNA-1273-P201SEmRNA-1273-P201-US201-1114US2011114A0PBO Placebo A0BLINDED TREATMENT 2020-07-24T10:522020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1114US2011114A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-03-08 B9CmRNA-1273-P201SEmRNA-1273-P201-US201-1115US2011115ASCREEN Screening ASCREENING 2020-06-12 2020-06-26 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1116US2011116ASCREEN Screening ASCREENING 2020-06-12 2020-06-27T12:10ÁðAmRNA-1273-P201SEmRNA-1273-P201-US201-1116US2011116A PBO Placebo A BLINDED TREATMENT 2020-06-27T12:102020-07-27T13:10ABmRNA-1273-P201SEmRNA-1273-P201-US201-1116US2011116A0PBO Placebo A0BLINDED TREATMENT 2020-07-27T13:102020-08-24 BB;mRNA-1273-P201SEmRNA-1273-P201-US201-1116US2011116A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-03-04 B;BûmRNA-1273-P201SEmRNA-1273-P201-US201-1117US2011117ASCREEN Screening ASCREENING 2020-06-12 2020-06-26T14:31ÁàAmRNA-1273-P201SEmRNA-1273-P201-US201-1117US2011117A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T14:312020-07-24T09:54ABmRNA-1273-P201SEmRNA-1273-P201-US201-1117US2011117A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-24T09:542020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1117US2011117A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-03-02 B9BúmRNA-1273-P201SEmRNA-1273-P201-US201-1118US2011118ASCREEN Screening ASCREENING 2020-06-12 2020-06-26T16:27ÁàAmRNA-1273-P201SEmRNA-1273-P201-US201-1118US2011118A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T16:272020-07-24T08:40ABmRNA-1273-P201SEmRNA-1273-P201-US201-1118US2011118A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-24T08:402020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1118US2011118A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-03-09 B9CmRNA-1273-P201SEmRNA-1273-P201-US201-1119US2011119ASCREEN Screening ASCREENING 2020-06-12 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1120US2011120ASCREEN Screening ASCREENING 2020-06-15 2020-06-27T11:41ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US201-1120US2011120A PBO Placebo A BLINDED TREATMENT 2020-06-27T11:412020-07-27T12:42ABmRNA-1273-P201SEmRNA-1273-P201-US201-1120US2011120A0PBO Placebo A0BLINDED TREATMENT 2020-07-27T12:422020-08-24 BB;mRNA-1273-P201SEmRNA-1273-P201-US201-1120US2011120A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-03-08 B;BÿmRNA-1273-P201SEmRNA-1273-P201-US201-1121US2011121ASCREEN Screening ASCREENING 2020-06-15 2020-07-02T15:58ÂAmRNA-1273-P201SEmRNA-1273-P201-US201-1121US2011121A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-02T15:582020-07-30T15:05ABmRNA-1273-P201SEmRNA-1273-P201-US201-1121US2011121A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-30T15:052020-08-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US201-1121US2011121A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-09 B:BßmRNA-1273-P201SEmRNA-1273-P201-US201-1122US2011122ASCREEN Screening ASCREENING 2020-06-16 2020-06-26T08:49Á AmRNA-1273-P201SEmRNA-1273-P201-US201-1122US2011122A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T08:492020-07-24T08:12ABmRNA-1273-P201SEmRNA-1273-P201-US201-1122US2011122A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-24T08:122020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1122US2011122A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-03-09 B9CmRNA-1273-P201SEmRNA-1273-P201-US201-1123US2011025ASCREEN Screening ASCREENING 2020-05-27 2020-06-17 ÂÁmRNA-1273-P201SEmRNA-1273-P201-US201-1123US2011123A SCREEN Screening ASCREENING 2020-06-17 2020-06-26T16:56ÁAmRNA-1273-P201SEmRNA-1273-P201-US201-1123US2011123A0V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T16:562020-07-24T16:13ABmRNA-1273-P201SEmRNA-1273-P201-US201-1123US2011123A@V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-24T16:132020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1123US2011123APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-03-10 B9C mRNA-1273-P201SEmRNA-1273-P201-US201-1124US2011081ASCREEN Screening ASCREENING 2020-05-29 2020-06-17 ÂÁmRNA-1273-P201SEmRNA-1273-P201-US201-1124US2011124A SCREEN Screening ASCREENING 2020-06-17 2020-06-26T14:03ÁAmRNA-1273-P201SEmRNA-1273-P201-US201-1124US2011124A0PBO Placebo A BLINDED TREATMENT 2020-06-26T14:032020-07-24T09:28ABmRNA-1273-P201SEmRNA-1273-P201-US201-1124US2011124A@PBO Placebo A0BLINDED TREATMENT 2020-07-24T09:282020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1124US2011124APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-03-02 B9BúmRNA-1273-P201SEmRNA-1273-P201-US201-1125US2011017ASCREEN Screening ASCREENING 2020-05-26 2020-06-17 Â%ÁðmRNA-1273-P201SEmRNA-1273-P201-US201-1125US2011125A SCREEN Screening ASCREENING 2020-06-17 2020-07-02T17:15ÁðAmRNA-1273-P201SEmRNA-1273-P201-US201-1125US2011125A0V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-02T17:152020-07-29T15:10ABmRNA-1273-P201SEmRNA-1273-P201-US201-1125US2011125A@V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-29T15:102020-08-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US201-1125US2011125APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-09 B:BßmRNA-1273-P201SEmRNA-1273-P201-US201-1126US2011038ASCREEN Screening ASCREENING 2020-05-27 2020-06-18 ÂÁ€mRNA-1273-P201SEmRNA-1273-P201-US201-1126US2011126A SCREEN Screening ASCREENING 2020-06-18 2020-06-26T09:45Á€AmRNA-1273-P201SEmRNA-1273-P201-US201-1126US2011126A0PBO Placebo A BLINDED TREATMENT 2020-06-26T09:452020-07-24T10:21ABmRNA-1273-P201SEmRNA-1273-P201-US201-1126US2011126A@PBO Placebo A0BLINDED TREATMENT 2020-07-24T10:212020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1126US2011126APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-03-09 B9CmRNA-1273-P201SEmRNA-1273-P201-US201-1127US2011013ASCREEN Screening ASCREENING 2020-05-26 2020-06-18 ÂÁ€mRNA-1273-P201SEmRNA-1273-P201-US201-1127US2011127A SCREEN Screening ASCREENING 2020-06-18 2020-06-26T15:28Á€AmRNA-1273-P201SEmRNA-1273-P201-US201-1127US2011127A0V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T15:282020-07-24T13:08ABmRNA-1273-P201SEmRNA-1273-P201-US201-1127US2011127A@V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-24T13:082020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1127US2011127APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-03-30 B9C`mRNA-1273-P201SEmRNA-1273-P201-US201-1128US2011047ASCREEN Screening ASCREENING 2020-05-27 2020-06-18 Â"ÁÀmRNA-1273-P201SEmRNA-1273-P201-US201-1128US2011128A SCREEN Screening ASCREENING 2020-06-18 2020-06-30T11:11ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US201-1128US2011128A0V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-30T11:112020-07-29T11:17ABmRNA-1273-P201SEmRNA-1273-P201-US201-1128US2011128A@V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T11:172020-08-26 BB:mRNA-1273-P201SEmRNA-1273-P201-US201-1128US2011128APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-03-09 B:BýmRNA-1273-P201SEmRNA-1273-P201-US201-1130US2011073ASCREEN Screening ASCREENING 2020-05-28 2020-06-18 ÂÁ€mRNA-1273-P201SEmRNA-1273-P201-US201-1130US2011130A SCREEN Screening ASCREENING 2020-06-18 2020-06-26T15:03Á€AmRNA-1273-P201SEmRNA-1273-P201-US201-1130US2011130A0PBO Placebo A BLINDED TREATMENT 2020-06-26T15:032020-07-24T14:15ABmRNA-1273-P201SEmRNA-1273-P201-US201-1130US2011130A@PBO Placebo A0BLINDED TREATMENT 2020-07-24T14:152020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1130US2011130APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-03-08 B9CmRNA-1273-P201SEmRNA-1273-P201-US201-1131US2011131ASCREEN Screening ASCREENING 2020-06-18 2020-06-26T16:00Á€AmRNA-1273-P201SEmRNA-1273-P201-US201-1131US2011131A PBO Placebo A BLINDED TREATMENT 2020-06-26T16:002020-07-24T15:05ABmRNA-1273-P201SEmRNA-1273-P201-US201-1131US2011131A0PBO Placebo A0BLINDED TREATMENT 2020-07-24T15:052020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1131US2011131A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-04-02 B9CmRNA-1273-P201SEmRNA-1273-P201-US201-1132US2011026ASCREEN Screening ASCREENING 2020-05-27 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1132US2011132A SCREEN Screening ASCREENING 2020-06-18 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1133US2011133ASCREEN Screening ASCREENING 2020-06-18 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1134US2011134ASCREEN Screening ASCREENING 2020-06-19 2020-07-03 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1135US2011135ASCREEN Screening ASCREENING 2020-06-19 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1136US2011136ASCREEN Screening ASCREENING 2020-06-19 2020-06-26 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1137US2011058ASCREEN Screening ASCREENING 2020-05-28 2020-06-22 ÂÁ@mRNA-1273-P201SEmRNA-1273-P201-US201-1137US2011137A SCREEN Screening ASCREENING 2020-06-22 2020-06-26T09:14Á@AmRNA-1273-P201SEmRNA-1273-P201-US201-1137US2011137A0V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T09:142020-07-24T09:00ABmRNA-1273-P201SEmRNA-1273-P201-US201-1137US2011137A@V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-24T09:002020-08-19 BB7mRNA-1273-P201SEmRNA-1273-P201-US201-1137US2011137APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-19 2021-03-10 B7C mRNA-1273-P201SEmRNA-1273-P201-US201-1138US2011031ASCREEN Screening ASCREENING 2020-05-27 2020-06-22 ÂÁPmRNA-1273-P201SEmRNA-1273-P201-US201-1138US2011138A SCREEN Screening ASCREENING 2020-06-22 2020-06-27T11:10ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1138US2011138A0V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-27T11:102020-07-27T09:48ABmRNA-1273-P201SEmRNA-1273-P201-US201-1138US2011138A@V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-27T09:482020-08-26 BB=mRNA-1273-P201SEmRNA-1273-P201-US201-1138US2011138APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-02-09 B=BämRNA-1273-P201SEmRNA-1273-P201-US201-1139US2011139ASCREEN Screening ASCREENING 2020-06-22 2020-06-26T12:46Á@AmRNA-1273-P201SEmRNA-1273-P201-US201-1139US2011139A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T12:462020-07-24T12:30ABmRNA-1273-P201SEmRNA-1273-P201-US201-1139US2011139A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-24T12:302020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1139US2011139A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2020-09-23 B9BZmRNA-1273-P201SEmRNA-1273-P201-US201-1140US2011016ASCREEN Screening ASCREENING 2020-05-26 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1140US2011140A SCREEN Screening ASCREENING 2020-06-22 2020-06-25 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1142US2011044ASCREEN Screening ASCREENING 2020-05-27 2020-06-22 Â!ÁpmRNA-1273-P201SEmRNA-1273-P201-US201-1142US2011142A SCREEN Screening ASCREENING 2020-06-22 2020-06-29T12:21ÁpAmRNA-1273-P201SEmRNA-1273-P201-US201-1142US2011142A0PBO Placebo A BLINDED TREATMENT 2020-06-29T12:212020-07-27T15:42ABmRNA-1273-P201SEmRNA-1273-P201-US201-1142US2011142A@PBO Placebo A0BLINDED TREATMENT 2020-07-27T15:422020-08-26 BB;mRNA-1273-P201SEmRNA-1273-P201-US201-1142US2011142APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-03-08 B;BýmRNA-1273-P201SEmRNA-1273-P201-US201-1143US2011143ASCREEN Screening ASCREENING 2020-06-23 2020-06-25 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1144US2011144ASCREEN Screening ASCREENING 2020-06-23 2020-06-25 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1145US2011145ASCREEN Screening ASCREENING 2020-06-23 2020-06-26T13:32Á0AmRNA-1273-P201SEmRNA-1273-P201-US201-1145US2011145A PBO Placebo A BLINDED TREATMENT 2020-06-26T13:322020-07-24T11:51ABmRNA-1273-P201SEmRNA-1273-P201-US201-1145US2011145A0PBO Placebo A0BLINDED TREATMENT 2020-07-24T11:512020-08-20 BB8mRNA-1273-P201SEmRNA-1273-P201-US201-1145US2011145A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-20 2021-03-03 B8BûmRNA-1273-P201SEmRNA-1273-P201-US201-1146US2011082ASCREEN Screening ASCREENING 2020-05-29 2020-06-24 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1146US2011146A SCREEN Screening ASCREENING 2020-06-24 2020-06-24 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1147US2011147ASCREEN Screening ASCREENING 2020-06-24 2020-06-26 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1148US2011148ASCREEN Screening ASCREENING 2020-06-25 2020-06-27 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1149US2011010ASCREEN Screening ASCREENING 2020-05-26 2020-06-25 Â"Á@mRNA-1273-P201SEmRNA-1273-P201-US201-1149US2011149A SCREEN Screening ASCREENING 2020-06-25 2020-06-29T12:50Á@AmRNA-1273-P201SEmRNA-1273-P201-US201-1149US2011149A0V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-29T12:502020-07-27T15:17ABmRNA-1273-P201SEmRNA-1273-P201-US201-1149US2011149A@V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-27T15:172020-08-31 BB@mRNA-1273-P201SEmRNA-1273-P201-US201-1149US2011149APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-03-01 B@BömRNA-1273-P201SEmRNA-1273-P201-US201-1150US2011129ASCREEN Screening ASCREENING 2020-06-18 2020-06-25 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1150US2011150A SCREEN Screening ASCREENING 2020-06-25 2020-06-27 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1151US2011151ASCREEN Screening ASCREENING 2020-06-25 2020-06-27 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1152US2011152ASCREEN Screening ASCREENING 2020-06-25 2020-06-29T11:47Á@AmRNA-1273-P201SEmRNA-1273-P201-US201-1152US2011152A PBO Placebo A BLINDED TREATMENT 2020-06-29T11:472020-07-27T12:16ABmRNA-1273-P201SEmRNA-1273-P201-US201-1152US2011152A0PBO Placebo A0BLINDED TREATMENT 2020-07-27T12:162020-08-31 BB@mRNA-1273-P201SEmRNA-1273-P201-US201-1152US2011152A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-09 B@BâmRNA-1273-P201SEmRNA-1273-P201-US201-1153US2011141ASCREEN Screening ASCREENING 2020-06-22 2020-06-25 ÁpÁ@mRNA-1273-P201SEmRNA-1273-P201-US201-1153US2011153A SCREEN Screening ASCREENING 2020-06-25 2020-06-29T14:33Á@AmRNA-1273-P201SEmRNA-1273-P201-US201-1153US2011153A0V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-29T14:332020-07-27T14:24ABmRNA-1273-P201SEmRNA-1273-P201-US201-1153US2011153A@V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-27T14:242020-08-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1153US2011153APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-03-09 B9BþmRNA-1273-P201SEmRNA-1273-P201-US201-1154US2011002ASCREEN Screening ASCREENING 2020-05-26 2020-06-25 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1154US2011154A SCREEN Screening ASCREENING 2020-06-25 2020-06-27 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1155US2011155ASCREEN Screening ASCREENING 2020-06-25 2020-06-30T15:01ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1155US2011155A PBO Placebo A BLINDED TREATMENT 2020-06-30T15:012020-07-28T14:30ABmRNA-1273-P201SEmRNA-1273-P201-US201-1155US2011155A0PBO Placebo A0BLINDED TREATMENT 2020-07-28T14:302020-08-26 BB:mRNA-1273-P201SEmRNA-1273-P201-US201-1155US2011155A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-03-09 B:BýmRNA-1273-P201SEmRNA-1273-P201-US201-1156US2011156ASCREEN Screening ASCREENING 2020-06-25 2020-06-30T13:28ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1156US2011156A PBO Placebo A BLINDED TREATMENT 2020-06-30T13:282020-07-28T10:06ABmRNA-1273-P201SEmRNA-1273-P201-US201-1156US2011156A0PBO Placebo A0BLINDED TREATMENT 2020-07-28T10:062020-08-26 BB:mRNA-1273-P201SEmRNA-1273-P201-US201-1156US2011156A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-03-08 B:BümRNA-1273-P201SEmRNA-1273-P201-US201-1157US2011110ASCREEN Screening ASCREENING 2020-06-11 2020-06-25 ÂÁPmRNA-1273-P201SEmRNA-1273-P201-US201-1157US2011157A SCREEN Screening ASCREENING 2020-06-25 2020-06-30T17:36ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1157US2011157A0PBO Placebo A BLINDED TREATMENT 2020-06-30T17:362020-07-28T17:34ABmRNA-1273-P201SEmRNA-1273-P201-US201-1157US2011157A@PBO Placebo A0BLINDED TREATMENT 2020-07-28T17:342020-08-27 BB;mRNA-1273-P201SEmRNA-1273-P201-US201-1157US2011157APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-03-08 B;BümRNA-1273-P201SEmRNA-1273-P201-US201-1158US2011036ASCREEN Screening ASCREENING 2020-05-27 2020-06-26 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1158US2011158A SCREEN Screening ASCREENING 2020-06-26 2020-06-30 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1159US2011159ASCREEN Screening ASCREENING 2020-06-30 2020-07-02T12:51Á AmRNA-1273-P201SEmRNA-1273-P201-US201-1159US2011159A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-02T12:512020-07-30T13:03ABmRNA-1273-P201SEmRNA-1273-P201-US201-1159US2011159A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-30T13:032020-08-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1159US2011159A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-03-10 B9BümRNA-1273-P201SEmRNA-1273-P201-US201-1160US2011160ASCREEN Screening ASCREENING 2020-06-30 2020-07-02 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1161US2011161ASCREEN Screening ASCREENING 2020-07-01 2020-07-03 ..mRNA-1273-P201SEmRNA-1273-P201-US201-1162US2011162ASCREEN Screening ASCREENING 2020-07-01 2020-07-06T16:32ÁPAmRNA-1273-P201SEmRNA-1273-P201-US201-1162US2011162A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-06T16:322020-08-03T17:00ABmRNA-1273-P201SEmRNA-1273-P201-US201-1162US2011162A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-03T17:002020-08-31 BB9mRNA-1273-P201SEmRNA-1273-P201-US201-1162US2011162A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-04-14 B9C°mRNA-1273-P201SEmRNA-1273-P201-US202-1001US2021001ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1002US2021002ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1003US2021003ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T16:10Á0AmRNA-1273-P201SEmRNA-1273-P201-US202-1003US2021003A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-05-29T16:102020-06-30T08:59AB!mRNA-1273-P201SEmRNA-1273-P201-US202-1003US2021003A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-30T08:592020-07-27 B!B<mRNA-1273-P201SEmRNA-1273-P201-US202-1003US2021003A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-03-15 B<C0mRNA-1273-P201SEmRNA-1273-P201-US202-1004US2021004ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T11:22Á0AmRNA-1273-P201SEmRNA-1273-P201-US202-1004US2021004A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-05-29T11:222020-06-26T09:45ABmRNA-1273-P201SEmRNA-1273-P201-US202-1004US2021004A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-26T09:452020-07-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US202-1004US2021004A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-24 2021-03-05 B9CmRNA-1273-P201SEmRNA-1273-P201-US202-1005US2021005ASCREEN Screening ASCREENING 2020-05-26 2020-06-24 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1007US2021007ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T12:55Á`AmRNA-1273-P201SEmRNA-1273-P201-US202-1007US2021007A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T12:552020-06-29T09:52ABmRNA-1273-P201SEmRNA-1273-P201-US202-1007US2021007A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-29T09:522020-07-29 BB;mRNA-1273-P201SEmRNA-1273-P201-US202-1007US2021007A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-02-18 B;CpmRNA-1273-P201SEmRNA-1273-P201-US202-1008US2021008ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1009US2021009ASCREEN Screening ASCREENING 2020-05-26 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1011US2021011ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T15:35Á0AmRNA-1273-P201SEmRNA-1273-P201-US202-1011US2021011A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-05-29T15:352020-06-26T10:49ABmRNA-1273-P201SEmRNA-1273-P201-US202-1011US2021011A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-26T10:492020-07-21 BB6mRNA-1273-P201SEmRNA-1273-P201-US202-1011US2021011A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-21 2021-02-25 B6CmRNA-1273-P201SEmRNA-1273-P201-US202-1012US2021012ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T10:50Á`AmRNA-1273-P201SEmRNA-1273-P201-US202-1012US2021012A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T10:502020-06-29T10:18ABmRNA-1273-P201SEmRNA-1273-P201-US202-1012US2021012A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T10:182020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US202-1012US2021012A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-01-28 B9BòmRNA-1273-P201SEmRNA-1273-P201-US202-1013US2021013ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1014US2021014ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1015US2021015ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T10:50Á0AmRNA-1273-P201SEmRNA-1273-P201-US202-1015US2021015A PBO Placebo A BLINDED TREATMENT 2020-05-29T10:502020-06-26T09:55ABmRNA-1273-P201SEmRNA-1273-P201-US202-1015US2021015A0PBO Placebo A0BLINDED TREATMENT 2020-06-26T09:552020-07-23 BB8mRNA-1273-P201SEmRNA-1273-P201-US202-1015US2021015A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-23 2021-01-28 B8BõmRNA-1273-P201SEmRNA-1273-P201-US202-1017US2021017ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1018US2021018ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T13:35Á0AmRNA-1273-P201SEmRNA-1273-P201-US202-1018US2021018A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-05-29T13:352020-07-13T14:02AB.mRNA-1273-P201SEmRNA-1273-P201-US202-1018US2021018A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-13T14:022020-08-11 B.BKmRNA-1273-P201SEmRNA-1273-P201-US202-1018US2021018A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-11 2021-01-28 BKBõmRNA-1273-P201SEmRNA-1273-P201-US202-1019US2021019ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T15:05Á0AmRNA-1273-P201SEmRNA-1273-P201-US202-1019US2021019A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-05-29T15:052020-07-02T16:34AB#mRNA-1273-P201SEmRNA-1273-P201-US202-1019US2021019A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-02T16:342020-07-31 B#B@mRNA-1273-P201SEmRNA-1273-P201-US202-1019US2021019A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-02-18 B@C mRNA-1273-P201SEmRNA-1273-P201-US202-1020US2021020ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T12:25Á`AmRNA-1273-P201SEmRNA-1273-P201-US202-1020US2021020A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T12:252020-06-30T11:09ABmRNA-1273-P201SEmRNA-1273-P201-US202-1020US2021020A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T11:092020-07-29 BB;mRNA-1273-P201SEmRNA-1273-P201-US202-1020US2021020A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-01-29 B;BómRNA-1273-P201SEmRNA-1273-P201-US202-1021US2021021ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T11:49Á0AmRNA-1273-P201SEmRNA-1273-P201-US202-1021US2021021A PBO Placebo A BLINDED TREATMENT 2020-05-29T11:492020-06-26T10:04ABmRNA-1273-P201SEmRNA-1273-P201-US202-1021US2021021A0PBO Placebo A0BLINDED TREATMENT 2020-06-26T10:042020-07-22 BB7mRNA-1273-P201SEmRNA-1273-P201-US202-1021US2021021A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-22 2021-01-15 B7BèmRNA-1273-P201SEmRNA-1273-P201-US202-1022US2021022ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T13:13Á`AmRNA-1273-P201SEmRNA-1273-P201-US202-1022US2021022A PBO Placebo A BLINDED TREATMENT 2020-06-01T13:132020-07-06T11:51AB$mRNA-1273-P201SEmRNA-1273-P201-US202-1022US2021022A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T11:512020-08-04 B$BAmRNA-1273-P201SEmRNA-1273-P201-US202-1022US2021022A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-01-28 BABòmRNA-1273-P201SEmRNA-1273-P201-US202-1025US2021025ASCREEN Screening ASCREENING 2020-05-26 2020-06-24 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1026US2021026ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1027US2021027ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1028US2021028ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1030US2021030ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1031US2021031ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T16:32Á`AmRNA-1273-P201SEmRNA-1273-P201-US202-1031US2021031A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T16:322020-06-29T13:57ABmRNA-1273-P201SEmRNA-1273-P201-US202-1031US2021031A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-29T13:572020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US202-1031US2021031A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-01 B9BömRNA-1273-P201SEmRNA-1273-P201-US202-1032US2021032ASCREEN Screening ASCREENING 2020-05-26 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1033US2021033ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1034US2021034ASCREEN Screening ASCREENING 2020-05-26 2020-06-16 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1036US2021036ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1037US2021037ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1038US2021038ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1041US2021041ASCREEN Screening ASCREENING 2020-05-27 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1043US2021043ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T16:21ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1043US2021043A PBO Placebo A BLINDED TREATMENT 2020-06-01T16:212020-07-02T10:50AB mRNA-1273-P201SEmRNA-1273-P201-US202-1043US2021043A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T10:502020-07-29 B B;mRNA-1273-P201SEmRNA-1273-P201-US202-1043US2021043A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-01-29 B;BómRNA-1273-P201SEmRNA-1273-P201-US202-1045US2021045ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T17:58ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1045US2021045A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T17:582020-06-29T15:10ABmRNA-1273-P201SEmRNA-1273-P201-US202-1045US2021045A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T15:102020-08-03 BB@mRNA-1273-P201SEmRNA-1273-P201-US202-1045US2021045A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-01-28 B@BòmRNA-1273-P201SEmRNA-1273-P201-US202-1047US2021047ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T17:48ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1047US2021047A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T17:482020-06-29T14:07ABmRNA-1273-P201SEmRNA-1273-P201-US202-1047US2021047A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T14:072020-07-24 BB6mRNA-1273-P201SEmRNA-1273-P201-US202-1047US2021047A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-24 2021-01-28 B6BòmRNA-1273-P201SEmRNA-1273-P201-US202-1048US2021048ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1049US2021049ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1050US2021050ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1051US2021051ASCREEN Screening ASCREENING 2020-05-27 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1052US2021052ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1053US2021053ASCREEN Screening ASCREENING 2020-05-27 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1054US2021054ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1055US2021055ASCREEN Screening ASCREENING 2020-05-28 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1056US2021056ASCREEN Screening ASCREENING 2020-05-27 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1057US2021057ASCREEN Screening ASCREENING 2020-05-27 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1058US2021058ASCREEN Screening ASCREENING 2020-05-27 2020-06-05T09:48ÁAmRNA-1273-P201SEmRNA-1273-P201-US202-1058US2021058A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-05T09:482020-07-07T09:22AB!mRNA-1273-P201SEmRNA-1273-P201-US202-1058US2021058A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T09:222020-08-03 B!B<mRNA-1273-P201SEmRNA-1273-P201-US202-1058US2021058A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-24 B<CmRNA-1273-P201SEmRNA-1273-P201-US202-1059US2021059ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T09:06Á`AmRNA-1273-P201SEmRNA-1273-P201-US202-1059US2021059A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T09:062020-07-02T09:13ABmRNA-1273-P201SEmRNA-1273-P201-US202-1059US2021059A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-02T09:132020-07-31 BB<mRNA-1273-P201SEmRNA-1273-P201-US202-1059US2021059A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-03-15 B<CðmRNA-1273-P201SEmRNA-1273-P201-US202-1060US2021060ASCREEN Screening ASCREENING 2020-05-27 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1061US2021061ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T10:48Á`AmRNA-1273-P201SEmRNA-1273-P201-US202-1061US2021061A PBO Placebo A BLINDED TREATMENT 2020-06-02T10:482020-06-30T10:09ABmRNA-1273-P201SEmRNA-1273-P201-US202-1061US2021061A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T10:092020-07-27 BB8mRNA-1273-P201SEmRNA-1273-P201-US202-1061US2021061A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-01-28 B8BñmRNA-1273-P201SEmRNA-1273-P201-US202-1062US2021062ASCREEN Screening ASCREENING 2020-05-27 2020-06-04T11:13Á€AmRNA-1273-P201SEmRNA-1273-P201-US202-1062US2021062A PBO Placebo A BLINDED TREATMENT 2020-06-04T11:132020-07-02T12:04ABmRNA-1273-P201SEmRNA-1273-P201-US202-1062US2021062A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T12:042020-07-27 BB6mRNA-1273-P201SEmRNA-1273-P201-US202-1062US2021062A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-19 B6CPmRNA-1273-P201SEmRNA-1273-P201-US202-1063US2021063ASCREEN Screening ASCREENING 2020-05-27 2020-06-04T09:10Á€AmRNA-1273-P201SEmRNA-1273-P201-US202-1063US2021063A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-04T09:102020-07-07T08:56AB"mRNA-1273-P201SEmRNA-1273-P201-US202-1063US2021063A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T08:562020-08-05 B"B?mRNA-1273-P201SEmRNA-1273-P201-US202-1063US2021063A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-03-04 B?C mRNA-1273-P201SEmRNA-1273-P201-US202-1064US2021064ASCREEN Screening ASCREENING 2020-05-27 2020-06-08T08:48ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US202-1064US2021064A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T08:482020-07-09T12:38AB mRNA-1273-P201SEmRNA-1273-P201-US202-1064US2021064A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-09T12:382020-08-03 B B9mRNA-1273-P201SEmRNA-1273-P201-US202-1064US2021064A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-03-19 B9CÐmRNA-1273-P201SEmRNA-1273-P201-US202-1065US2021065ASCREEN Screening ASCREENING 2020-05-27 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1066US2021066ASCREEN Screening ASCREENING 2020-05-27 2020-06-04 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1067US2021067ASCREEN Screening ASCREENING 2020-05-27 2020-06-05T12:38ÁAmRNA-1273-P201SEmRNA-1273-P201-US202-1067US2021067A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-05T12:382020-07-06T11:22AB mRNA-1273-P201SEmRNA-1273-P201-US202-1067US2021067A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-06T11:222020-08-06 B B?mRNA-1273-P201SEmRNA-1273-P201-US202-1067US2021067A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-01-29 B?BïmRNA-1273-P201SEmRNA-1273-P201-US202-1068US2021068ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T16:41Á`AmRNA-1273-P201SEmRNA-1273-P201-US202-1068US2021068A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T16:412020-07-01T16:37ABmRNA-1273-P201SEmRNA-1273-P201-US202-1068US2021068A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T16:372020-07-29 BB:mRNA-1273-P201SEmRNA-1273-P201-US202-1068US2021068A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-02-23 B:C°mRNA-1273-P201SEmRNA-1273-P201-US202-1069US2021069ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1071US2021071ASCREEN Screening ASCREENING 2020-05-28 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1072US2021072ASCREEN Screening ASCREENING 2020-05-28 2020-06-04 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1073US2021073ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T12:11ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1073US2021073A PBO Placebo A BLINDED TREATMENT 2020-06-02T12:112020-06-30T09:24ABmRNA-1273-P201SEmRNA-1273-P201-US202-1073US2021073A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T09:242020-07-31 BB<mRNA-1273-P201SEmRNA-1273-P201-US202-1073US2021073A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-02-01 B<BõmRNA-1273-P201SEmRNA-1273-P201-US202-1074US2021074ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T09:14ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1074US2021074A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T09:142020-07-07T14:25AB$mRNA-1273-P201SEmRNA-1273-P201-US202-1074US2021074A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T14:252020-08-04 B$B@mRNA-1273-P201SEmRNA-1273-P201-US202-1074US2021074A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-03-15 B@CðmRNA-1273-P201SEmRNA-1273-P201-US202-1075US2021075ASCREEN Screening ASCREENING 2020-05-28 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1077US2021077ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1078US2021078ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T10:22Á`AmRNA-1273-P201SEmRNA-1273-P201-US202-1078US2021078A PBO Placebo A BLINDED TREATMENT 2020-06-03T10:222020-07-01T08:56ABmRNA-1273-P201SEmRNA-1273-P201-US202-1078US2021078A0PBO Placebo A0BLINDED TREATMENT 2020-07-01T08:562020-07-30 BB:mRNA-1273-P201SEmRNA-1273-P201-US202-1078US2021078A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-01-29 B:BñmRNA-1273-P201SEmRNA-1273-P201-US202-1079US2021079ASCREEN Screening ASCREENING 2020-05-28 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1080US2021080ASCREEN Screening ASCREENING 2020-05-28 2020-06-05T15:06Á€AmRNA-1273-P201SEmRNA-1273-P201-US202-1080US2021080A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-05T15:062020-07-08T09:28AB"mRNA-1273-P201SEmRNA-1273-P201-US202-1080US2021080A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-08T09:282020-08-07 B"B@mRNA-1273-P201SEmRNA-1273-P201-US202-1080US2021080A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-07 2021-03-09 B@C`mRNA-1273-P201SEmRNA-1273-P201-US202-1081US2021081ASCREEN Screening ASCREENING 2020-05-28 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1082US2021082ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T11:03Á`AmRNA-1273-P201SEmRNA-1273-P201-US202-1082US2021082A PBO Placebo A BLINDED TREATMENT 2020-06-03T11:032020-07-07T11:02AB#mRNA-1273-P201SEmRNA-1273-P201-US202-1082US2021082A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T11:022020-08-07 B#BBmRNA-1273-P201SEmRNA-1273-P201-US202-1082US2021082A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-07 2021-01-15 BBBãmRNA-1273-P201SEmRNA-1273-P201-US202-1083US2021083ASCREEN Screening ASCREENING 2020-05-28 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1084US2021084ASCREEN Screening ASCREENING 2020-05-28 2020-06-05T16:20Á€AmRNA-1273-P201SEmRNA-1273-P201-US202-1084US2021084A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-05T16:202020-07-07T10:31AB!mRNA-1273-P201SEmRNA-1273-P201-US202-1084US2021084A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T10:312020-08-03 B!B<mRNA-1273-P201SEmRNA-1273-P201-US202-1084US2021084A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-18 B<C0mRNA-1273-P201SEmRNA-1273-P201-US202-1085US2021085ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1086US2021086ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1087US2021087ASCREEN Screening ASCREENING 2020-05-28 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1088US2021088ASCREEN Screening ASCREENING 2020-05-28 2020-06-16 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1089US2021089ASCREEN Screening ASCREENING 2020-05-28 2020-06-08T14:40Á°AmRNA-1273-P201SEmRNA-1273-P201-US202-1089US2021089A PBO Placebo A BLINDED TREATMENT 2020-06-08T14:402020-07-08T13:44ABmRNA-1273-P201SEmRNA-1273-P201-US202-1089US2021089A0PBO Placebo A0BLINDED TREATMENT 2020-07-08T13:442020-08-04 BB:mRNA-1273-P201SEmRNA-1273-P201-US202-1089US2021089A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-01-29 B:BìmRNA-1273-P201SEmRNA-1273-P201-US202-1090US2021090ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T10:04ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1090US2021090A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T10:042020-07-06T09:21AB#mRNA-1273-P201SEmRNA-1273-P201-US202-1090US2021090A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-06T09:212020-07-31 B#B<mRNA-1273-P201SEmRNA-1273-P201-US202-1090US2021090A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-02-02 B<BömRNA-1273-P201SEmRNA-1273-P201-US202-1091US2021091ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1092US2021092ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1093US2021093ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T10:07Á`AmRNA-1273-P201SEmRNA-1273-P201-US202-1093US2021093A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T10:072020-07-06T09:52AB"mRNA-1273-P201SEmRNA-1273-P201-US202-1093US2021093A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-06T09:522020-08-06 B"BAmRNA-1273-P201SEmRNA-1273-P201-US202-1093US2021093A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-03-02 BACmRNA-1273-P201SEmRNA-1273-P201-US202-1094US2021094ASCREEN Screening ASCREENING 2020-05-28 2020-06-05T15:26Á€AmRNA-1273-P201SEmRNA-1273-P201-US202-1094US2021094A PBO Placebo A BLINDED TREATMENT 2020-06-05T15:262020-07-13 AB'mRNA-1273-P201SEmRNA-1273-P201-US202-1094US2021094A0FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-14 2021-03-10 B(CpmRNA-1273-P201SEmRNA-1273-P201-US202-1095US2021095ASCREEN Screening ASCREENING 2020-05-28 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1096US2021096ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T14:16Á`AmRNA-1273-P201SEmRNA-1273-P201-US202-1096US2021096A PBO Placebo A BLINDED TREATMENT 2020-06-03T14:162020-07-02T13:53ABmRNA-1273-P201SEmRNA-1273-P201-US202-1096US2021096A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T13:532020-07-27 BB7mRNA-1273-P201SEmRNA-1273-P201-US202-1096US2021096A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-03-08 B7CpmRNA-1273-P201SEmRNA-1273-P201-US202-1097US2021097ASCREEN Screening ASCREENING 2020-05-28 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1098US2021098ASCREEN Screening ASCREENING 2020-05-28 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1099US2021099ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T16:52ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1099US2021099A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T16:522020-06-30T14:17ABmRNA-1273-P201SEmRNA-1273-P201-US202-1099US2021099A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-30T14:172020-07-27 BB8mRNA-1273-P201SEmRNA-1273-P201-US202-1099US2021099A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-23 B8C°mRNA-1273-P201SEmRNA-1273-P201-US202-1100US2021100ASCREEN Screening ASCREENING 2020-05-28 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1101US2021101ASCREEN Screening ASCREENING 2020-05-28 2020-06-08T12:33Á°AmRNA-1273-P201SEmRNA-1273-P201-US202-1101US2021101A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T12:332020-07-09T11:18AB mRNA-1273-P201SEmRNA-1273-P201-US202-1101US2021101A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-09T11:182020-08-04 B B:mRNA-1273-P201SEmRNA-1273-P201-US202-1101US2021101A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-03-02 B:CÀmRNA-1273-P201SEmRNA-1273-P201-US202-1102US2021102ASCREEN Screening ASCREENING 2020-05-28 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1103US2021103ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1105US2021105ASCREEN Screening ASCREENING 2020-05-28 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1107US2021107ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T09:03Á`AmRNA-1273-P201SEmRNA-1273-P201-US202-1107US2021107A PBO Placebo A BLINDED TREATMENT 2020-06-03T09:032020-07-02T09:24ABmRNA-1273-P201SEmRNA-1273-P201-US202-1107US2021107A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T09:242020-07-27 BB7mRNA-1273-P201SEmRNA-1273-P201-US202-1107US2021107A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-01-29 B7BñmRNA-1273-P201SEmRNA-1273-P201-US202-1108US2021108ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1109US2021109ASCREEN Screening ASCREENING 2020-05-29 2020-06-16 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1110US2021110ASCREEN Screening ASCREENING 2020-05-29 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1111US2021111ASCREEN Screening ASCREENING 2020-05-29 2020-06-08T09:23Á AmRNA-1273-P201SEmRNA-1273-P201-US202-1111US2021111A PBO Placebo A BLINDED TREATMENT 2020-06-08T09:232020-07-21T10:48AB,mRNA-1273-P201SEmRNA-1273-P201-US202-1111US2021111A0PBO Placebo A0BLINDED TREATMENT 2020-07-21T10:482020-08-17 B,BGmRNA-1273-P201SEmRNA-1273-P201-US202-1111US2021111A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-17 2021-02-19 BGCmRNA-1273-P201SEmRNA-1273-P201-US202-1112US2021112ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1113US2021113ASCREEN Screening ASCREENING 2020-05-29 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1114US2021114ASCREEN Screening ASCREENING 2020-05-29 2020-06-26T09:31ÂAmRNA-1273-P201SEmRNA-1273-P201-US202-1114US2021114A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T09:312020-07-29T10:15AB"mRNA-1273-P201SEmRNA-1273-P201-US202-1114US2021114A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T10:152020-08-25 B"B=mRNA-1273-P201SEmRNA-1273-P201-US202-1114US2021114A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-01-28 B=BÙmRNA-1273-P201SEmRNA-1273-P201-US202-1115US2021115ASCREEN Screening ASCREENING 2020-05-29 2020-06-26T10:24ÂAmRNA-1273-P201SEmRNA-1273-P201-US202-1115US2021115A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T10:242020-07-31T11:50AB$mRNA-1273-P201SEmRNA-1273-P201-US202-1115US2021115A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-31T11:502020-08-28 B$B@mRNA-1273-P201SEmRNA-1273-P201-US202-1115US2021115A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-03-11 B@C0mRNA-1273-P201SEmRNA-1273-P201-US202-1116US2021116ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1117US2021117ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1118US2021118ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1119US2021119ASCREEN Screening ASCREENING 2020-05-29 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1120US2021120ASCREEN Screening ASCREENING 2020-05-29 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1121US2021121ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T15:21ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1121US2021121A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T15:212020-07-01T10:57ABmRNA-1273-P201SEmRNA-1273-P201-US202-1121US2021121A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T10:572020-08-05 BB@mRNA-1273-P201SEmRNA-1273-P201-US202-1121US2021121A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-03-19 B@C mRNA-1273-P201SEmRNA-1273-P201-US202-1122US2021122ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1123US2021123ASCREEN Screening ASCREENING 2020-05-29 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1124US2021124ASCREEN Screening ASCREENING 2020-05-29 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1125US2021125ASCREEN Screening ASCREENING 2020-06-01 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1126US2021126ASCREEN Screening ASCREENING 2020-06-01 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1127US2021127ASCREEN Screening ASCREENING 2020-06-01 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1128US2021128ASCREEN Screening ASCREENING 2020-06-01 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1129US2021129ASCREEN Screening ASCREENING 2020-06-01 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1130US2021130ASCREEN Screening ASCREENING 2020-06-01 2020-06-26T10:15ÂAmRNA-1273-P201SEmRNA-1273-P201-US202-1130US2021130A PBO Placebo A BLINDED TREATMENT 2020-06-26T10:152020-07-29T11:35AB"mRNA-1273-P201SEmRNA-1273-P201-US202-1130US2021130A0PBO Placebo A0BLINDED TREATMENT 2020-07-29T11:352020-08-27 B"B?mRNA-1273-P201SEmRNA-1273-P201-US202-1130US2021130A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-02-19 B?BïmRNA-1273-P201SEmRNA-1273-P201-US202-1131US2021131ASCREEN Screening ASCREENING 2020-06-01 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1132US2021132ASCREEN Screening ASCREENING 2020-06-01 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1133US2021133ASCREEN Screening ASCREENING 2020-06-01 2020-06-26T12:23ÂAmRNA-1273-P201SEmRNA-1273-P201-US202-1133US2021133A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T12:232020-07-29T12:43AB"mRNA-1273-P201SEmRNA-1273-P201-US202-1133US2021133A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-29T12:432020-08-27 B"B?mRNA-1273-P201SEmRNA-1273-P201-US202-1133US2021133A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-01-29 B?BÚmRNA-1273-P201SEmRNA-1273-P201-US202-1134US2021134ASCREEN Screening ASCREENING 2020-06-01 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1135US2021135ASCREEN Screening ASCREENING 2020-06-01 2020-06-05T10:14Á@AmRNA-1273-P201SEmRNA-1273-P201-US202-1135US2021135A PBO Placebo A BLINDED TREATMENT 2020-06-05T10:142020-07-07T10:48AB!mRNA-1273-P201SEmRNA-1273-P201-US202-1135US2021135A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T10:482020-08-03 B!B<mRNA-1273-P201SEmRNA-1273-P201-US202-1135US2021135A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-03-04 B<CmRNA-1273-P201SEmRNA-1273-P201-US202-1136US2021136ASCREEN Screening ASCREENING 2020-06-01 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1137US2021137ASCREEN Screening ASCREENING 2020-06-01 2020-06-08T16:13ÁpAmRNA-1273-P201SEmRNA-1273-P201-US202-1137US2021137A PBO Placebo A BLINDED TREATMENT 2020-06-08T16:132020-07-07T16:21ABmRNA-1273-P201SEmRNA-1273-P201-US202-1137US2021137A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T16:212020-08-18 BBHmRNA-1273-P201SEmRNA-1273-P201-US202-1137US2021137A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-18 2021-03-19 BHCÐmRNA-1273-P201SEmRNA-1273-P201-US202-1138US2021138ASCREEN Screening ASCREENING 2020-06-01 2020-06-04T13:57Á0AmRNA-1273-P201SEmRNA-1273-P201-US202-1138US2021138A PBO Placebo A BLINDED TREATMENT 2020-06-04T13:572020-07-06T09:32AB!mRNA-1273-P201SEmRNA-1273-P201-US202-1138US2021138A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T09:322020-08-10 B!BDmRNA-1273-P201SEmRNA-1273-P201-US202-1138US2021138A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-22 BDC€mRNA-1273-P201SEmRNA-1273-P201-US202-1139US2021139ASCREEN Screening ASCREENING 2020-06-01 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1140US2021140ASCREEN Screening ASCREENING 2020-06-02 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1141US2021141ASCREEN Screening ASCREENING 2020-06-02 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1142US2021142ASCREEN Screening ASCREENING 2020-06-02 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1143US2021143ASCREEN Screening ASCREENING 2020-06-02 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1144US2021144ASCREEN Screening ASCREENING 2020-06-02 2020-06-05T11:22Á0AmRNA-1273-P201SEmRNA-1273-P201-US202-1144US2021144A PBO Placebo A BLINDED TREATMENT 2020-06-05T11:222020-07-06T10:42AB mRNA-1273-P201SEmRNA-1273-P201-US202-1144US2021144A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T10:422020-08-10 B BCmRNA-1273-P201SEmRNA-1273-P201-US202-1144US2021144A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-03-19 BCCmRNA-1273-P201SEmRNA-1273-P201-US202-1145US2021145ASCREEN Screening ASCREENING 2020-06-02 2020-06-04T16:42Á AmRNA-1273-P201SEmRNA-1273-P201-US202-1145US2021145A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-04T16:422020-07-09T12:48AB$mRNA-1273-P201SEmRNA-1273-P201-US202-1145US2021145A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-09T12:482020-08-12 B$BFmRNA-1273-P201SEmRNA-1273-P201-US202-1145US2021145A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-12 2021-03-08 BFC`mRNA-1273-P201SEmRNA-1273-P201-US202-1146US2021146ASCREEN Screening ASCREENING 2020-06-02 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1147US2021147ASCREEN Screening ASCREENING 2020-06-02 2020-06-05T14:43Á0AmRNA-1273-P201SEmRNA-1273-P201-US202-1147US2021147A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-05T14:432020-07-07T17:14AB!mRNA-1273-P201SEmRNA-1273-P201-US202-1147US2021147A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T17:142020-08-03 B!B<mRNA-1273-P201SEmRNA-1273-P201-US202-1147US2021147A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-18 B<C0mRNA-1273-P201SEmRNA-1273-P201-US202-1148US2021148ASCREEN Screening ASCREENING 2020-06-02 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1149US2021149ASCREEN Screening ASCREENING 2020-06-03 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1150US2021150ASCREEN Screening ASCREENING 2020-06-03 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1151US2021151ASCREEN Screening ASCREENING 2020-06-03 2020-06-08T16:40ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1151US2021151A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T16:402020-07-09T14:47AB mRNA-1273-P201SEmRNA-1273-P201-US202-1151US2021151A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-09T14:472020-08-03 B B9mRNA-1273-P201SEmRNA-1273-P201-US202-1151US2021151A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-18 B9CmRNA-1273-P201SEmRNA-1273-P201-US202-1152US2021152ASCREEN Screening ASCREENING 2020-06-03 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1153US2021153ASCREEN Screening ASCREENING 2020-06-03 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1154US2021154ASCREEN Screening ASCREENING 2020-06-03 2020-06-05T14:21Á AmRNA-1273-P201SEmRNA-1273-P201-US202-1154US2021154A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-05T14:212020-07-08T14:50AB"mRNA-1273-P201SEmRNA-1273-P201-US202-1154US2021154A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-08T14:502020-08-10 B"BCmRNA-1273-P201SEmRNA-1273-P201-US202-1154US2021154A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-18 BCC0mRNA-1273-P201SEmRNA-1273-P201-US202-1155US2021155ASCREEN Screening ASCREENING 2020-06-03 2020-06-08T17:34ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1155US2021155A PBO Placebo A BLINDED TREATMENT 2020-06-08T17:342020-07-13T15:40AB$mRNA-1273-P201SEmRNA-1273-P201-US202-1155US2021155A0PBO Placebo A0BLINDED TREATMENT 2020-07-13T15:402020-08-12 B$BBmRNA-1273-P201SEmRNA-1273-P201-US202-1155US2021155A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-12 2021-02-24 BBC`mRNA-1273-P201SEmRNA-1273-P201-US202-1156US2021156ASCREEN Screening ASCREENING 2020-06-03 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1157US2021157ASCREEN Screening ASCREENING 2020-06-03 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1158US2021158ASCREEN Screening ASCREENING 2020-06-03 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1159US2021159ASCREEN Screening ASCREENING 2020-06-03 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1160US2021160ASCREEN Screening ASCREENING 2020-06-03 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1161US2021161ASCREEN Screening ASCREENING 2020-06-03 2020-06-08T17:13ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1161US2021161A PBO Placebo A BLINDED TREATMENT 2020-06-08T17:132020-07-07T10:14ABmRNA-1273-P201SEmRNA-1273-P201-US202-1161US2021161A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T10:142020-08-04 BB:mRNA-1273-P201SEmRNA-1273-P201-US202-1161US2021161A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-23 B:CPmRNA-1273-P201SEmRNA-1273-P201-US202-1162US2021162ASCREEN Screening ASCREENING 2020-06-03 2020-06-08T12:39ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1162US2021162A PBO Placebo A BLINDED TREATMENT 2020-06-08T12:392020-06-08 AAmRNA-1273-P201SEmRNA-1273-P201-US202-1162US2021162A0FUPA Part A Follow up A@PART A FOLLOW-UP 2020-06-09 2021-03-18 A CÀmRNA-1273-P201SEmRNA-1273-P201-US202-1163US2021163ASCREEN Screening ASCREENING 2020-06-03 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1164US2021164ASCREEN Screening ASCREENING 2020-06-03 2020-06-08T09:13ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1164US2021164A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T09:132020-07-08T10:54ABmRNA-1273-P201SEmRNA-1273-P201-US202-1164US2021164A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-08T10:542020-08-10 BB@mRNA-1273-P201SEmRNA-1273-P201-US202-1164US2021164A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-23 B@CPmRNA-1273-P201SEmRNA-1273-P201-US202-1165US2021165ASCREEN Screening ASCREENING 2020-06-03 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1166US2021166ASCREEN Screening ASCREENING 2020-06-03 2020-06-05T13:06Á AmRNA-1273-P201SEmRNA-1273-P201-US202-1166US2021166A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-05T13:062020-07-07T11:54AB!mRNA-1273-P201SEmRNA-1273-P201-US202-1166US2021166A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T11:542020-08-03 B!B<mRNA-1273-P201SEmRNA-1273-P201-US202-1166US2021166A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-04-02 B<CàmRNA-1273-P201SEmRNA-1273-P201-US202-1167US2021167ASCREEN Screening ASCREENING 2020-06-03 2020-06-08T11:57ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1167US2021167A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T11:572020-07-07T14:41ABmRNA-1273-P201SEmRNA-1273-P201-US202-1167US2021167A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T14:412020-08-04 BB:mRNA-1273-P201SEmRNA-1273-P201-US202-1167US2021167A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-19 B:CmRNA-1273-P201SEmRNA-1273-P201-US202-1168US2021168ASCREEN Screening ASCREENING 2020-06-03 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1169US2021169ASCREEN Screening ASCREENING 2020-06-03 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1170US2021170ASCREEN Screening ASCREENING 2020-06-03 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1171US2021171ASCREEN Screening ASCREENING 2020-06-03 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1172US2021172ASCREEN Screening ASCREENING 2020-06-03 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1173US2021173ASCREEN Screening ASCREENING 2020-06-04 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1174US2021174ASCREEN Screening ASCREENING 2020-06-04 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1175US2021175ASCREEN Screening ASCREENING 2020-06-04 2020-06-08T14:28Á@AmRNA-1273-P201SEmRNA-1273-P201-US202-1175US2021175A PBO Placebo A BLINDED TREATMENT 2020-06-08T14:282020-07-08T12:21ABmRNA-1273-P201SEmRNA-1273-P201-US202-1175US2021175A0PBO Placebo A0BLINDED TREATMENT 2020-07-08T12:212020-08-03 BB9mRNA-1273-P201SEmRNA-1273-P201-US202-1175US2021175A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-19 B9CmRNA-1273-P201SEmRNA-1273-P201-US202-1176US2021176ASCREEN Screening ASCREENING 2020-06-04 2020-06-04 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1177US2021177ASCREEN Screening ASCREENING 2020-06-05 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1178US2021178ASCREEN Screening ASCREENING 2020-06-05 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1179US2021179ASCREEN Screening ASCREENING 2020-06-05 2020-06-08T15:12Á0AmRNA-1273-P201SEmRNA-1273-P201-US202-1179US2021179A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T15:122020-07-07T15:07ABmRNA-1273-P201SEmRNA-1273-P201-US202-1179US2021179A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T15:072020-08-04 BB:mRNA-1273-P201SEmRNA-1273-P201-US202-1179US2021179A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-01-28 B:BëmRNA-1273-P201SEmRNA-1273-P201-US202-1180US2021180ASCREEN Screening ASCREENING 2020-06-05 2020-06-08T17:04Á0AmRNA-1273-P201SEmRNA-1273-P201-US202-1180US2021180A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T17:042020-07-08T09:58ABmRNA-1273-P201SEmRNA-1273-P201-US202-1180US2021180A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-08T09:582020-08-07 BB=mRNA-1273-P201SEmRNA-1273-P201-US202-1180US2021180A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-07 2021-02-19 B=CmRNA-1273-P201SEmRNA-1273-P201-US202-1181US2021181ASCREEN Screening ASCREENING 2020-06-05 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1182US2021182ASCREEN Screening ASCREENING 2020-06-05 2020-06-08T09:49Á0AmRNA-1273-P201SEmRNA-1273-P201-US202-1182US2021182A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T09:492020-07-07T09:54ABmRNA-1273-P201SEmRNA-1273-P201-US202-1182US2021182A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T09:542020-07-31 BB6mRNA-1273-P201SEmRNA-1273-P201-US202-1182US2021182A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-03-05 B6CðmRNA-1273-P201SEmRNA-1273-P201-US202-1183US2021183ASCREEN Screening ASCREENING 2020-06-05 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1184US2021184ASCREEN Screening ASCREENING 2020-06-10 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1185US2021185ASCREEN Screening ASCREENING 2020-06-10 2020-06-26T14:07ÂAmRNA-1273-P201SEmRNA-1273-P201-US202-1185US2021185A PBO Placebo A BLINDED TREATMENT 2020-06-26T14:072020-07-31T16:32AB$mRNA-1273-P201SEmRNA-1273-P201-US202-1185US2021185A0PBO Placebo A0BLINDED TREATMENT 2020-07-31T16:322020-08-25 B$B=mRNA-1273-P201SEmRNA-1273-P201-US202-1185US2021185A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-03-10 B=C mRNA-1273-P201SEmRNA-1273-P201-US202-1186US2021186ASCREEN Screening ASCREENING 2020-06-10 2020-06-26T11:14ÂAmRNA-1273-P201SEmRNA-1273-P201-US202-1186US2021186A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T11:142020-07-27T09:18AB mRNA-1273-P201SEmRNA-1273-P201-US202-1186US2021186A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-27T09:182020-08-25 B B=mRNA-1273-P201SEmRNA-1273-P201-US202-1186US2021186A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-02 B=BÞmRNA-1273-P201SEmRNA-1273-P201-US202-1187US2021187ASCREEN Screening ASCREENING 2020-06-11 2020-06-11 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1188US2021188ASCREEN Screening ASCREENING 2020-06-11 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1189US2021189ASCREEN Screening ASCREENING 2020-06-11 2020-06-26T10:59ÁðAmRNA-1273-P201SEmRNA-1273-P201-US202-1189US2021189A PBO Placebo A BLINDED TREATMENT 2020-06-26T10:592020-07-27T12:19AB mRNA-1273-P201SEmRNA-1273-P201-US202-1189US2021189A0PBO Placebo A0BLINDED TREATMENT 2020-07-27T12:192020-08-24 B B<mRNA-1273-P201SEmRNA-1273-P201-US202-1189US2021189A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-19 B<BïmRNA-1273-P201SEmRNA-1273-P201-US202-1190US2021190ASCREEN Screening ASCREENING 2020-06-11 2020-06-26T14:32ÁðAmRNA-1273-P201SEmRNA-1273-P201-US202-1190US2021190A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T14:322020-07-29T15:00AB"mRNA-1273-P201SEmRNA-1273-P201-US202-1190US2021190A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-29T15:002020-08-25 B"B=mRNA-1273-P201SEmRNA-1273-P201-US202-1190US2021190A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-03-19 B=C°mRNA-1273-P201SEmRNA-1273-P201-US202-1191US2021191ASCREEN Screening ASCREENING 2020-06-11 2020-06-11 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1192US2021192ASCREEN Screening ASCREENING 2020-06-12 2020-06-26T09:13ÁàAmRNA-1273-P201SEmRNA-1273-P201-US202-1192US2021192A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T09:132020-07-27T10:22AB mRNA-1273-P201SEmRNA-1273-P201-US202-1192US2021192A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-27T10:222020-08-21 B B9mRNA-1273-P201SEmRNA-1273-P201-US202-1192US2021192A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-03-15 B9CpmRNA-1273-P201SEmRNA-1273-P201-US202-1193US2021193ASCREEN Screening ASCREENING 2020-06-12 2020-06-19 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1194US2021194ASCREEN Screening ASCREENING 2020-06-12 2020-06-19 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1195US2021195ASCREEN Screening ASCREENING 2020-06-12 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1196US2021196ASCREEN Screening ASCREENING 2020-06-12 2020-07-02T11:37ÂAmRNA-1273-P201SEmRNA-1273-P201-US202-1196US2021196A PBO Placebo A BLINDED TREATMENT 2020-07-02T11:372020-08-03T14:14AB!mRNA-1273-P201SEmRNA-1273-P201-US202-1196US2021196A0PBO Placebo A0BLINDED TREATMENT 2020-08-03T14:142020-08-31 B!B=mRNA-1273-P201SEmRNA-1273-P201-US202-1196US2021196A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-01-21 B=BÌmRNA-1273-P201SEmRNA-1273-P201-US202-1197US2021197ASCREEN Screening ASCREENING 2020-06-12 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1198US2021198ASCREEN Screening ASCREENING 2020-06-15 2020-06-29T10:56ÁàAmRNA-1273-P201SEmRNA-1273-P201-US202-1198US2021198A PBO Placebo A BLINDED TREATMENT 2020-06-29T10:562020-08-04T10:33AB%mRNA-1273-P201SEmRNA-1273-P201-US202-1198US2021198A0PBO Placebo A0BLINDED TREATMENT 2020-08-04T10:332020-09-01 B%BAmRNA-1273-P201SEmRNA-1273-P201-US202-1198US2021198A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-01 2021-02-08 BABámRNA-1273-P201SEmRNA-1273-P201-US202-1199US2021199ASCREEN Screening ASCREENING 2020-06-15 2020-06-15 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1201US2021201ASCREEN Screening ASCREENING 2020-06-15 2020-07-07 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1202US2021006ASCREEN Screening ASCREENING 2020-05-26 2020-06-16 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1202US2021202A SCREEN Screening ASCREENING 2020-06-16 2020-06-26 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1203US2021203ASCREEN Screening ASCREENING 2020-06-16 2020-07-07 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1204US2021204ASCREEN Screening ASCREENING 2020-06-16 2020-06-16 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1205US2021035ASCREEN Screening ASCREENING 2020-05-27 2020-06-17 ÂÁmRNA-1273-P201SEmRNA-1273-P201-US202-1205US2021205A SCREEN Screening ASCREENING 2020-06-17 2020-06-26T15:09ÁAmRNA-1273-P201SEmRNA-1273-P201-US202-1205US2021205A0V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T15:092020-07-31T09:34AB$mRNA-1273-P201SEmRNA-1273-P201-US202-1205US2021205A@V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-31T09:342020-08-25 B$B=mRNA-1273-P201SEmRNA-1273-P201-US202-1205US2021205APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-03-03 B=BûmRNA-1273-P201SEmRNA-1273-P201-US202-1206US2021029ASCREEN Screening ASCREENING 2020-05-26 2020-06-17 Â%ÁðmRNA-1273-P201SEmRNA-1273-P201-US202-1206US2021206A SCREEN Screening ASCREENING 2020-06-17 2020-07-02T12:16ÁðAmRNA-1273-P201SEmRNA-1273-P201-US202-1206US2021206A0PBO Placebo A BLINDED TREATMENT 2020-07-02T12:162020-08-04T10:47AB"mRNA-1273-P201SEmRNA-1273-P201-US202-1206US2021206A@PBO Placebo A0BLINDED TREATMENT 2020-08-04T10:472020-09-08 B"BEmRNA-1273-P201SEmRNA-1273-P201-US202-1206US2021206APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-08 2021-02-22 BEBìmRNA-1273-P201SEmRNA-1273-P201-US202-1207US2021104ASCREEN Screening ASCREENING 2020-05-28 2020-06-17 ÂÁmRNA-1273-P201SEmRNA-1273-P201-US202-1207US2021207A SCREEN Screening ASCREENING 2020-06-17 2020-06-26T16:00ÁAmRNA-1273-P201SEmRNA-1273-P201-US202-1207US2021207A0PBO Placebo A BLINDED TREATMENT 2020-06-26T16:002020-08-06T11:18AB*mRNA-1273-P201SEmRNA-1273-P201-US202-1207US2021207A@PBO Placebo A0BLINDED TREATMENT 2020-08-06T11:182020-09-03 B*BFmRNA-1273-P201SEmRNA-1273-P201-US202-1207US2021207APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-03 2021-01-28 BFBÙmRNA-1273-P201SEmRNA-1273-P201-US202-1208US2021044ASCREEN Screening ASCREENING 2020-05-27 2020-06-17 Â#ÁàmRNA-1273-P201SEmRNA-1273-P201-US202-1208US2021208A SCREEN Screening ASCREENING 2020-06-17 2020-07-01T15:52ÁàAmRNA-1273-P201SEmRNA-1273-P201-US202-1208US2021208A0V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-01T15:522020-07-29T16:20ABmRNA-1273-P201SEmRNA-1273-P201-US202-1208US2021208A@V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T16:202020-09-08 BBFmRNA-1273-P201SEmRNA-1273-P201-US202-1208US2021208APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-08 2021-01-28 BFBÔmRNA-1273-P201SEmRNA-1273-P201-US202-1209US2021046ASCREEN Screening ASCREENING 2020-05-27 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1209US2021209A SCREEN Screening ASCREENING 2020-06-18 2020-06-30 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1210US2021042ASCREEN Screening ASCREENING 2020-05-27 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1210US2021210A SCREEN Screening ASCREENING 2020-06-18 2020-06-29 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1211US2021010ASCREEN Screening ASCREENING 2020-05-26 2020-06-18 Â%ÁàmRNA-1273-P201SEmRNA-1273-P201-US202-1211US2021211A SCREEN Screening ASCREENING 2020-06-18 2020-07-02T15:28ÁàAmRNA-1273-P201SEmRNA-1273-P201-US202-1211US2021211A0V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-02T15:282020-07-31T10:25ABmRNA-1273-P201SEmRNA-1273-P201-US202-1211US2021211A@V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-31T10:252020-08-25 BB7mRNA-1273-P201SEmRNA-1273-P201-US202-1211US2021211APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-01-28 B7BÓmRNA-1273-P201SEmRNA-1273-P201-US202-1212US2021212ASCREEN Screening ASCREENING 2020-06-18 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1213US2021076ASCREEN Screening ASCREENING 2020-05-28 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1213US2021213A SCREEN Screening ASCREENING 2020-06-18 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1214US2021040ASCREEN Screening ASCREENING 2020-05-27 2020-06-18 ÂÁ€mRNA-1273-P201SEmRNA-1273-P201-US202-1214US2021214A SCREEN Screening ASCREENING 2020-06-18 2020-06-26T15:27Á€AmRNA-1273-P201SEmRNA-1273-P201-US202-1214US2021214A0V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T15:272020-07-24T15:43ABmRNA-1273-P201SEmRNA-1273-P201-US202-1214US2021214A@V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-24T15:432020-08-20 BB8mRNA-1273-P201SEmRNA-1273-P201-US202-1214US2021214APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-20 2021-03-11 B8C0mRNA-1273-P201SEmRNA-1273-P201-US202-1215US2021070ASCREEN Screening ASCREENING 2020-05-27 2020-06-18 Â!Á°mRNA-1273-P201SEmRNA-1273-P201-US202-1215US2021215A SCREEN Screening ASCREENING 2020-06-18 2020-06-29T12:40Á°AmRNA-1273-P201SEmRNA-1273-P201-US202-1215US2021215A0V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-29T12:402020-08-03T15:53AB$mRNA-1273-P201SEmRNA-1273-P201-US202-1215US2021215A@V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-03T15:532020-09-08 B$BHmRNA-1273-P201SEmRNA-1273-P201-US202-1215US2021215APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-08 2021-01-28 BHBÖmRNA-1273-P201SEmRNA-1273-P201-US202-1216US2021039ASCREEN Screening ASCREENING 2020-05-27 2020-06-19 Â$ÁÐmRNA-1273-P201SEmRNA-1273-P201-US202-1216US2021216A SCREEN Screening ASCREENING 2020-06-19 2020-07-02T10:14ÁÐAmRNA-1273-P201SEmRNA-1273-P201-US202-1216US2021216A0V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-02T10:142020-08-03T14:09AB!mRNA-1273-P201SEmRNA-1273-P201-US202-1216US2021216A@V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-03T14:092020-08-28 B!B:mRNA-1273-P201SEmRNA-1273-P201-US202-1216US2021216APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-03-02 B:BômRNA-1273-P201SEmRNA-1273-P201-US202-1217US2021200ASCREEN Screening ASCREENING 2020-06-15 2020-06-19 ÁàÁ mRNA-1273-P201SEmRNA-1273-P201-US202-1217US2021217A SCREEN Screening ASCREENING 2020-06-19 2020-06-29T12:29Á AmRNA-1273-P201SEmRNA-1273-P201-US202-1217US2021217A0V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-29T12:292020-07-29T13:15ABmRNA-1273-P201SEmRNA-1273-P201-US202-1217US2021217A@V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-29T13:152020-08-26 BB;mRNA-1273-P201SEmRNA-1273-P201-US202-1217US2021217APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-03-22 B;C°mRNA-1273-P201SEmRNA-1273-P201-US202-1218US2021106ASCREEN Screening ASCREENING 2020-05-28 2020-06-23 Â!ÁpmRNA-1273-P201SEmRNA-1273-P201-US202-1218US2021218A SCREEN Screening ASCREENING 2020-06-23 2020-06-30T11:34ÁpAmRNA-1273-P201SEmRNA-1273-P201-US202-1218US2021218A0V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-30T11:342020-07-31T17:20AB mRNA-1273-P201SEmRNA-1273-P201-US202-1218US2021218A@V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-31T17:202020-08-25 B B9mRNA-1273-P201SEmRNA-1273-P201-US202-1218US2021218APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-24 B9BðmRNA-1273-P201SEmRNA-1273-P201-US202-1219US2021024ASCREEN Screening ASCREENING 2020-05-26 2020-06-23 Â#ÁpmRNA-1273-P201SEmRNA-1273-P201-US202-1219US2021219A SCREEN Screening ASCREENING 2020-06-23 2020-06-30T10:42ÁpAmRNA-1273-P201SEmRNA-1273-P201-US202-1219US2021219A0PBO Placebo A BLINDED TREATMENT 2020-06-30T10:422020-07-31T12:19AB mRNA-1273-P201SEmRNA-1273-P201-US202-1219US2021219A@PBO Placebo A0BLINDED TREATMENT 2020-07-31T12:192020-09-03 B BBmRNA-1273-P201SEmRNA-1273-P201-US202-1219US2021219APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-03 2021-02-19 BBBëmRNA-1273-P201SEmRNA-1273-P201-US202-1220US2021016ASCREEN Screening ASCREENING 2020-05-26 2020-06-24 Â"ÁPmRNA-1273-P201SEmRNA-1273-P201-US202-1220US2021220A SCREEN Screening ASCREENING 2020-06-24 2020-06-29T12:06ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1220US2021220A0V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-29T12:062020-07-29T14:15ABmRNA-1273-P201SEmRNA-1273-P201-US202-1220US2021220A@V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-29T14:152020-08-25 BB:mRNA-1273-P201SEmRNA-1273-P201-US202-1220US2021220APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-03-15 B:C@mRNA-1273-P201SEmRNA-1273-P201-US202-1221US2021221ASCREEN Screening ASCREENING 2020-06-29 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1222US2021023ASCREEN Screening ASCREENING 2020-05-26 2020-06-29 Â%Á0mRNA-1273-P201SEmRNA-1273-P201-US202-1222US2021222A SCREEN Screening ASCREENING 2020-06-29 2020-07-02T15:07Á0AmRNA-1273-P201SEmRNA-1273-P201-US202-1222US2021222A0PBO Placebo A BLINDED TREATMENT 2020-07-02T15:072020-07-31T12:30ABmRNA-1273-P201SEmRNA-1273-P201-US202-1222US2021222A@PBO Placebo A0BLINDED TREATMENT 2020-07-31T12:302020-08-25 BB7mRNA-1273-P201SEmRNA-1273-P201-US202-1222US2021222APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-08 B7BÞmRNA-1273-P201SEmRNA-1273-P201-US202-1223US2021223ASCREEN Screening ASCREENING 2020-06-29 2020-06-29 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1224US2021224ASCREEN Screening ASCREENING 2020-06-30 2020-06-30 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1225US2021225ASCREEN Screening ASCREENING 2020-06-30 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1226US2021226ASCREEN Screening ASCREENING 2020-06-30 2020-07-06T14:24Á`AmRNA-1273-P201SEmRNA-1273-P201-US202-1226US2021226A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-06T14:242020-08-04T10:19ABmRNA-1273-P201SEmRNA-1273-P201-US202-1226US2021226A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-04T10:192020-09-03 BB<mRNA-1273-P201SEmRNA-1273-P201-US202-1226US2021226A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-03 2021-02-25 B<BëmRNA-1273-P201SEmRNA-1273-P201-US202-1227US2021227ASCREEN Screening ASCREENING 2020-06-01 2020-07-01 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1228US2021228ASCREEN Screening ASCREENING 2020-07-01 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1229US2021229ASCREEN Screening ASCREENING 2020-07-01 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1230US2021230ASCREEN Screening ASCREENING 2020-07-01 2020-07-06T15:40ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1230US2021230A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-06T15:402020-08-03T11:55ABmRNA-1273-P201SEmRNA-1273-P201-US202-1230US2021230A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-03T11:552020-09-03 BB<mRNA-1273-P201SEmRNA-1273-P201-US202-1230US2021230A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-03 2021-02-17 B<BãmRNA-1273-P201SEmRNA-1273-P201-US202-1231US2021231ASCREEN Screening ASCREENING 2020-07-02 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1232US2021232ASCREEN Screening ASCREENING 2020-07-02 2020-07-06T14:53Á@AmRNA-1273-P201SEmRNA-1273-P201-US202-1232US2021232A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-06T14:532020-08-06T10:56AB mRNA-1273-P201SEmRNA-1273-P201-US202-1232US2021232A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-06T10:562020-09-10 B BCmRNA-1273-P201SEmRNA-1273-P201-US202-1232US2021232A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-10 2021-02-18 BCBämRNA-1273-P201SEmRNA-1273-P201-US202-1233US2021233ASCREEN Screening ASCREENING 2020-07-02 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1234US2021234ASCREEN Screening ASCREENING 2020-07-02 2020-07-07T12:53ÁPAmRNA-1273-P201SEmRNA-1273-P201-US202-1234US2021234A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-07T12:532020-08-04T11:23ABmRNA-1273-P201SEmRNA-1273-P201-US202-1234US2021234A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-04T11:232020-09-03 BB;mRNA-1273-P201SEmRNA-1273-P201-US202-1234US2021234A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-03 2021-02-19 B;BämRNA-1273-P201SEmRNA-1273-P201-US202-1235US2021235ASCREEN Screening ASCREENING 2020-07-06 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1236US2021236ASCREEN Screening ASCREENING 2020-07-06 2020-07-06 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1237US2021237ASCREEN Screening ASCREENING 2020-07-06 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1238US2021238ASCREEN Screening ASCREENING 2020-07-06 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1239US2021239ASCREEN Screening ASCREENING 2020-07-06 2020-07-06 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1240US2021240ASCREEN Screening ASCREENING 2020-07-07 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US202-1241US2021241ASCREEN Screening ASCREENING 2020-07-07 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1001US2031001ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T14:55Á0AmRNA-1273-P201SEmRNA-1273-P201-US203-1001US2031001A PBO Placebo A BLINDED TREATMENT 2020-05-29T14:552020-06-30T16:01AB!mRNA-1273-P201SEmRNA-1273-P201-US203-1001US2031001A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T16:012020-07-29 B!B>mRNA-1273-P201SEmRNA-1273-P201-US203-1001US2031001A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-02-02 B>BúmRNA-1273-P201SEmRNA-1273-P201-US203-1002US2031002ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T08:33Á0AmRNA-1273-P201SEmRNA-1273-P201-US203-1002US2031002A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-05-29T08:332020-06-29T08:16AB mRNA-1273-P201SEmRNA-1273-P201-US203-1002US2031002A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T08:162020-07-27 B B<mRNA-1273-P201SEmRNA-1273-P201-US203-1002US2031002A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-02 B<BúmRNA-1273-P201SEmRNA-1273-P201-US203-1003US2031003ASCREEN Screening ASCREENING 2020-05-26 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1004US2031004ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T14:24Á0AmRNA-1273-P201SEmRNA-1273-P201-US203-1004US2031004A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-05-29T14:242020-06-29T09:40AB mRNA-1273-P201SEmRNA-1273-P201-US203-1004US2031004A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T09:402020-08-03 B BCmRNA-1273-P201SEmRNA-1273-P201-US203-1004US2031004A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-09 BCCmRNA-1273-P201SEmRNA-1273-P201-US203-1005US2031005ASCREEN Screening ASCREENING 2020-05-26 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1006US2031006ASCREEN Screening ASCREENING 2020-05-26 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1007US2031007ASCREEN Screening ASCREENING 2020-05-26 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1008US2031008ASCREEN Screening ASCREENING 2020-05-26 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1009US2031009ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T09:58Á`AmRNA-1273-P201SEmRNA-1273-P201-US203-1009US2031009A PBO Placebo A BLINDED TREATMENT 2020-06-01T09:582020-07-01T12:12ABmRNA-1273-P201SEmRNA-1273-P201-US203-1009US2031009A0PBO Placebo A0BLINDED TREATMENT 2020-07-01T12:122020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1009US2031009A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-04 B9BùmRNA-1273-P201SEmRNA-1273-P201-US203-1010US2031010ASCREEN Screening ASCREENING 2020-05-26 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1011US2031011ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T15:53Á0AmRNA-1273-P201SEmRNA-1273-P201-US203-1011US2031011A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-05-29T15:532020-07-01T11:44AB"mRNA-1273-P201SEmRNA-1273-P201-US203-1011US2031011A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-01T11:442020-08-05 B"BEmRNA-1273-P201SEmRNA-1273-P201-US203-1011US2031011A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-16 BEC€mRNA-1273-P201SEmRNA-1273-P201-US203-1012US2031012ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T14:35Á`AmRNA-1273-P201SEmRNA-1273-P201-US203-1012US2031012A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T14:352020-06-29T10:07ABmRNA-1273-P201SEmRNA-1273-P201-US203-1012US2031012A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-29T10:072020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1012US2031012A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-09 B9BþmRNA-1273-P201SEmRNA-1273-P201-US203-1013US2031013ASCREEN Screening ASCREENING 2020-05-26 2020-06-02T09:14ÁpAmRNA-1273-P201SEmRNA-1273-P201-US203-1013US2031013A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T09:142020-06-30T08:52ABmRNA-1273-P201SEmRNA-1273-P201-US203-1013US2031013A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-30T08:522020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1013US2031013A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-04 B9BømRNA-1273-P201SEmRNA-1273-P201-US203-1014US2031014ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T13:17Á0AmRNA-1273-P201SEmRNA-1273-P201-US203-1014US2031014A PBO Placebo A BLINDED TREATMENT 2020-05-29T13:172020-06-29T13:50AB mRNA-1273-P201SEmRNA-1273-P201-US203-1014US2031014A0PBO Placebo A0BLINDED TREATMENT 2020-06-29T13:502020-07-27 B B<mRNA-1273-P201SEmRNA-1273-P201-US203-1014US2031014A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-04 B<BümRNA-1273-P201SEmRNA-1273-P201-US203-1015US2031015ASCREEN Screening ASCREENING 2020-05-26 2020-06-09 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1016US2031016ASCREEN Screening ASCREENING 2020-05-26 2020-06-04T12:41ÁAmRNA-1273-P201SEmRNA-1273-P201-US203-1016US2031016A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-04T12:412020-07-02T10:24ABmRNA-1273-P201SEmRNA-1273-P201-US203-1016US2031016A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-02T10:242020-07-27 BB6mRNA-1273-P201SEmRNA-1273-P201-US203-1016US2031016A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-03-19 B6CmRNA-1273-P201SEmRNA-1273-P201-US203-1017US2031017ASCREEN Screening ASCREENING 2020-05-26 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1018US2031018ASCREEN Screening ASCREENING 2020-05-26 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1019US2031019ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T08:59Á0AmRNA-1273-P201SEmRNA-1273-P201-US203-1019US2031019A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-05-29T08:592020-07-02T08:31AB#mRNA-1273-P201SEmRNA-1273-P201-US203-1019US2031019A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-02T08:312020-07-30 B#B?mRNA-1273-P201SEmRNA-1273-P201-US203-1019US2031019A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-04 B?BümRNA-1273-P201SEmRNA-1273-P201-US203-1020US2031020ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T12:40Á0AmRNA-1273-P201SEmRNA-1273-P201-US203-1020US2031020A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-05-29T12:402020-07-01T09:07AB"mRNA-1273-P201SEmRNA-1273-P201-US203-1020US2031020A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T09:072020-08-03 B"BCmRNA-1273-P201SEmRNA-1273-P201-US203-1020US2031020A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-02 BCBúmRNA-1273-P201SEmRNA-1273-P201-US203-1021US2031021ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T10:13Á`AmRNA-1273-P201SEmRNA-1273-P201-US203-1021US2031021A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T10:132020-06-29T10:02ABmRNA-1273-P201SEmRNA-1273-P201-US203-1021US2031021A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-29T10:022020-07-30 BB<mRNA-1273-P201SEmRNA-1273-P201-US203-1021US2031021A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-25 B<CàmRNA-1273-P201SEmRNA-1273-P201-US203-1022US2031022ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T12:25Á0AmRNA-1273-P201SEmRNA-1273-P201-US203-1022US2031022A PBO Placebo A BLINDED TREATMENT 2020-05-29T12:252020-06-29T14:06AB mRNA-1273-P201SEmRNA-1273-P201-US203-1022US2031022A0PBO Placebo A0BLINDED TREATMENT 2020-06-29T14:062020-07-27 B B<mRNA-1273-P201SEmRNA-1273-P201-US203-1022US2031022A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-11 B<C0mRNA-1273-P201SEmRNA-1273-P201-US203-1023US2031023ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T11:15Á0AmRNA-1273-P201SEmRNA-1273-P201-US203-1023US2031023A PBO Placebo A BLINDED TREATMENT 2020-05-29T11:152020-07-02T11:58AB#mRNA-1273-P201SEmRNA-1273-P201-US203-1023US2031023A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T11:582020-07-27 B#B<mRNA-1273-P201SEmRNA-1273-P201-US203-1023US2031023A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-02 B<BúmRNA-1273-P201SEmRNA-1273-P201-US203-1024US2031024ASCREEN Screening ASCREENING 2020-05-26 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1025US2031025ASCREEN Screening ASCREENING 2020-05-26 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1026US2031026ASCREEN Screening ASCREENING 2020-05-27 2020-05-29T15:44Á AmRNA-1273-P201SEmRNA-1273-P201-US203-1026US2031026A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-05-29T15:442020-06-26T13:58ABmRNA-1273-P201SEmRNA-1273-P201-US203-1026US2031026A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-26T13:582020-07-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1026US2031026A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-24 2021-02-09 B9CmRNA-1273-P201SEmRNA-1273-P201-US203-1027US2031027ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T08:32ÁPAmRNA-1273-P201SEmRNA-1273-P201-US203-1027US2031027A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T08:322020-06-29T15:02ABmRNA-1273-P201SEmRNA-1273-P201-US203-1027US2031027A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-29T15:022020-07-30 BB<mRNA-1273-P201SEmRNA-1273-P201-US203-1027US2031027A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-11 B<CmRNA-1273-P201SEmRNA-1273-P201-US203-1028US2031028ASCREEN Screening ASCREENING 2020-05-27 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1029US2031029ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T09:07Á`AmRNA-1273-P201SEmRNA-1273-P201-US203-1029US2031029A PBO Placebo A BLINDED TREATMENT 2020-06-02T09:072020-07-07T08:49AB$mRNA-1273-P201SEmRNA-1273-P201-US203-1029US2031029A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T08:492020-08-04 B$B@mRNA-1273-P201SEmRNA-1273-P201-US203-1029US2031029A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-02 B@BömRNA-1273-P201SEmRNA-1273-P201-US203-1030US2031030ASCREEN Screening ASCREENING 2020-05-27 2020-06-03T09:06ÁpAmRNA-1273-P201SEmRNA-1273-P201-US203-1030US2031030A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T09:062020-07-01T10:22ABmRNA-1273-P201SEmRNA-1273-P201-US203-1030US2031030A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-01T10:222020-08-03 BB>mRNA-1273-P201SEmRNA-1273-P201-US203-1030US2031030A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-11 B>BþmRNA-1273-P201SEmRNA-1273-P201-US203-1031US2031031ASCREEN Screening ASCREENING 2020-05-27 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1032US2031032ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1033US2031033ASCREEN Screening ASCREENING 2020-05-27 2020-06-03T09:35ÁpAmRNA-1273-P201SEmRNA-1273-P201-US203-1033US2031033A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T09:352020-07-01T10:12ABmRNA-1273-P201SEmRNA-1273-P201-US203-1033US2031033A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T10:122020-07-30 BB:mRNA-1273-P201SEmRNA-1273-P201-US203-1033US2031033A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-02 B:BõmRNA-1273-P201SEmRNA-1273-P201-US203-1034US2031034ASCREEN Screening ASCREENING 2020-05-27 2020-06-09 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1035US2031035ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T11:40ÁPAmRNA-1273-P201SEmRNA-1273-P201-US203-1035US2031035A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T11:402020-06-29T10:42ABmRNA-1273-P201SEmRNA-1273-P201-US203-1035US2031035A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-29T10:422020-07-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US203-1035US2031035A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-11 B:CmRNA-1273-P201SEmRNA-1273-P201-US203-1036US2031036ASCREEN Screening ASCREENING 2020-05-27 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1037US2031037ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T08:46Á`AmRNA-1273-P201SEmRNA-1273-P201-US203-1037US2031037A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T08:462020-06-30T08:21ABmRNA-1273-P201SEmRNA-1273-P201-US203-1037US2031037A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-30T08:212020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1037US2031037A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-04 B9BømRNA-1273-P201SEmRNA-1273-P201-US203-1038US2031038ASCREEN Screening ASCREENING 2020-05-27 2020-06-03T09:56ÁpAmRNA-1273-P201SEmRNA-1273-P201-US203-1038US2031038A PBO Placebo A BLINDED TREATMENT 2020-06-03T09:562020-07-02T13:00ABmRNA-1273-P201SEmRNA-1273-P201-US203-1038US2031038A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T13:002020-07-30 BB:mRNA-1273-P201SEmRNA-1273-P201-US203-1038US2031038A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-25 B:CÀmRNA-1273-P201SEmRNA-1273-P201-US203-1039US2031039ASCREEN Screening ASCREENING 2020-05-27 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1040US2031040ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T13:07ÁPAmRNA-1273-P201SEmRNA-1273-P201-US203-1040US2031040A PBO Placebo A BLINDED TREATMENT 2020-06-01T13:072020-06-30T08:32ABmRNA-1273-P201SEmRNA-1273-P201-US203-1040US2031040A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T08:322020-07-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US203-1040US2031040A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-22 B:C°mRNA-1273-P201SEmRNA-1273-P201-US203-1041US2031041ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T09:56Á`AmRNA-1273-P201SEmRNA-1273-P201-US203-1041US2031041A PBO Placebo A BLINDED TREATMENT 2020-06-02T09:562020-07-01T09:13ABmRNA-1273-P201SEmRNA-1273-P201-US203-1041US2031041A0PBO Placebo A0BLINDED TREATMENT 2020-07-01T09:132020-07-30 BB;mRNA-1273-P201SEmRNA-1273-P201-US203-1041US2031041A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-27 B;CðmRNA-1273-P201SEmRNA-1273-P201-US203-1042US2031042ASCREEN Screening ASCREENING 2020-05-27 2020-06-04T15:59Á€AmRNA-1273-P201SEmRNA-1273-P201-US203-1042US2031042A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-04T15:592020-07-06T14:34AB!mRNA-1273-P201SEmRNA-1273-P201-US203-1042US2031042A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-06T14:342020-08-03 B!B=mRNA-1273-P201SEmRNA-1273-P201-US203-1042US2031042A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-04 B=BömRNA-1273-P201SEmRNA-1273-P201-US203-1043US2031043ASCREEN Screening ASCREENING 2020-05-27 2020-06-04T17:42Á€AmRNA-1273-P201SEmRNA-1273-P201-US203-1043US2031043A PBO Placebo A BLINDED TREATMENT 2020-06-04T17:422020-07-02T14:58ABmRNA-1273-P201SEmRNA-1273-P201-US203-1043US2031043A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T14:582020-07-30 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1043US2031043A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-09 B9BûmRNA-1273-P201SEmRNA-1273-P201-US203-1044US2031044ASCREEN Screening ASCREENING 2020-05-27 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1045US2031045ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T10:12Á`AmRNA-1273-P201SEmRNA-1273-P201-US203-1045US2031045A PBO Placebo A BLINDED TREATMENT 2020-06-02T10:122020-07-13 AB*mRNA-1273-P201SEmRNA-1273-P201-US203-1046US2031046ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1047US2031047ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T13:54ÁPAmRNA-1273-P201SEmRNA-1273-P201-US203-1047US2031047A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T13:542020-06-29T16:48ABmRNA-1273-P201SEmRNA-1273-P201-US203-1047US2031047A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-29T16:482020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1047US2031047A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-04 B9BùmRNA-1273-P201SEmRNA-1273-P201-US203-1048US2031048ASCREEN Screening ASCREENING 2020-05-28 2020-06-01T17:03Á@AmRNA-1273-P201SEmRNA-1273-P201-US203-1048US2031048A PBO Placebo A BLINDED TREATMENT 2020-06-01T17:032020-06-30T08:42ABmRNA-1273-P201SEmRNA-1273-P201-US203-1048US2031048A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T08:422020-07-30 BB<mRNA-1273-P201SEmRNA-1273-P201-US203-1048US2031048A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-04 B<BùmRNA-1273-P201SEmRNA-1273-P201-US203-1049US2031049ASCREEN Screening ASCREENING 2020-05-28 2020-06-01T16:26Á@AmRNA-1273-P201SEmRNA-1273-P201-US203-1049US2031049A PBO Placebo A BLINDED TREATMENT 2020-06-01T16:262020-07-01T15:37ABmRNA-1273-P201SEmRNA-1273-P201-US203-1049US2031049A0PBO Placebo A0BLINDED TREATMENT 2020-07-01T15:372020-07-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US203-1049US2031049A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-02 B:B÷mRNA-1273-P201SEmRNA-1273-P201-US203-1050US2031050ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T10:24Á`AmRNA-1273-P201SEmRNA-1273-P201-US203-1050US2031050A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T10:242020-07-01T09:55ABmRNA-1273-P201SEmRNA-1273-P201-US203-1050US2031050A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T09:552020-08-03 BB>mRNA-1273-P201SEmRNA-1273-P201-US203-1050US2031050A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-03-01 B>CmRNA-1273-P201SEmRNA-1273-P201-US203-1051US2031051ASCREEN Screening ASCREENING 2020-05-28 2020-06-01T16:33Á@AmRNA-1273-P201SEmRNA-1273-P201-US203-1051US2031051A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T16:332020-06-29T14:18ABmRNA-1273-P201SEmRNA-1273-P201-US203-1051US2031051A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T14:182020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1051US2031051A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-12 B9CmRNA-1273-P201SEmRNA-1273-P201-US203-1052US2031052ASCREEN Screening ASCREENING 2020-05-28 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1053US2031053ASCREEN Screening ASCREENING 2020-05-28 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1054US2031054ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1055US2031055ASCREEN Screening ASCREENING 2020-05-28 2020-06-09 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1056US2031056ASCREEN Screening ASCREENING 2020-05-28 2020-06-01T16:05Á@AmRNA-1273-P201SEmRNA-1273-P201-US203-1056US2031056A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T16:052020-06-30T15:50ABmRNA-1273-P201SEmRNA-1273-P201-US203-1056US2031056A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T15:502020-07-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US203-1056US2031056A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-18 B:CpmRNA-1273-P201SEmRNA-1273-P201-US203-1057US2031057ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T10:55Á`AmRNA-1273-P201SEmRNA-1273-P201-US203-1057US2031057A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T10:552020-07-01T08:25ABmRNA-1273-P201SEmRNA-1273-P201-US203-1057US2031057A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-01T08:252020-07-30 BB:mRNA-1273-P201SEmRNA-1273-P201-US203-1057US2031057A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-12 B:BÿmRNA-1273-P201SEmRNA-1273-P201-US203-1058US2031058ASCREEN Screening ASCREENING 2020-05-28 2020-06-01T16:48Á@AmRNA-1273-P201SEmRNA-1273-P201-US203-1058US2031058A PBO Placebo A BLINDED TREATMENT 2020-06-01T16:482020-07-01T16:08ABmRNA-1273-P201SEmRNA-1273-P201-US203-1058US2031058A0PBO Placebo A0BLINDED TREATMENT 2020-07-01T16:082020-07-31 BB=mRNA-1273-P201SEmRNA-1273-P201-US203-1058US2031058A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-02-09 B=BþmRNA-1273-P201SEmRNA-1273-P201-US203-1059US2031059ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1060US2031060ASCREEN Screening ASCREENING 2020-05-28 2020-06-04T16:53ÁpAmRNA-1273-P201SEmRNA-1273-P201-US203-1060US2031060A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-04T16:532020-07-02T14:38ABmRNA-1273-P201SEmRNA-1273-P201-US203-1060US2031060A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-02T14:382020-07-28 BB7mRNA-1273-P201SEmRNA-1273-P201-US203-1060US2031060A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-09 B7BûmRNA-1273-P201SEmRNA-1273-P201-US203-1061US2031061ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1062US2031062ASCREEN Screening ASCREENING 2020-05-28 2020-06-04T17:10ÁpAmRNA-1273-P201SEmRNA-1273-P201-US203-1062US2031062A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-04T17:102020-07-02T17:04ABmRNA-1273-P201SEmRNA-1273-P201-US203-1062US2031062A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-02T17:042020-07-28 BB7mRNA-1273-P201SEmRNA-1273-P201-US203-1062US2031062A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-09 B7BûmRNA-1273-P201SEmRNA-1273-P201-US203-1063US2031063ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T16:42ÁPAmRNA-1273-P201SEmRNA-1273-P201-US203-1063US2031063A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T16:422020-07-02T16:36ABmRNA-1273-P201SEmRNA-1273-P201-US203-1063US2031063A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-02T16:362020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1063US2031063A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-02 B9BömRNA-1273-P201SEmRNA-1273-P201-US203-1064US2031064ASCREEN Screening ASCREENING 2020-05-29 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1065US2031065ASCREEN Screening ASCREENING 2020-05-29 2020-06-04 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1066US2031066ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T09:35Á@AmRNA-1273-P201SEmRNA-1273-P201-US203-1066US2031066A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T09:352020-06-30T10:53ABmRNA-1273-P201SEmRNA-1273-P201-US203-1066US2031066A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T10:532020-07-29 BB:mRNA-1273-P201SEmRNA-1273-P201-US203-1066US2031066A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-02-09 B:BýmRNA-1273-P201SEmRNA-1273-P201-US203-1067US2031067ASCREEN Screening ASCREENING 2020-05-29 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1068US2031068ASCREEN Screening ASCREENING 2020-05-29 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1069US2031069ASCREEN Screening ASCREENING 2020-05-29 2020-06-09 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1070US2031070ASCREEN Screening ASCREENING 2020-05-29 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1071US2031071ASCREEN Screening ASCREENING 2020-05-29 2020-06-04T17:34Á`AmRNA-1273-P201SEmRNA-1273-P201-US203-1071US2031071A PBO Placebo A BLINDED TREATMENT 2020-06-04T17:342020-07-02T07:56ABmRNA-1273-P201SEmRNA-1273-P201-US203-1071US2031071A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T07:562020-07-31 BB:mRNA-1273-P201SEmRNA-1273-P201-US203-1071US2031071A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-02-09 B:BûmRNA-1273-P201SEmRNA-1273-P201-US203-1072US2031072ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T12:40ÁPAmRNA-1273-P201SEmRNA-1273-P201-US203-1072US2031072A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T12:402020-07-06T12:24AB"mRNA-1273-P201SEmRNA-1273-P201-US203-1072US2031072A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-06T12:242020-08-07 B"BBmRNA-1273-P201SEmRNA-1273-P201-US203-1072US2031072A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-07 2021-02-04 BBB÷mRNA-1273-P201SEmRNA-1273-P201-US203-1073US2031073ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T11:22Á@AmRNA-1273-P201SEmRNA-1273-P201-US203-1073US2031073A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T11:222020-07-02T16:45ABmRNA-1273-P201SEmRNA-1273-P201-US203-1073US2031073A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-02T16:452020-08-04 BB@mRNA-1273-P201SEmRNA-1273-P201-US203-1073US2031073A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-18 B@C`mRNA-1273-P201SEmRNA-1273-P201-US203-1074US2031074ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T17:03Á@AmRNA-1273-P201SEmRNA-1273-P201-US203-1074US2031074A PBO Placebo A BLINDED TREATMENT 2020-06-02T17:032020-06-30T15:23ABmRNA-1273-P201SEmRNA-1273-P201-US203-1074US2031074A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T15:232020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1074US2031074A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-15 B9C0mRNA-1273-P201SEmRNA-1273-P201-US203-1075US2031075ASCREEN Screening ASCREENING 2020-06-01 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1076US2031076ASCREEN Screening ASCREENING 2020-06-01 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1077US2031077ASCREEN Screening ASCREENING 2020-06-01 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1078US2031078ASCREEN Screening ASCREENING 2020-06-01 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1079US2031079ASCREEN Screening ASCREENING 2020-06-02 2020-06-04T16:39Á AmRNA-1273-P201SEmRNA-1273-P201-US203-1079US2031079A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-04T16:392020-07-02T10:50ABmRNA-1273-P201SEmRNA-1273-P201-US203-1079US2031079A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-02T10:502020-07-31 BB:mRNA-1273-P201SEmRNA-1273-P201-US203-1079US2031079A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-03-03 B:CmRNA-1273-P201SEmRNA-1273-P201-US203-1080US2031080ASCREEN Screening ASCREENING 2020-06-02 2020-06-04T14:21Á AmRNA-1273-P201SEmRNA-1273-P201-US203-1080US2031080A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-04T14:212020-07-02T14:46ABmRNA-1273-P201SEmRNA-1273-P201-US203-1080US2031080A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-02T14:462020-08-06 BB@mRNA-1273-P201SEmRNA-1273-P201-US203-1080US2031080A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-19 B@CPmRNA-1273-P201SEmRNA-1273-P201-US203-1081US2031081ASCREEN Screening ASCREENING 2020-06-02 2020-06-04T12:01Á AmRNA-1273-P201SEmRNA-1273-P201-US203-1081US2031081A PBO Placebo A BLINDED TREATMENT 2020-06-04T12:012020-07-02T09:49ABmRNA-1273-P201SEmRNA-1273-P201-US203-1081US2031081A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T09:492020-08-03 BB=mRNA-1273-P201SEmRNA-1273-P201-US203-1081US2031081A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-04 B=BömRNA-1273-P201SEmRNA-1273-P201-US203-1082US2031082ASCREEN Screening ASCREENING 2020-06-02 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1083US2031083ASCREEN Screening ASCREENING 2020-06-05 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1084US2031084ASCREEN Screening ASCREENING 2020-06-05 2020-06-10T14:18ÁPAmRNA-1273-P201SEmRNA-1273-P201-US203-1084US2031084A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-10T14:182020-07-08T09:06ABmRNA-1273-P201SEmRNA-1273-P201-US203-1084US2031084A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-08T09:062020-08-05 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1084US2031084A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-11 B9B÷mRNA-1273-P201SEmRNA-1273-P201-US203-1085US2031085ASCREEN Screening ASCREENING 2020-06-08 2020-06-26T09:03ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1085US2031085A PBO Placebo A BLINDED TREATMENT 2020-06-26T09:032020-07-29T09:35AB"mRNA-1273-P201SEmRNA-1273-P201-US203-1085US2031085A0PBO Placebo A0BLINDED TREATMENT 2020-07-29T09:352020-08-26 B"B>mRNA-1273-P201SEmRNA-1273-P201-US203-1085US2031085A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-02-11 B>BçmRNA-1273-P201SEmRNA-1273-P201-US203-1086US2031086ASCREEN Screening ASCREENING 2020-06-08 2020-06-26T08:44ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1086US2031086A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T08:442020-07-27T12:09AB mRNA-1273-P201SEmRNA-1273-P201-US203-1086US2031086A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-27T12:092020-08-24 B B<mRNA-1273-P201SEmRNA-1273-P201-US203-1086US2031086A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-11 B<BçmRNA-1273-P201SEmRNA-1273-P201-US203-1087US2031087ASCREEN Screening ASCREENING 2020-06-08 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1088US2031088ASCREEN Screening ASCREENING 2020-06-08 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1089US2031089ASCREEN Screening ASCREENING 2020-06-08 2020-06-26T10:40ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1089US2031089A PBO Placebo A BLINDED TREATMENT 2020-06-26T10:402020-07-29T10:16AB"mRNA-1273-P201SEmRNA-1273-P201-US203-1089US2031089A0PBO Placebo A0BLINDED TREATMENT 2020-07-29T10:162020-08-27 B"B?mRNA-1273-P201SEmRNA-1273-P201-US203-1089US2031089A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-02-04 B?BàmRNA-1273-P201SEmRNA-1273-P201-US203-1090US2031090ASCREEN Screening ASCREENING 2020-06-08 2020-06-09 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1091US2031091ASCREEN Screening ASCREENING 2020-06-08 2020-06-26T11:02ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1091US2031091A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T11:022020-07-27T10:29AB mRNA-1273-P201SEmRNA-1273-P201-US203-1091US2031091A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-27T10:292020-08-24 B B<mRNA-1273-P201SEmRNA-1273-P201-US203-1091US2031091A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-11 B<BçmRNA-1273-P201SEmRNA-1273-P201-US203-1092US2031092ASCREEN Screening ASCREENING 2020-06-08 2020-06-30T12:06ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1092US2031092A PBO Placebo A BLINDED TREATMENT 2020-06-30T12:062020-07-29T11:29ABmRNA-1273-P201SEmRNA-1273-P201-US203-1092US2031092A0PBO Placebo A0BLINDED TREATMENT 2020-07-29T11:292020-08-25 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1092US2031092A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-13 B9BåmRNA-1273-P201SEmRNA-1273-P201-US203-1093US2031093ASCREEN Screening ASCREENING 2020-06-08 2020-07-01T16:38ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1093US2031093A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-01T16:382020-07-31T11:36ABmRNA-1273-P201SEmRNA-1273-P201-US203-1093US2031093A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-31T11:362020-09-04 BBBmRNA-1273-P201SEmRNA-1273-P201-US203-1093US2031093A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-04 2021-02-12 BBBãmRNA-1273-P201SEmRNA-1273-P201-US203-1095US2031095ASCREEN Screening ASCREENING 2020-06-09 2020-06-29T09:01ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1095US2031095A PBO Placebo A BLINDED TREATMENT 2020-06-29T09:012020-07-27T10:10ABmRNA-1273-P201SEmRNA-1273-P201-US203-1095US2031095A0PBO Placebo A0BLINDED TREATMENT 2020-07-27T10:102020-08-21 BB6mRNA-1273-P201SEmRNA-1273-P201-US203-1095US2031095A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-02-16 B6BémRNA-1273-P201SEmRNA-1273-P201-US203-1096US2031096ASCREEN Screening ASCREENING 2020-06-09 2020-06-26T10:48ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1096US2031096A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T10:482020-07-27T12:28AB mRNA-1273-P201SEmRNA-1273-P201-US203-1096US2031096A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-27T12:282020-08-24 B B<mRNA-1273-P201SEmRNA-1273-P201-US203-1096US2031096A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-11 B<BçmRNA-1273-P201SEmRNA-1273-P201-US203-1097US2031097ASCREEN Screening ASCREENING 2020-06-09 2020-06-30T12:22ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1097US2031097A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-30T12:222020-08-03T16:14AB#mRNA-1273-P201SEmRNA-1273-P201-US203-1097US2031097A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-03T16:142020-09-02 B#BAmRNA-1273-P201SEmRNA-1273-P201-US203-1097US2031097A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-02 2021-02-11 BABãmRNA-1273-P201SEmRNA-1273-P201-US203-1098US2031098ASCREEN Screening ASCREENING 2020-06-09 2020-06-29T12:51ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1098US2031098A PBO Placebo A BLINDED TREATMENT 2020-06-29T12:512020-07-29T12:10ABmRNA-1273-P201SEmRNA-1273-P201-US203-1098US2031098A0PBO Placebo A0BLINDED TREATMENT 2020-07-29T12:102020-08-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1098US2031098A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-09 B9BâmRNA-1273-P201SEmRNA-1273-P201-US203-1099US2031099ASCREEN Screening ASCREENING 2020-06-09 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1100US2031100ASCREEN Screening ASCREENING 2020-06-09 2020-07-01T15:44ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1100US2031100A PBO Placebo A BLINDED TREATMENT 2020-07-01T15:442020-08-03T16:34AB"mRNA-1273-P201SEmRNA-1273-P201-US203-1100US2031100A0PBO Placebo A0BLINDED TREATMENT 2020-08-03T16:342020-09-02 B"B@mRNA-1273-P201SEmRNA-1273-P201-US203-1100US2031100A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-02 2021-02-13 B@BämRNA-1273-P201SEmRNA-1273-P201-US203-1101US2031101ASCREEN Screening ASCREENING 2020-06-09 2020-06-29T12:58ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1101US2031101A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-29T12:582020-08-03T17:15AB$mRNA-1273-P201SEmRNA-1273-P201-US203-1101US2031101A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-03T17:152020-09-01 B$BAmRNA-1273-P201SEmRNA-1273-P201-US203-1101US2031101A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-01 2021-02-18 BABëmRNA-1273-P201SEmRNA-1273-P201-US203-1102US2031102ASCREEN Screening ASCREENING 2020-06-09 2020-07-02T17:14ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1102US2031102A PBO Placebo A BLINDED TREATMENT 2020-07-02T17:142020-08-03T17:52AB!mRNA-1273-P201SEmRNA-1273-P201-US203-1102US2031102A0PBO Placebo A0BLINDED TREATMENT 2020-08-03T17:522020-08-28 B!B:mRNA-1273-P201SEmRNA-1273-P201-US203-1102US2031102A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-04 B:BÚmRNA-1273-P201SEmRNA-1273-P201-US203-1103US2031103ASCREEN Screening ASCREENING 2020-06-09 2020-06-29T13:09ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1103US2031103A PBO Placebo A BLINDED TREATMENT 2020-06-29T13:092020-07-30T17:12AB mRNA-1273-P201SEmRNA-1273-P201-US203-1103US2031103A0PBO Placebo A0BLINDED TREATMENT 2020-07-30T17:122020-08-27 B B<mRNA-1273-P201SEmRNA-1273-P201-US203-1103US2031103A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-02-02 B<BÛmRNA-1273-P201SEmRNA-1273-P201-US203-1104US2031104ASCREEN Screening ASCREENING 2020-06-10 2020-06-26T08:35ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1104US2031104A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T08:352020-07-31T13:14AB$mRNA-1273-P201SEmRNA-1273-P201-US203-1104US2031104A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-31T13:142020-08-25 B$B=mRNA-1273-P201SEmRNA-1273-P201-US203-1104US2031104A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-11 B=BçmRNA-1273-P201SEmRNA-1273-P201-US203-1105US2031105ASCREEN Screening ASCREENING 2020-06-10 2020-06-26T09:19ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1105US2031105A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T09:192020-07-28T09:23AB!mRNA-1273-P201SEmRNA-1273-P201-US203-1105US2031105A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-28T09:232020-08-24 B!B<mRNA-1273-P201SEmRNA-1273-P201-US203-1105US2031105A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-13 B<BémRNA-1273-P201SEmRNA-1273-P201-US203-1106US2031106ASCREEN Screening ASCREENING 2020-06-10 2020-06-26T12:46ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1106US2031106A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T12:462020-07-29T17:16AB"mRNA-1273-P201SEmRNA-1273-P201-US203-1106US2031106A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-29T17:162020-08-27 B"B?mRNA-1273-P201SEmRNA-1273-P201-US203-1106US2031106A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-02-18 B?BîmRNA-1273-P201SEmRNA-1273-P201-US203-1107US2031107ASCREEN Screening ASCREENING 2020-06-10 2020-06-29T08:39ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1107US2031107A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-29T08:392020-07-27T12:44ABmRNA-1273-P201SEmRNA-1273-P201-US203-1107US2031107A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-27T12:442020-09-02 BBBmRNA-1273-P201SEmRNA-1273-P201-US203-1107US2031107A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-02 2021-02-11 BBBämRNA-1273-P201SEmRNA-1273-P201-US203-1108US2031108ASCREEN Screening ASCREENING 2020-06-10 2020-07-06T14:14ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1108US2031108A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-06T14:142020-08-03T10:36ABmRNA-1273-P201SEmRNA-1273-P201-US203-1108US2031108A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-03T10:362020-08-28 BB6mRNA-1273-P201SEmRNA-1273-P201-US203-1108US2031108A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-13 B6BßmRNA-1273-P201SEmRNA-1273-P201-US203-1109US2031109ASCREEN Screening ASCREENING 2020-06-10 2020-06-26T13:44ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1109US2031109A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T13:442020-07-27T11:13AB mRNA-1273-P201SEmRNA-1273-P201-US203-1109US2031109A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-27T11:132020-08-24 B B<mRNA-1273-P201SEmRNA-1273-P201-US203-1109US2031109A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-11 B<BçmRNA-1273-P201SEmRNA-1273-P201-US203-1110US2031110ASCREEN Screening ASCREENING 2020-06-10 2020-06-26T13:32ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1110US2031110A PBO Placebo A BLINDED TREATMENT 2020-06-26T13:322020-07-28T12:00AB!mRNA-1273-P201SEmRNA-1273-P201-US203-1110US2031110A0PBO Placebo A0BLINDED TREATMENT 2020-07-28T12:002020-08-26 B!B>mRNA-1273-P201SEmRNA-1273-P201-US203-1110US2031110A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-02-09 B>BåmRNA-1273-P201SEmRNA-1273-P201-US203-1111US2031111ASCREEN Screening ASCREENING 2020-06-10 2020-06-26T13:12ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1111US2031111A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T13:122020-07-27T11:55AB mRNA-1273-P201SEmRNA-1273-P201-US203-1111US2031111A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-27T11:552020-08-21 B B9mRNA-1273-P201SEmRNA-1273-P201-US203-1111US2031111A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-02-11 B9BçmRNA-1273-P201SEmRNA-1273-P201-US203-1112US2031112ASCREEN Screening ASCREENING 2020-06-10 2020-06-26T10:29ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1112US2031112A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T10:292020-07-27T09:46AB mRNA-1273-P201SEmRNA-1273-P201-US203-1112US2031112A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-27T09:462020-09-02 B BEmRNA-1273-P201SEmRNA-1273-P201-US203-1112US2031112A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-02 2021-02-12 BEBèmRNA-1273-P201SEmRNA-1273-P201-US203-1113US2031113ASCREEN Screening ASCREENING 2020-06-11 2020-06-11 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1114US2031114ASCREEN Screening ASCREENING 2020-06-11 2020-07-01T13:45ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1114US2031114A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-01T13:452020-07-29T09:20ABmRNA-1273-P201SEmRNA-1273-P201-US203-1114US2031114A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-29T09:202020-08-27 BB:mRNA-1273-P201SEmRNA-1273-P201-US203-1114US2031114A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-02-16 B:BçmRNA-1273-P201SEmRNA-1273-P201-US203-1115US2031115ASCREEN Screening ASCREENING 2020-06-11 2020-06-24 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1116US2031116ASCREEN Screening ASCREENING 2020-06-11 2020-06-29T08:45ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1116US2031116A PBO Placebo A BLINDED TREATMENT 2020-06-29T08:452020-07-30T11:14AB mRNA-1273-P201SEmRNA-1273-P201-US203-1116US2031116A0PBO Placebo A0BLINDED TREATMENT 2020-07-30T11:142020-08-28 B B=mRNA-1273-P201SEmRNA-1273-P201-US203-1116US2031116A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-04 B=BÝmRNA-1273-P201SEmRNA-1273-P201-US203-1117US2031117ASCREEN Screening ASCREENING 2020-06-11 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1118US2031118ASCREEN Screening ASCREENING 2020-06-11 2020-06-11 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1119US2031119ASCREEN Screening ASCREENING 2020-06-11 2020-06-23 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1120US2031120ASCREEN Screening ASCREENING 2020-06-11 2020-06-11 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1121US2031121ASCREEN Screening ASCREENING 2020-06-12 2020-06-30T14:02ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1121US2031121A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-30T14:022020-07-28T14:10ABmRNA-1273-P201SEmRNA-1273-P201-US203-1121US2031121A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-28T14:102020-08-24 BB8mRNA-1273-P201SEmRNA-1273-P201-US203-1121US2031121A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-23 B8BïmRNA-1273-P201SEmRNA-1273-P201-US203-1122US2031122ASCREEN Screening ASCREENING 2020-06-12 2020-06-29T13:34ÂAmRNA-1273-P201SEmRNA-1273-P201-US203-1122US2031122A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-29T13:342020-07-29T16:21ABmRNA-1273-P201SEmRNA-1273-P201-US203-1122US2031122A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T16:212020-08-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1122US2031122A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-13 B9BæmRNA-1273-P201SEmRNA-1273-P201-US203-1123US2031123ASCREEN Screening ASCREENING 2020-06-17 2020-06-17 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1124US2031124ASCREEN Screening ASCREENING 2020-06-17 2020-06-29T17:01ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US203-1124US2031124A PBO Placebo A BLINDED TREATMENT 2020-06-29T17:012020-07-29T17:59ABmRNA-1273-P201SEmRNA-1273-P201-US203-1124US2031124A0PBO Placebo A0BLINDED TREATMENT 2020-07-29T17:592020-08-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1124US2031124A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-12 B9BåmRNA-1273-P201SEmRNA-1273-P201-US203-1125US2031125ASCREEN Screening ASCREENING 2020-06-19 2020-06-26T11:23ÁpAmRNA-1273-P201SEmRNA-1273-P201-US203-1125US2031125A PBO Placebo A BLINDED TREATMENT 2020-06-26T11:232020-07-28T11:01AB!mRNA-1273-P201SEmRNA-1273-P201-US203-1125US2031125A0PBO Placebo A0BLINDED TREATMENT 2020-07-28T11:012020-08-24 B!B<mRNA-1273-P201SEmRNA-1273-P201-US203-1125US2031125A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-04 B<BàmRNA-1273-P201SEmRNA-1273-P201-US203-1126US2031126ASCREEN Screening ASCREENING 2020-06-19 2020-06-19 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1127US2031094ASCREEN Screening ASCREENING 2020-06-09 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1127US2031127A SCREEN Screening ASCREENING 2020-06-22 2020-06-26 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1128US2031128ASCREEN Screening ASCREENING 2020-06-23 2020-07-01T14:30Á€AmRNA-1273-P201SEmRNA-1273-P201-US203-1128US2031128A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-01T14:302020-07-29T13:38ABmRNA-1273-P201SEmRNA-1273-P201-US203-1128US2031128A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-29T13:382020-08-26 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1128US2031128A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-02-13 B9BämRNA-1273-P201SEmRNA-1273-P201-US203-1129US2031129ASCREEN Screening ASCREENING 2020-06-25 2020-07-01T14:02Á`AmRNA-1273-P201SEmRNA-1273-P201-US203-1129US2031129A PBO Placebo A BLINDED TREATMENT 2020-07-01T14:022020-07-30T15:19ABmRNA-1273-P201SEmRNA-1273-P201-US203-1129US2031129A0PBO Placebo A0BLINDED TREATMENT 2020-07-30T15:192020-08-28 BB;mRNA-1273-P201SEmRNA-1273-P201-US203-1129US2031129A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-04 B;BÛmRNA-1273-P201SEmRNA-1273-P201-US203-1130US2031130ASCREEN Screening ASCREENING 2020-06-25 2020-07-06 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1131US2031131ASCREEN Screening ASCREENING 2020-06-29 2020-07-02T15:14Á0AmRNA-1273-P201SEmRNA-1273-P201-US203-1131US2031131A PBO Placebo A BLINDED TREATMENT 2020-07-02T15:142020-07-31T12:07ABmRNA-1273-P201SEmRNA-1273-P201-US203-1131US2031131A0PBO Placebo A0BLINDED TREATMENT 2020-07-31T12:072020-08-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US203-1131US2031131A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-02-26 B9BðmRNA-1273-P201SEmRNA-1273-P201-US203-1132US2031132ASCREEN Screening ASCREENING 2020-06-29 2020-06-30 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1133US2031133ASCREEN Screening ASCREENING 2020-07-02 2020-07-02 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1134US2031134ASCREEN Screening ASCREENING 2020-07-06 2020-07-06 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1135US2031135ASCREEN Screening ASCREENING 2020-07-06 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US203-1136US2031136ASCREEN Screening ASCREENING 2020-07-07 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1001US2041001ASCREEN Screening ASCREENING 2020-05-26 2020-06-04 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1002US2041002ASCREEN Screening ASCREENING 2020-05-26 2020-06-02T11:08ÁpAmRNA-1273-P201SEmRNA-1273-P201-US204-1002US2041002A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T11:082020-06-30T10:24ABmRNA-1273-P201SEmRNA-1273-P201-US204-1002US2041002A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T10:242020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1002US2041002A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-15 B9C0mRNA-1273-P201SEmRNA-1273-P201-US204-1003US2041003ASCREEN Screening ASCREENING 2020-05-26 2020-06-02T15:39ÁpAmRNA-1273-P201SEmRNA-1273-P201-US204-1003US2041003A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T15:392020-06-30T15:37ABmRNA-1273-P201SEmRNA-1273-P201-US204-1003US2041003A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T15:372020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1003US2041003A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-04-27 B9C mRNA-1273-P201SEmRNA-1273-P201-US204-1004US2041004ASCREEN Screening ASCREENING 2020-05-26 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1005US2041005ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T13:37Á0AmRNA-1273-P201SEmRNA-1273-P201-US204-1005US2041005A PBO Placebo A BLINDED TREATMENT 2020-05-29T13:372020-06-26T12:02ABmRNA-1273-P201SEmRNA-1273-P201-US204-1005US2041005A0PBO Placebo A0BLINDED TREATMENT 2020-06-26T12:022020-07-28 BB=mRNA-1273-P201SEmRNA-1273-P201-US204-1005US2041005A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-03-08 B=CÀmRNA-1273-P201SEmRNA-1273-P201-US204-1006US2041006ASCREEN Screening ASCREENING 2020-05-26 2020-06-02T10:14ÁpAmRNA-1273-P201SEmRNA-1273-P201-US204-1006US2041006A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T10:142020-07-02T10:53ABmRNA-1273-P201SEmRNA-1273-P201-US204-1006US2041006A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-02T10:532020-07-30 BB;mRNA-1273-P201SEmRNA-1273-P201-US204-1006US2041006A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-15 B;C0mRNA-1273-P201SEmRNA-1273-P201-US204-1007US2041007ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T11:09Á`AmRNA-1273-P201SEmRNA-1273-P201-US204-1007US2041007A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T11:092020-06-29T11:19ABmRNA-1273-P201SEmRNA-1273-P201-US204-1007US2041007A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T11:192020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1007US2041007A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-18 B9CpmRNA-1273-P201SEmRNA-1273-P201-US204-1008US2041008ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T15:27Á`AmRNA-1273-P201SEmRNA-1273-P201-US204-1008US2041008A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T15:272020-07-01T15:55ABmRNA-1273-P201SEmRNA-1273-P201-US204-1008US2041008A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T15:552020-08-11 BBHmRNA-1273-P201SEmRNA-1273-P201-US204-1008US2041008A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-11 2021-02-15 BHC@mRNA-1273-P201SEmRNA-1273-P201-US204-1009US2041009ASCREEN Screening ASCREENING 2020-05-26 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1010US2041010ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T14:54Á0AmRNA-1273-P201SEmRNA-1273-P201-US204-1010US2041010A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-05-29T14:542020-06-29T08:48AB mRNA-1273-P201SEmRNA-1273-P201-US204-1010US2041010A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-29T08:482020-07-27 B B<mRNA-1273-P201SEmRNA-1273-P201-US204-1010US2041010A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-19 B<C°mRNA-1273-P201SEmRNA-1273-P201-US204-1011US2041011ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T13:19Á`AmRNA-1273-P201SEmRNA-1273-P201-US204-1011US2041011A PBO Placebo A BLINDED TREATMENT 2020-06-01T13:192020-07-01T08:52ABmRNA-1273-P201SEmRNA-1273-P201-US204-1011US2041011A0PBO Placebo A0BLINDED TREATMENT 2020-07-01T08:522020-08-17 BBNmRNA-1273-P201SEmRNA-1273-P201-US204-1011US2041011A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-17 2021-02-19 BNC€mRNA-1273-P201SEmRNA-1273-P201-US204-1012US2041012ASCREEN Screening ASCREENING 2020-05-26 2020-06-02T08:44ÁpAmRNA-1273-P201SEmRNA-1273-P201-US204-1012US2041012A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T08:442020-07-07T14:00AB$mRNA-1273-P201SEmRNA-1273-P201-US204-1012US2041012A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T14:002020-08-06 B$BBmRNA-1273-P201SEmRNA-1273-P201-US204-1012US2041012A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-16 BBC@mRNA-1273-P201SEmRNA-1273-P201-US204-1013US2041013ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T16:10Á0AmRNA-1273-P201SEmRNA-1273-P201-US204-1013US2041013A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-05-29T16:102020-06-29T11:13AB mRNA-1273-P201SEmRNA-1273-P201-US204-1013US2041013A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T11:132020-07-27 B B<mRNA-1273-P201SEmRNA-1273-P201-US204-1013US2041013A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-17 B<CmRNA-1273-P201SEmRNA-1273-P201-US204-1014US2041014ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T15:28Á0AmRNA-1273-P201SEmRNA-1273-P201-US204-1014US2041014A PBO Placebo A BLINDED TREATMENT 2020-05-29T15:282020-06-26T09:48ABmRNA-1273-P201SEmRNA-1273-P201-US204-1014US2041014A0PBO Placebo A0BLINDED TREATMENT 2020-06-26T09:482020-07-21 BB6mRNA-1273-P201SEmRNA-1273-P201-US204-1014US2041014A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-21 2021-02-16 B6C€mRNA-1273-P201SEmRNA-1273-P201-US204-1015US2041015ASCREEN Screening ASCREENING 2020-05-26 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1016US2041016ASCREEN Screening ASCREENING 2020-05-26 2020-06-02T16:27ÁpAmRNA-1273-P201SEmRNA-1273-P201-US204-1016US2041016A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T16:272020-07-14T13:22AB+mRNA-1273-P201SEmRNA-1273-P201-US204-1016US2041016A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-14T13:222020-08-12 B+BHmRNA-1273-P201SEmRNA-1273-P201-US204-1016US2041016A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-12 2021-02-16 BHC@mRNA-1273-P201SEmRNA-1273-P201-US204-1017US2041017ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1018US2041018ASCREEN Screening ASCREENING 2020-05-26 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1019US2041019ASCREEN Screening ASCREENING 2020-05-26 2020-06-02T14:47ÁpAmRNA-1273-P201SEmRNA-1273-P201-US204-1019US2041019A PBO Placebo A BLINDED TREATMENT 2020-06-02T14:472020-06-30T13:43ABmRNA-1273-P201SEmRNA-1273-P201-US204-1019US2041019A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T13:432020-08-12 BBHmRNA-1273-P201SEmRNA-1273-P201-US204-1019US2041019A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-12 2021-02-15 BHC0mRNA-1273-P201SEmRNA-1273-P201-US204-1020US2041020ASCREEN Screening ASCREENING 2020-05-26 2020-06-03T15:53Á€AmRNA-1273-P201SEmRNA-1273-P201-US204-1020US2041020A PBO Placebo A BLINDED TREATMENT 2020-06-03T15:532020-07-01T16:11ABmRNA-1273-P201SEmRNA-1273-P201-US204-1020US2041020A0PBO Placebo A0BLINDED TREATMENT 2020-07-01T16:112020-08-05 BB@mRNA-1273-P201SEmRNA-1273-P201-US204-1020US2041020A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-19 B@C`mRNA-1273-P201SEmRNA-1273-P201-US204-1021US2041021ASCREEN Screening ASCREENING 2020-05-26 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1022US2041022ASCREEN Screening ASCREENING 2020-05-27 2020-06-05T12:52ÁAmRNA-1273-P201SEmRNA-1273-P201-US204-1022US2041022A PBO Placebo A BLINDED TREATMENT 2020-06-05T12:522020-07-06T12:39AB mRNA-1273-P201SEmRNA-1273-P201-US204-1022US2041022A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T12:392020-08-04 B B=mRNA-1273-P201SEmRNA-1273-P201-US204-1022US2041022A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-12 B=BýmRNA-1273-P201SEmRNA-1273-P201-US204-1023US2041023ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T16:28ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1023US2041023A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T16:282020-06-29T16:32ABmRNA-1273-P201SEmRNA-1273-P201-US204-1023US2041023A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T16:322020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1023US2041023A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-17 B9C`mRNA-1273-P201SEmRNA-1273-P201-US204-1024US2041024ASCREEN Screening ASCREENING 2020-05-27 2020-06-03T15:20ÁpAmRNA-1273-P201SEmRNA-1273-P201-US204-1024US2041024A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T15:202020-07-02T08:51ABmRNA-1273-P201SEmRNA-1273-P201-US204-1024US2041024A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-02T08:512020-07-27 BB7mRNA-1273-P201SEmRNA-1273-P201-US204-1024US2041024A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-15 B7C mRNA-1273-P201SEmRNA-1273-P201-US204-1025US2041025ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T08:18Á`AmRNA-1273-P201SEmRNA-1273-P201-US204-1025US2041025A PBO Placebo A BLINDED TREATMENT 2020-06-02T08:182020-06-30T08:24ABmRNA-1273-P201SEmRNA-1273-P201-US204-1025US2041025A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T08:242020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1025US2041025A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-04-12 B9C°mRNA-1273-P201SEmRNA-1273-P201-US204-1026US2041026ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T09:55Á`AmRNA-1273-P201SEmRNA-1273-P201-US204-1026US2041026A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T09:552020-06-30T14:09ABmRNA-1273-P201SEmRNA-1273-P201-US204-1026US2041026A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-30T14:092020-07-27 BB8mRNA-1273-P201SEmRNA-1273-P201-US204-1026US2041026A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-18 B8C`mRNA-1273-P201SEmRNA-1273-P201-US204-1027US2041027ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T13:04ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1027US2041027A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T13:042020-06-29T10:54ABmRNA-1273-P201SEmRNA-1273-P201-US204-1027US2041027A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T10:542020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1027US2041027A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-16 B9CPmRNA-1273-P201SEmRNA-1273-P201-US204-1028US2041028ASCREEN Screening ASCREENING 2020-05-27 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1029US2041029ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T11:33ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1029US2041029A PBO Placebo A BLINDED TREATMENT 2020-06-01T11:332020-06-29T11:31ABmRNA-1273-P201SEmRNA-1273-P201-US204-1029US2041029A0PBO Placebo A0BLINDED TREATMENT 2020-06-29T11:312020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1029US2041029A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-19 B9C€mRNA-1273-P201SEmRNA-1273-P201-US204-1030US2041030ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T14:53ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1030US2041030A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T14:532020-06-30T14:43ABmRNA-1273-P201SEmRNA-1273-P201-US204-1030US2041030A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T14:432020-07-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US204-1030US2041030A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-18 B:CpmRNA-1273-P201SEmRNA-1273-P201-US204-1031US2041031ASCREEN Screening ASCREENING 2020-05-27 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1032US2041032ASCREEN Screening ASCREENING 2020-05-27 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1033US2041033ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1034US2041034ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T14:30ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1034US2041034A PBO Placebo A BLINDED TREATMENT 2020-06-01T14:302020-07-02T15:33AB mRNA-1273-P201SEmRNA-1273-P201-US204-1034US2041034A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T15:332020-08-05 B BBmRNA-1273-P201SEmRNA-1273-P201-US204-1034US2041034A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-19 BBC€mRNA-1273-P201SEmRNA-1273-P201-US204-1035US2041035ASCREEN Screening ASCREENING 2020-05-27 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1036US2041036ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T08:07Á`AmRNA-1273-P201SEmRNA-1273-P201-US204-1036US2041036A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T08:072020-06-30T08:45ABmRNA-1273-P201SEmRNA-1273-P201-US204-1036US2041036A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T08:452020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1036US2041036A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-16 B9C@mRNA-1273-P201SEmRNA-1273-P201-US204-1037US2041037ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1038US2041038ASCREEN Screening ASCREENING 2020-05-26 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1039US2041039ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1040US2041040ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1041US2041041ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T17:01ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1041US2041041A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T17:012020-07-06T16:47AB$mRNA-1273-P201SEmRNA-1273-P201-US204-1041US2041041A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-06T16:472020-08-03 B$B@mRNA-1273-P201SEmRNA-1273-P201-US204-1041US2041041A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-15 B@C@mRNA-1273-P201SEmRNA-1273-P201-US204-1042US2041042ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T16:46ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1042US2041042A PBO Placebo A BLINDED TREATMENT 2020-06-01T16:462020-07-06T16:59AB$mRNA-1273-P201SEmRNA-1273-P201-US204-1042US2041042A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T16:592020-08-03 B$B@mRNA-1273-P201SEmRNA-1273-P201-US204-1042US2041042A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-03-01 B@C mRNA-1273-P201SEmRNA-1273-P201-US204-1043US2041043ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T17:06Á`AmRNA-1273-P201SEmRNA-1273-P201-US204-1043US2041043A PBO Placebo A BLINDED TREATMENT 2020-06-03T17:062020-07-17 AB-mRNA-1273-P201SEmRNA-1273-P201-US204-1044US2041044ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1045US2041045ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1046US2041046ASCREEN Screening ASCREENING 2020-05-28 2020-06-04T13:25ÁpAmRNA-1273-P201SEmRNA-1273-P201-US204-1046US2041046A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-04T13:252020-07-02T09:33ABmRNA-1273-P201SEmRNA-1273-P201-US204-1046US2041046A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-02T09:332020-08-04 BB>mRNA-1273-P201SEmRNA-1273-P201-US204-1046US2041046A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-25 B>C°mRNA-1273-P201SEmRNA-1273-P201-US204-1047US2041047ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T08:31ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1047US2041047A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T08:312020-06-30T08:56ABmRNA-1273-P201SEmRNA-1273-P201-US204-1047US2041047A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T08:562020-08-04 BB@mRNA-1273-P201SEmRNA-1273-P201-US204-1047US2041047A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-16 B@C@mRNA-1273-P201SEmRNA-1273-P201-US204-1048US2041048ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T10:45ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1048US2041048A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T10:452020-07-01T15:45ABmRNA-1273-P201SEmRNA-1273-P201-US204-1048US2041048A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T15:452020-08-03 BB?mRNA-1273-P201SEmRNA-1273-P201-US204-1048US2041048A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-16 B?C@mRNA-1273-P201SEmRNA-1273-P201-US204-1049US2041049ASCREEN Screening ASCREENING 2020-05-28 2020-06-04T14:50ÁpAmRNA-1273-P201SEmRNA-1273-P201-US204-1049US2041049A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-04T14:502020-07-14T16:00AB)mRNA-1273-P201SEmRNA-1273-P201-US204-1049US2041049A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-14T16:002020-08-11 B)BEmRNA-1273-P201SEmRNA-1273-P201-US204-1049US2041049A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-11 2021-02-18 BEC@mRNA-1273-P201SEmRNA-1273-P201-US204-1050US2041050ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1051US2041051ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T14:11ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1051US2041051A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T14:112020-06-30T11:57ABmRNA-1273-P201SEmRNA-1273-P201-US204-1051US2041051A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T11:572020-07-27 BB8mRNA-1273-P201SEmRNA-1273-P201-US204-1051US2041051A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-16 B8C@mRNA-1273-P201SEmRNA-1273-P201-US204-1052US2041052ASCREEN Screening ASCREENING 2020-05-28 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1053US2041053ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T12:41ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1053US2041053A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T12:412020-07-07T16:00AB$mRNA-1273-P201SEmRNA-1273-P201-US204-1053US2041053A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T16:002020-08-10 B$BFmRNA-1273-P201SEmRNA-1273-P201-US204-1053US2041053A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-16 BFC@mRNA-1273-P201SEmRNA-1273-P201-US204-1054US2041054ASCREEN Screening ASCREENING 2020-05-28 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1055US2041055ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T11:01Á`AmRNA-1273-P201SEmRNA-1273-P201-US204-1055US2041055A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T11:012020-07-17 AB-mRNA-1273-P201SEmRNA-1273-P201-US204-1056US2041056ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T13:47ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1056US2041056A PBO Placebo A BLINDED TREATMENT 2020-06-02T13:472020-06-30T10:11ABmRNA-1273-P201SEmRNA-1273-P201-US204-1056US2041056A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T10:112020-07-30 BB;mRNA-1273-P201SEmRNA-1273-P201-US204-1056US2041056A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-15 B;C0mRNA-1273-P201SEmRNA-1273-P201-US204-1057US2041057ASCREEN Screening ASCREENING 2020-05-28 2020-06-04 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1058US2041058ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T13:54Á`AmRNA-1273-P201SEmRNA-1273-P201-US204-1058US2041058A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T13:542020-07-17 AB-mRNA-1273-P201SEmRNA-1273-P201-US204-1059US2041059ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T15:52ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1059US2041059A PBO Placebo A BLINDED TREATMENT 2020-06-02T15:522020-07-27 AB8mRNA-1273-P201SEmRNA-1273-P201-US204-1060US2041060ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T09:25ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1060US2041060A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T09:252020-07-01T09:27ABmRNA-1273-P201SEmRNA-1273-P201-US204-1060US2041060A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T09:272020-08-18 BBNmRNA-1273-P201SEmRNA-1273-P201-US204-1060US2041060A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-18 2021-05-27 BNC€mRNA-1273-P201SEmRNA-1273-P201-US204-1061US2041061ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T16:07ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1061US2041061A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T16:072020-07-06T12:06AB#mRNA-1273-P201SEmRNA-1273-P201-US204-1061US2041061A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-06T12:062020-08-13 B#BImRNA-1273-P201SEmRNA-1273-P201-US204-1061US2041061A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-13 2021-02-18 BIC`mRNA-1273-P201SEmRNA-1273-P201-US204-1062US2041062ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T11:45ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1062US2041062A PBO Placebo A BLINDED TREATMENT 2020-06-02T11:452020-06-30T10:57ABmRNA-1273-P201SEmRNA-1273-P201-US204-1062US2041062A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T10:572020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1062US2041062A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-17 B9CPmRNA-1273-P201SEmRNA-1273-P201-US204-1063US2041063ASCREEN Screening ASCREENING 2020-05-28 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1064US2041064ASCREEN Screening ASCREENING 2020-05-28 2020-06-08T16:50Á°AmRNA-1273-P201SEmRNA-1273-P201-US204-1064US2041064A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T16:502020-07-14T16:15AB%mRNA-1273-P201SEmRNA-1273-P201-US204-1064US2041064A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-14T16:152020-09-24 B%BmmRNA-1273-P201SEmRNA-1273-P201-US204-1065US2041065ASCREEN Screening ASCREENING 2020-05-28 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1066US2041066ASCREEN Screening ASCREENING 2020-05-28 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1067US2041067ASCREEN Screening ASCREENING 2020-05-28 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1068US2041068ASCREEN Screening ASCREENING 2020-05-28 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1069US2041069ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1070US2041070ASCREEN Screening ASCREENING 2020-05-29 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1071US2041071ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T18:00Á@AmRNA-1273-P201SEmRNA-1273-P201-US204-1071US2041071A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T18:002020-07-06T16:29AB#mRNA-1273-P201SEmRNA-1273-P201-US204-1071US2041071A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-06T16:292020-08-07 B#BCmRNA-1273-P201SEmRNA-1273-P201-US204-1071US2041071A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-07 2021-02-26 BCCàmRNA-1273-P201SEmRNA-1273-P201-US204-1072US2041072ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1073US2041073ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T17:30Á@AmRNA-1273-P201SEmRNA-1273-P201-US204-1073US2041073A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T17:302020-06-30T16:35ABmRNA-1273-P201SEmRNA-1273-P201-US204-1073US2041073A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-30T16:352020-07-27 BB8mRNA-1273-P201SEmRNA-1273-P201-US204-1073US2041073A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-17 B8CPmRNA-1273-P201SEmRNA-1273-P201-US204-1074US2041074ASCREEN Screening ASCREENING 2020-05-29 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1075US2041075ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T12:15Á@AmRNA-1273-P201SEmRNA-1273-P201-US204-1075US2041075A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T12:152020-07-01T11:40ABmRNA-1273-P201SEmRNA-1273-P201-US204-1075US2041075A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-01T11:402020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1075US2041075A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-18 B9C`mRNA-1273-P201SEmRNA-1273-P201-US204-1076US2041076ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T11:57Á@AmRNA-1273-P201SEmRNA-1273-P201-US204-1076US2041076A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T11:572020-07-06T12:29AB#mRNA-1273-P201SEmRNA-1273-P201-US204-1076US2041076A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-06T12:292020-08-05 B#BAmRNA-1273-P201SEmRNA-1273-P201-US204-1076US2041076A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-17 BACPmRNA-1273-P201SEmRNA-1273-P201-US204-1077US2041077ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T14:21ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1077US2041077A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T14:212020-07-01T11:05ABmRNA-1273-P201SEmRNA-1273-P201-US204-1077US2041077A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-01T11:052020-07-27 BB7mRNA-1273-P201SEmRNA-1273-P201-US204-1077US2041077A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-05-14 B7C mRNA-1273-P201SEmRNA-1273-P201-US204-1078US2041078ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T14:34ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1078US2041078A PBO Placebo A BLINDED TREATMENT 2020-06-03T14:342020-07-01T10:40ABmRNA-1273-P201SEmRNA-1273-P201-US204-1078US2041078A0PBO Placebo A0BLINDED TREATMENT 2020-07-01T10:402020-07-31 BB;mRNA-1273-P201SEmRNA-1273-P201-US204-1078US2041078A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-03-22 B;CPmRNA-1273-P201SEmRNA-1273-P201-US204-1079US2041079ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T17:22ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1079US2041079A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T17:222020-07-07T15:50AB#mRNA-1273-P201SEmRNA-1273-P201-US204-1079US2041079A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T15:502020-08-07 B#BBmRNA-1273-P201SEmRNA-1273-P201-US204-1079US2041079A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-07 2021-02-18 BBCPmRNA-1273-P201SEmRNA-1273-P201-US204-1080US2041080ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T17:45ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1080US2041080A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T17:452020-07-01T16:37ABmRNA-1273-P201SEmRNA-1273-P201-US204-1080US2041080A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T16:372020-07-28 BB8mRNA-1273-P201SEmRNA-1273-P201-US204-1080US2041080A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-16 B8C0mRNA-1273-P201SEmRNA-1273-P201-US204-1081US2041081ASCREEN Screening ASCREENING 2020-06-01 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1082US2041082ASCREEN Screening ASCREENING 2020-06-01 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1083US2041083ASCREEN Screening ASCREENING 2020-06-01 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1084US2041084ASCREEN Screening ASCREENING 2020-06-01 2020-06-04T12:35Á0AmRNA-1273-P201SEmRNA-1273-P201-US204-1084US2041084A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-04T12:352020-07-02T12:53ABmRNA-1273-P201SEmRNA-1273-P201-US204-1084US2041084A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-02T12:532020-08-05 BB?mRNA-1273-P201SEmRNA-1273-P201-US204-1084US2041084A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-17 B?C0mRNA-1273-P201SEmRNA-1273-P201-US204-1085US2041085ASCREEN Screening ASCREENING 2020-06-04 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1086US2041086ASCREEN Screening ASCREENING 2020-06-05 2020-06-08T10:09Á0AmRNA-1273-P201SEmRNA-1273-P201-US204-1086US2041086A PBO Placebo A BLINDED TREATMENT 2020-06-08T10:092020-07-06T09:59ABmRNA-1273-P201SEmRNA-1273-P201-US204-1086US2041086A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T09:592020-08-07 BB=mRNA-1273-P201SEmRNA-1273-P201-US204-1086US2041086A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-07 2020-12-18 B=BÂmRNA-1273-P201SEmRNA-1273-P201-US204-1087US2041087ASCREEN Screening ASCREENING 2020-06-05 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1088US2041088ASCREEN Screening ASCREENING 2020-06-05 2020-06-08T15:17Á0AmRNA-1273-P201SEmRNA-1273-P201-US204-1088US2041088A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T15:172020-07-10T13:53AB!mRNA-1273-P201SEmRNA-1273-P201-US204-1088US2041088A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-10T13:532020-08-10 B!B@mRNA-1273-P201SEmRNA-1273-P201-US204-1088US2041088A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-16 B@BþmRNA-1273-P201SEmRNA-1273-P201-US204-1089US2041089ASCREEN Screening ASCREENING 2020-06-05 2020-06-08T09:59Á0AmRNA-1273-P201SEmRNA-1273-P201-US204-1089US2041089A PBO Placebo A BLINDED TREATMENT 2020-06-08T09:592020-07-10T09:54AB!mRNA-1273-P201SEmRNA-1273-P201-US204-1089US2041089A0PBO Placebo A0BLINDED TREATMENT 2020-07-10T09:542020-08-07 B!B=mRNA-1273-P201SEmRNA-1273-P201-US204-1089US2041089A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-07 2021-02-16 B=BþmRNA-1273-P201SEmRNA-1273-P201-US204-1090US2041090ASCREEN Screening ASCREENING 2020-06-05 2020-06-08T15:38Á0AmRNA-1273-P201SEmRNA-1273-P201-US204-1090US2041090A PBO Placebo A BLINDED TREATMENT 2020-06-08T15:382020-07-10T14:24AB!mRNA-1273-P201SEmRNA-1273-P201-US204-1090US2041090A0PBO Placebo A0BLINDED TREATMENT 2020-07-10T14:242020-08-10 B!B@mRNA-1273-P201SEmRNA-1273-P201-US204-1090US2041090A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-15 B@BýmRNA-1273-P201SEmRNA-1273-P201-US204-1091US2041091ASCREEN Screening ASCREENING 2020-06-05 2020-06-10T12:07ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1091US2041091A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-10T12:072020-07-10T14:09ABmRNA-1273-P201SEmRNA-1273-P201-US204-1091US2041091A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-10T14:092020-08-10 BB>mRNA-1273-P201SEmRNA-1273-P201-US204-1091US2041091A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-15 B>BûmRNA-1273-P201SEmRNA-1273-P201-US204-1092US2041092ASCREEN Screening ASCREENING 2020-06-05 2020-06-08T16:05Á0AmRNA-1273-P201SEmRNA-1273-P201-US204-1092US2041092A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T16:052020-07-14T13:06AB%mRNA-1273-P201SEmRNA-1273-P201-US204-1092US2041092A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-14T13:062020-08-10 B%B@mRNA-1273-P201SEmRNA-1273-P201-US204-1092US2041092A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-16 B@BþmRNA-1273-P201SEmRNA-1273-P201-US204-1093US2041093ASCREEN Screening ASCREENING 2020-06-08 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1094US2041094ASCREEN Screening ASCREENING 2020-06-08 2020-06-26T13:28ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1094US2041094A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T13:282020-07-24T14:10ABmRNA-1273-P201SEmRNA-1273-P201-US204-1094US2041094A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-24T14:102020-08-20 BB8mRNA-1273-P201SEmRNA-1273-P201-US204-1094US2041094A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-20 2021-02-16 B8BìmRNA-1273-P201SEmRNA-1273-P201-US204-1095US2041095ASCREEN Screening ASCREENING 2020-06-09 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1096US2041096ASCREEN Screening ASCREENING 2020-06-09 2020-06-29T08:06ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1096US2041096A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-29T08:062020-07-28T08:32ABmRNA-1273-P201SEmRNA-1273-P201-US204-1096US2041096A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-28T08:322020-08-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1096US2041096A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-15 B9BèmRNA-1273-P201SEmRNA-1273-P201-US204-1097US2041097ASCREEN Screening ASCREENING 2020-06-09 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1098US2041098ASCREEN Screening ASCREENING 2020-06-09 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1099US2041099ASCREEN Screening ASCREENING 2020-06-09 2020-07-02 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1100US2041100ASCREEN Screening ASCREENING 2020-06-10 2020-06-29T08:23ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1100US2041100A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-29T08:232020-07-28T08:06ABmRNA-1273-P201SEmRNA-1273-P201-US204-1100US2041100A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-28T08:062020-08-25 BB:mRNA-1273-P201SEmRNA-1273-P201-US204-1100US2041100A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-17 B:BêmRNA-1273-P201SEmRNA-1273-P201-US204-1101US2041101ASCREEN Screening ASCREENING 2020-06-10 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1102US2041102ASCREEN Screening ASCREENING 2020-06-10 2020-06-26T08:37ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1102US2041102A PBO Placebo A BLINDED TREATMENT 2020-06-26T08:372020-07-24T13:07ABmRNA-1273-P201SEmRNA-1273-P201-US204-1102US2041102A0PBO Placebo A0BLINDED TREATMENT 2020-07-24T13:072020-08-18 BB6mRNA-1273-P201SEmRNA-1273-P201-US204-1102US2041102A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-18 2021-02-17 B6BímRNA-1273-P201SEmRNA-1273-P201-US204-1103US2041103ASCREEN Screening ASCREENING 2020-06-10 2020-06-26T11:33ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1103US2041103A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T11:332020-07-24T11:46ABmRNA-1273-P201SEmRNA-1273-P201-US204-1103US2041103A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-24T11:462020-08-18 BB6mRNA-1273-P201SEmRNA-1273-P201-US204-1103US2041103A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-18 2021-02-16 B6BìmRNA-1273-P201SEmRNA-1273-P201-US204-1104US2041104ASCREEN Screening ASCREENING 2020-06-10 2020-06-26T11:47ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1104US2041104A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T11:472020-07-24T12:10ABmRNA-1273-P201SEmRNA-1273-P201-US204-1104US2041104A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-24T12:102020-08-18 BB6mRNA-1273-P201SEmRNA-1273-P201-US204-1104US2041104A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-18 2021-02-16 B6BìmRNA-1273-P201SEmRNA-1273-P201-US204-1105US2041105ASCREEN Screening ASCREENING 2020-06-10 2020-07-02 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1106US2041106ASCREEN Screening ASCREENING 2020-06-11 2020-06-26T16:00ÁðAmRNA-1273-P201SEmRNA-1273-P201-US204-1106US2041106A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T16:002020-07-28T11:17AB!mRNA-1273-P201SEmRNA-1273-P201-US204-1106US2041106A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-28T11:172020-08-25 B!B=mRNA-1273-P201SEmRNA-1273-P201-US204-1106US2041106A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-04-19 B=C mRNA-1273-P201SEmRNA-1273-P201-US204-1107US2041107ASCREEN Screening ASCREENING 2020-06-11 2020-06-26T16:53ÁðAmRNA-1273-P201SEmRNA-1273-P201-US204-1107US2041107A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T16:532020-07-27T11:12AB mRNA-1273-P201SEmRNA-1273-P201-US204-1107US2041107A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-27T11:122020-08-24 B B<mRNA-1273-P201SEmRNA-1273-P201-US204-1107US2041107A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-15 B<BëmRNA-1273-P201SEmRNA-1273-P201-US204-1108US2041108ASCREEN Screening ASCREENING 2020-06-11 2020-06-26T09:30ÁðAmRNA-1273-P201SEmRNA-1273-P201-US204-1108US2041108A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T09:302020-07-27T16:10AB mRNA-1273-P201SEmRNA-1273-P201-US204-1108US2041108A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-27T16:102020-08-24 B B<mRNA-1273-P201SEmRNA-1273-P201-US204-1108US2041108A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-18 B<BîmRNA-1273-P201SEmRNA-1273-P201-US204-1109US2041109ASCREEN Screening ASCREENING 2020-06-11 2020-06-26T11:06ÁðAmRNA-1273-P201SEmRNA-1273-P201-US204-1109US2041109A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T11:062020-07-27T11:44AB mRNA-1273-P201SEmRNA-1273-P201-US204-1109US2041109A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-27T11:442020-08-21 B B9mRNA-1273-P201SEmRNA-1273-P201-US204-1109US2041109A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-02-16 B9BìmRNA-1273-P201SEmRNA-1273-P201-US204-1110US2041110ASCREEN Screening ASCREENING 2020-06-11 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1111US2041111ASCREEN Screening ASCREENING 2020-06-11 2020-06-29T12:13ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1111US2041111A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-29T12:132020-07-27T14:21ABmRNA-1273-P201SEmRNA-1273-P201-US204-1111US2041111A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-27T14:212020-08-27 BB<mRNA-1273-P201SEmRNA-1273-P201-US204-1111US2041111A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-02-15 B<BèmRNA-1273-P201SEmRNA-1273-P201-US204-1112US2041112ASCREEN Screening ASCREENING 2020-06-11 2020-06-26T13:02ÁðAmRNA-1273-P201SEmRNA-1273-P201-US204-1112US2041112A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T13:022020-07-28T16:05AB!mRNA-1273-P201SEmRNA-1273-P201-US204-1112US2041112A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-28T16:052020-09-01 B!BDmRNA-1273-P201SEmRNA-1273-P201-US204-1112US2041112A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-01 2021-02-18 BDBîmRNA-1273-P201SEmRNA-1273-P201-US204-1113US2041113ASCREEN Screening ASCREENING 2020-06-11 2020-06-30T10:38ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1113US2041113A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-30T10:382020-07-28T14:17ABmRNA-1273-P201SEmRNA-1273-P201-US204-1113US2041113A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-28T14:172020-08-25 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1113US2041113A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-16 B9BèmRNA-1273-P201SEmRNA-1273-P201-US204-1114US2041114ASCREEN Screening ASCREENING 2020-06-11 2020-06-26T15:39ÁðAmRNA-1273-P201SEmRNA-1273-P201-US204-1114US2041114A PBO Placebo A BLINDED TREATMENT 2020-06-26T15:392020-08-03T11:51AB'mRNA-1273-P201SEmRNA-1273-P201-US204-1114US2041114A0PBO Placebo A0BLINDED TREATMENT 2020-08-03T11:512020-09-01 B'BDmRNA-1273-P201SEmRNA-1273-P201-US204-1114US2041114A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-01 2021-02-19 BDBïmRNA-1273-P201SEmRNA-1273-P201-US204-1115US2041115ASCREEN Screening ASCREENING 2020-06-11 2020-07-01T13:21ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1115US2041115A PBO Placebo A BLINDED TREATMENT 2020-07-01T13:212020-08-04T11:52AB#mRNA-1273-P201SEmRNA-1273-P201-US204-1115US2041115A0PBO Placebo A0BLINDED TREATMENT 2020-08-04T11:522020-08-31 B#B>mRNA-1273-P201SEmRNA-1273-P201-US204-1115US2041115A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-04-13 B>CðmRNA-1273-P201SEmRNA-1273-P201-US204-1116US2041116ASCREEN Screening ASCREENING 2020-06-11 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1117US2041117ASCREEN Screening ASCREENING 2020-06-11 2020-06-26T15:09ÁðAmRNA-1273-P201SEmRNA-1273-P201-US204-1117US2041117A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T15:092020-07-28T16:11AB!mRNA-1273-P201SEmRNA-1273-P201-US204-1117US2041117A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-28T16:112020-08-25 B!B=mRNA-1273-P201SEmRNA-1273-P201-US204-1117US2041117A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-17 B=BímRNA-1273-P201SEmRNA-1273-P201-US204-1118US2041118ASCREEN Screening ASCREENING 2020-06-11 2020-06-29T16:42ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1118US2041118A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-29T16:422020-07-28T13:51ABmRNA-1273-P201SEmRNA-1273-P201-US204-1118US2041118A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-28T13:512020-08-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1118US2041118A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-17 B9BêmRNA-1273-P201SEmRNA-1273-P201-US204-1119US2041119ASCREEN Screening ASCREENING 2020-06-11 2020-07-06T13:49ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1119US2041119A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-06T13:492020-08-04T10:05ABmRNA-1273-P201SEmRNA-1273-P201-US204-1119US2041119A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-04T10:052020-09-01 BB:mRNA-1273-P201SEmRNA-1273-P201-US204-1119US2041119A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-01 2021-02-15 B:BámRNA-1273-P201SEmRNA-1273-P201-US204-1120US2041120ASCREEN Screening ASCREENING 2020-06-11 2020-06-30T14:26ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1120US2041120A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-30T14:262020-07-28T09:40ABmRNA-1273-P201SEmRNA-1273-P201-US204-1120US2041120A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-28T09:402020-08-24 BB8mRNA-1273-P201SEmRNA-1273-P201-US204-1120US2041120A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-17 B8BémRNA-1273-P201SEmRNA-1273-P201-US204-1121US2041121ASCREEN Screening ASCREENING 2020-06-12 2020-07-01T15:29ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1121US2041121A PBO Placebo A BLINDED TREATMENT 2020-07-01T15:292020-07-31T10:40ABmRNA-1273-P201SEmRNA-1273-P201-US204-1121US2041121A0PBO Placebo A0BLINDED TREATMENT 2020-07-31T10:402020-08-25 BB8mRNA-1273-P201SEmRNA-1273-P201-US204-1121US2041121A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-16 B8BçmRNA-1273-P201SEmRNA-1273-P201-US204-1122US2041122ASCREEN Screening ASCREENING 2020-06-12 2020-06-29T09:22ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1122US2041122A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-29T09:222020-07-27T14:07ABmRNA-1273-P201SEmRNA-1273-P201-US204-1122US2041122A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-27T14:072020-08-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1122US2041122A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-18 B9BëmRNA-1273-P201SEmRNA-1273-P201-US204-1123US2041123ASCREEN Screening ASCREENING 2020-06-12 2020-06-26T09:22ÁàAmRNA-1273-P201SEmRNA-1273-P201-US204-1123US2041123A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T09:222020-07-24T11:01ABmRNA-1273-P201SEmRNA-1273-P201-US204-1123US2041123A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-24T11:012020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1123US2041123A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-02-19 B9BïmRNA-1273-P201SEmRNA-1273-P201-US204-1124US2041124ASCREEN Screening ASCREENING 2020-06-12 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1125US2041125ASCREEN Screening ASCREENING 2020-06-12 2020-06-29T15:36ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1125US2041125A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-29T15:362020-07-28T16:39ABmRNA-1273-P201SEmRNA-1273-P201-US204-1125US2041125A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-28T16:392020-08-25 BB:mRNA-1273-P201SEmRNA-1273-P201-US204-1125US2041125A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-19 B:BìmRNA-1273-P201SEmRNA-1273-P201-US204-1126US2041126ASCREEN Screening ASCREENING 2020-06-12 2020-06-26T12:45ÁàAmRNA-1273-P201SEmRNA-1273-P201-US204-1126US2041126A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T12:452020-07-28T11:11AB!mRNA-1273-P201SEmRNA-1273-P201-US204-1126US2041126A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-28T11:112020-08-28 B!B@mRNA-1273-P201SEmRNA-1273-P201-US204-1126US2041126A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-17 B@BímRNA-1273-P201SEmRNA-1273-P201-US204-1127US2041127ASCREEN Screening ASCREENING 2020-06-12 2020-06-26T12:19ÁàAmRNA-1273-P201SEmRNA-1273-P201-US204-1127US2041127A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T12:192020-07-24T12:24ABmRNA-1273-P201SEmRNA-1273-P201-US204-1127US2041127A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-24T12:242020-08-24 BB<mRNA-1273-P201SEmRNA-1273-P201-US204-1127US2041127A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-03-11 B<C0mRNA-1273-P201SEmRNA-1273-P201-US204-1128US2041128ASCREEN Screening ASCREENING 2020-06-12 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1129US2041129ASCREEN Screening ASCREENING 2020-06-15 2020-06-24 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1130US2041130ASCREEN Screening ASCREENING 2020-06-15 2020-06-26T15:14Á°AmRNA-1273-P201SEmRNA-1273-P201-US204-1130US2041130A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T15:142020-07-24T11:25ABmRNA-1273-P201SEmRNA-1273-P201-US204-1130US2041130A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-24T11:252020-08-18 BB6mRNA-1273-P201SEmRNA-1273-P201-US204-1130US2041130A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-18 2021-02-17 B6BímRNA-1273-P201SEmRNA-1273-P201-US204-1131US2041131ASCREEN Screening ASCREENING 2020-06-15 2020-06-29T14:32ÁàAmRNA-1273-P201SEmRNA-1273-P201-US204-1131US2041131A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-29T14:322020-08-10T10:11AB+mRNA-1273-P201SEmRNA-1273-P201-US204-1131US2041131A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-10T10:112020-09-15 B+BOmRNA-1273-P201SEmRNA-1273-P201-US204-1131US2041131A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-15 2021-02-16 BOBémRNA-1273-P201SEmRNA-1273-P201-US204-1132US2041132ASCREEN Screening ASCREENING 2020-06-15 2020-06-26T08:50Á°AmRNA-1273-P201SEmRNA-1273-P201-US204-1132US2041132A PBO Placebo A BLINDED TREATMENT 2020-06-26T08:502020-07-27T11:52AB mRNA-1273-P201SEmRNA-1273-P201-US204-1132US2041132A0PBO Placebo A0BLINDED TREATMENT 2020-07-27T11:522020-08-25 B B=mRNA-1273-P201SEmRNA-1273-P201-US204-1132US2041132A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-18 B=BîmRNA-1273-P201SEmRNA-1273-P201-US204-1133US2041133ASCREEN Screening ASCREENING 2020-06-15 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1134US2041134ASCREEN Screening ASCREENING 2020-06-15 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1135US2041135ASCREEN Screening ASCREENING 2020-06-15 2020-06-15 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1136US2041136ASCREEN Screening ASCREENING 2020-06-15 2020-07-01T11:54ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1136US2041136A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-01T11:542020-08-03T15:19AB"mRNA-1273-P201SEmRNA-1273-P201-US204-1136US2041136A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-03T15:192020-09-01 B"B?mRNA-1273-P201SEmRNA-1273-P201-US204-1136US2041136A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-01 2021-02-16 B?BçmRNA-1273-P201SEmRNA-1273-P201-US204-1137US2041137ASCREEN Screening ASCREENING 2020-06-15 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1138US2041138ASCREEN Screening ASCREENING 2020-06-16 2020-06-26T14:37Á AmRNA-1273-P201SEmRNA-1273-P201-US204-1138US2041138A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T14:372020-07-24T11:33ABmRNA-1273-P201SEmRNA-1273-P201-US204-1138US2041138A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-24T11:332020-08-18 BB6mRNA-1273-P201SEmRNA-1273-P201-US204-1138US2041138A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-18 2021-02-16 B6BìmRNA-1273-P201SEmRNA-1273-P201-US204-1139US2041139ASCREEN Screening ASCREENING 2020-06-16 2020-06-29T14:15ÁÐAmRNA-1273-P201SEmRNA-1273-P201-US204-1139US2041139A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-29T14:152020-07-28T11:45ABmRNA-1273-P201SEmRNA-1273-P201-US204-1139US2041139A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-28T11:452020-08-25 BB:mRNA-1273-P201SEmRNA-1273-P201-US204-1139US2041139A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-16 B:BémRNA-1273-P201SEmRNA-1273-P201-US204-1140US2041140ASCREEN Screening ASCREENING 2020-06-16 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1141US2041141ASCREEN Screening ASCREENING 2020-06-16 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1142US2041142ASCREEN Screening ASCREENING 2020-06-16 2020-07-02T15:57ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1142US2041142A PBO Placebo A BLINDED TREATMENT 2020-07-02T15:572020-07-31T11:50ABmRNA-1273-P201SEmRNA-1273-P201-US204-1142US2041142A0PBO Placebo A0BLINDED TREATMENT 2020-07-31T11:502020-08-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US204-1142US2041142A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-17 B:BçmRNA-1273-P201SEmRNA-1273-P201-US204-1143US2041143ASCREEN Screening ASCREENING 2020-06-16 2020-06-19 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1144US2041144ASCREEN Screening ASCREENING 2020-06-16 2020-06-26T14:31Á AmRNA-1273-P201SEmRNA-1273-P201-US204-1144US2041144A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T14:312020-07-28T12:05AB!mRNA-1273-P201SEmRNA-1273-P201-US204-1144US2041144A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-28T12:052020-08-25 B!B=mRNA-1273-P201SEmRNA-1273-P201-US204-1144US2041144A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-18 B=BîmRNA-1273-P201SEmRNA-1273-P201-US204-1145US2041145ASCREEN Screening ASCREENING 2020-06-17 2020-07-02T16:45ÁðAmRNA-1273-P201SEmRNA-1273-P201-US204-1145US2041145A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-02T16:452020-07-31T09:20ABmRNA-1273-P201SEmRNA-1273-P201-US204-1145US2041145A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-31T09:202020-08-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US204-1145US2041145A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-17 B:BçmRNA-1273-P201SEmRNA-1273-P201-US204-1146US2041146ASCREEN Screening ASCREENING 2020-06-17 2020-07-02T17:03ÁðAmRNA-1273-P201SEmRNA-1273-P201-US204-1146US2041146A PBO Placebo A BLINDED TREATMENT 2020-07-02T17:032020-07-31T08:42ABmRNA-1273-P201SEmRNA-1273-P201-US204-1146US2041146A0PBO Placebo A0BLINDED TREATMENT 2020-07-31T08:422020-08-26 BB8mRNA-1273-P201SEmRNA-1273-P201-US204-1146US2041146A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-02-15 B8BåmRNA-1273-P201SEmRNA-1273-P201-US204-1147US2041147ASCREEN Screening ASCREENING 2020-06-17 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1148US2041148ASCREEN Screening ASCREENING 2020-06-17 2020-06-17 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1149US2041149ASCREEN Screening ASCREENING 2020-06-18 2020-07-06T15:53ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1149US2041149A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-06T15:532020-08-03T12:40ABmRNA-1273-P201SEmRNA-1273-P201-US204-1149US2041149A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-03T12:402020-09-02 BB;mRNA-1273-P201SEmRNA-1273-P201-US204-1149US2041149A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-02 2021-02-17 B;BãmRNA-1273-P201SEmRNA-1273-P201-US204-1150US2041150ASCREEN Screening ASCREENING 2020-06-18 2020-07-01T11:13ÁÐAmRNA-1273-P201SEmRNA-1273-P201-US204-1150US2041150A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-01T11:132020-08-03T10:00AB"mRNA-1273-P201SEmRNA-1273-P201-US204-1150US2041150A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-03T10:002020-09-02 B"B@mRNA-1273-P201SEmRNA-1273-P201-US204-1150US2041150A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-02 2021-02-17 B@BèmRNA-1273-P201SEmRNA-1273-P201-US204-1151US2041151ASCREEN Screening ASCREENING 2020-06-19 2020-07-06T14:56ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1151US2041151A PBO Placebo A BLINDED TREATMENT 2020-07-06T14:562020-08-04T11:21ABmRNA-1273-P201SEmRNA-1273-P201-US204-1151US2041151A0PBO Placebo A0BLINDED TREATMENT 2020-08-04T11:212020-09-01 BB:mRNA-1273-P201SEmRNA-1273-P201-US204-1151US2041151A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-01 2021-02-18 B:BämRNA-1273-P201SEmRNA-1273-P201-US204-1152US2041152ASCREEN Screening ASCREENING 2020-06-19 2020-07-07T15:20ÂAmRNA-1273-P201SEmRNA-1273-P201-US204-1152US2041152A PBO Placebo A BLINDED TREATMENT 2020-07-07T15:202020-08-04T11:00ABmRNA-1273-P201SEmRNA-1273-P201-US204-1152US2041152A0PBO Placebo A0BLINDED TREATMENT 2020-08-04T11:002020-09-03 BB;mRNA-1273-P201SEmRNA-1273-P201-US204-1152US2041152A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-03 2021-03-03 B;BðmRNA-1273-P201SEmRNA-1273-P201-US204-1153US2041153ASCREEN Screening ASCREENING 2020-06-23 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1154US2041154ASCREEN Screening ASCREENING 2020-06-25 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1155US2041155ASCREEN Screening ASCREENING 2020-06-29 2020-07-06T15:33ÁpAmRNA-1273-P201SEmRNA-1273-P201-US204-1155US2041155A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-06T15:332020-08-03T14:15ABmRNA-1273-P201SEmRNA-1273-P201-US204-1155US2041155A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-03T14:152020-08-31 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1155US2041155A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-19 B9BåmRNA-1273-P201SEmRNA-1273-P201-US204-1156US2041156ASCREEN Screening ASCREENING 2020-06-29 2020-06-29 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1157US2041157ASCREEN Screening ASCREENING 2020-06-29 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1158US2041158ASCREEN Screening ASCREENING 2020-06-30 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1159US2041159ASCREEN Screening ASCREENING 2020-06-30 2020-06-30 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1160US2041160ASCREEN Screening ASCREENING 2020-06-30 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1161US2041161ASCREEN Screening ASCREENING 2020-07-01 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1162US2041162ASCREEN Screening ASCREENING 2020-07-01 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1163US2041163ASCREEN Screening ASCREENING 2020-07-01 2020-07-01 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1164US2041164ASCREEN Screening ASCREENING 2020-07-01 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1165US2041165ASCREEN Screening ASCREENING 2020-07-01 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1166US2041166ASCREEN Screening ASCREENING 2020-07-01 2020-07-06T14:12ÁPAmRNA-1273-P201SEmRNA-1273-P201-US204-1166US2041166A PBO Placebo A BLINDED TREATMENT 2020-07-06T14:122020-08-03T08:41ABmRNA-1273-P201SEmRNA-1273-P201-US204-1166US2041166A0PBO Placebo A0BLINDED TREATMENT 2020-08-03T08:412020-08-31 BB9mRNA-1273-P201SEmRNA-1273-P201-US204-1166US2041166A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-19 B9BåmRNA-1273-P201SEmRNA-1273-P201-US204-1167US2041167ASCREEN Screening ASCREENING 2020-07-01 2020-07-07 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1168US2041168ASCREEN Screening ASCREENING 2020-07-01 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1169US2041169ASCREEN Screening ASCREENING 2020-07-02 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1170US2041170ASCREEN Screening ASCREENING 2020-07-07 2020-07-07 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1171US2041171ASCREEN Screening ASCREENING 2020-07-07 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US204-1172US2041172ASCREEN Screening ASCREENING 2020-07-07 2020-07-07 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1001US2051001ASCREEN Screening ASCREENING 2020-05-26 2020-06-04T09:50ÁAmRNA-1273-P201SEmRNA-1273-P201-US205-1001US2051001A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-04T09:502020-07-02T09:25ABmRNA-1273-P201SEmRNA-1273-P201-US205-1001US2051001A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-02T09:252020-07-29 BB8mRNA-1273-P201SEmRNA-1273-P201-US205-1001US2051001A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-02-18 B8C@mRNA-1273-P201SEmRNA-1273-P201-US205-1002US2051002ASCREEN Screening ASCREENING 2020-05-26 2020-06-02T12:58ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1002US2051002A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T12:582020-07-02T10:26ABmRNA-1273-P201SEmRNA-1273-P201-US205-1002US2051002A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-02T10:262020-07-27 BB8mRNA-1273-P201SEmRNA-1273-P201-US205-1002US2051002A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-15 B8C0mRNA-1273-P201SEmRNA-1273-P201-US205-1003US2051003ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T13:45Á0AmRNA-1273-P201SEmRNA-1273-P201-US205-1003US2051003A UNPLAN mRNA-1273: >100-125 ug.BLINDED TREATMENT 2020-05-29T13:452020-06-23T11:23ABmRNA-1273-P201SEmRNA-1273-P201-US205-1003US2051003A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-23T11:232020-07-28 BB=mRNA-1273-P201SEmRNA-1273-P201-US205-1003US2051003A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2020-11-30 B=BºmRNA-1273-P201SEmRNA-1273-P201-US205-1004US2051004ASCREEN Screening ASCREENING 2020-05-26 2020-06-11 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1005US2051005ASCREEN Screening ASCREENING 2020-05-26 2020-06-11 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1006US2051006ASCREEN Screening ASCREENING 2020-05-26 2020-06-11 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1007US2051007ASCREEN Screening ASCREENING 2020-05-26 2020-06-11 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1008US2051008ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T13:14Á0AmRNA-1273-P201SEmRNA-1273-P201-US205-1008US2051008A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-05-29T13:142020-06-30T10:16AB!mRNA-1273-P201SEmRNA-1273-P201-US205-1008US2051008A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T10:162020-07-27 B!B<mRNA-1273-P201SEmRNA-1273-P201-US205-1008US2051008A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-12 B<C@mRNA-1273-P201SEmRNA-1273-P201-US205-1009US2051009ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T10:38Á`AmRNA-1273-P201SEmRNA-1273-P201-US205-1009US2051009A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T10:382020-06-30T08:58ABmRNA-1273-P201SEmRNA-1273-P201-US205-1009US2051009A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T08:582020-08-04 BB@mRNA-1273-P201SEmRNA-1273-P201-US205-1009US2051009A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-18 B@C`mRNA-1273-P201SEmRNA-1273-P201-US205-1010US2051010ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T13:37Á`AmRNA-1273-P201SEmRNA-1273-P201-US205-1010US2051010A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T13:372020-06-30T10:47ABmRNA-1273-P201SEmRNA-1273-P201-US205-1010US2051010A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T10:472020-07-29 BB:mRNA-1273-P201SEmRNA-1273-P201-US205-1010US2051010A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-02-16 B:C@mRNA-1273-P201SEmRNA-1273-P201-US205-1011US2051011ASCREEN Screening ASCREENING 2020-05-27 2020-06-03T13:08ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1011US2051011A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T13:082020-07-07T10:28AB#mRNA-1273-P201SEmRNA-1273-P201-US205-1011US2051011A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T10:282020-07-30 B#B:mRNA-1273-P201SEmRNA-1273-P201-US205-1011US2051011A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-16 B:C0mRNA-1273-P201SEmRNA-1273-P201-US205-1012US2051012ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T14:37Á`AmRNA-1273-P201SEmRNA-1273-P201-US205-1012US2051012A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T14:372020-07-01T12:02ABmRNA-1273-P201SEmRNA-1273-P201-US205-1012US2051012A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T12:022020-07-27 BB8mRNA-1273-P201SEmRNA-1273-P201-US205-1012US2051012A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-15 B8C0mRNA-1273-P201SEmRNA-1273-P201-US205-1013US2051013ASCREEN Screening ASCREENING 2020-05-27 2020-06-03T12:14ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1013US2051013A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T12:142020-07-01T15:29ABmRNA-1273-P201SEmRNA-1273-P201-US205-1013US2051013A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T15:292020-07-29 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1013US2051013A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-03-10 B9CmRNA-1273-P201SEmRNA-1273-P201-US205-1014US2051014ASCREEN Screening ASCREENING 2020-05-27 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1015US2051015ASCREEN Screening ASCREENING 2020-05-27 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1016US2051016ASCREEN Screening ASCREENING 2020-05-27 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1017US2051017ASCREEN Screening ASCREENING 2020-05-27 2020-06-05T13:35ÁAmRNA-1273-P201SEmRNA-1273-P201-US205-1017US2051017A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-05T13:352020-07-07T09:47AB!mRNA-1273-P201SEmRNA-1273-P201-US205-1017US2051017A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T09:472020-07-29 B!B7mRNA-1273-P201SEmRNA-1273-P201-US205-1017US2051017A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-02-22 B7CpmRNA-1273-P201SEmRNA-1273-P201-US205-1018US2051018ASCREEN Screening ASCREENING 2020-05-27 2020-06-08T09:29ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US205-1018US2051018A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T09:292020-07-07T15:07ABmRNA-1273-P201SEmRNA-1273-P201-US205-1018US2051018A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T15:072020-08-05 BB;mRNA-1273-P201SEmRNA-1273-P201-US205-1018US2051018A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-15 B;BýmRNA-1273-P201SEmRNA-1273-P201-US205-1019US2051019ASCREEN Screening ASCREENING 2020-05-27 2020-06-09T10:53ÁÐAmRNA-1273-P201SEmRNA-1273-P201-US205-1019US2051019A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-09T10:532020-07-07T15:05ABmRNA-1273-P201SEmRNA-1273-P201-US205-1019US2051019A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T15:052020-08-10 BB?mRNA-1273-P201SEmRNA-1273-P201-US205-1019US2051019A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-15 B?BümRNA-1273-P201SEmRNA-1273-P201-US205-1020US2051020ASCREEN Screening ASCREENING 2020-05-27 2020-06-04T11:49Á€AmRNA-1273-P201SEmRNA-1273-P201-US205-1020US2051020A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-04T11:492020-07-02T14:21ABmRNA-1273-P201SEmRNA-1273-P201-US205-1020US2051020A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-02T14:212020-08-03 BB=mRNA-1273-P201SEmRNA-1273-P201-US205-1020US2051020A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-03-01 B=CðmRNA-1273-P201SEmRNA-1273-P201-US205-1021US2051021ASCREEN Screening ASCREENING 2020-05-28 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1022US2051022ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T09:31Á`AmRNA-1273-P201SEmRNA-1273-P201-US205-1022US2051022A PBO Placebo A BLINDED TREATMENT 2020-06-03T09:312020-07-07T09:45AB#mRNA-1273-P201SEmRNA-1273-P201-US205-1022US2051022A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T09:452020-07-29 B#B9mRNA-1273-P201SEmRNA-1273-P201-US205-1022US2051022A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-02-22 B9CmRNA-1273-P201SEmRNA-1273-P201-US205-1023US2051023ASCREEN Screening ASCREENING 2020-05-28 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1024US2051024ASCREEN Screening ASCREENING 2020-05-27 2020-06-02T10:50Á`AmRNA-1273-P201SEmRNA-1273-P201-US205-1024US2051024A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T10:502020-07-07T11:01AB$mRNA-1273-P201SEmRNA-1273-P201-US205-1024US2051024A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T11:012020-07-28 B$B9mRNA-1273-P201SEmRNA-1273-P201-US205-1024US2051024A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-15 B9C0mRNA-1273-P201SEmRNA-1273-P201-US205-1025US2051025ASCREEN Screening ASCREENING 2020-05-28 2020-06-05T12:21Á€AmRNA-1273-P201SEmRNA-1273-P201-US205-1025US2051025A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-05T12:212020-07-09T10:22AB#mRNA-1273-P201SEmRNA-1273-P201-US205-1025US2051025A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-09T10:222020-07-30 B#B8mRNA-1273-P201SEmRNA-1273-P201-US205-1025US2051025A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-16 B8CmRNA-1273-P201SEmRNA-1273-P201-US205-1026US2051026ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T10:34ÁPAmRNA-1273-P201SEmRNA-1273-P201-US205-1026US2051026A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T10:342020-06-30T10:13ABmRNA-1273-P201SEmRNA-1273-P201-US205-1026US2051026A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-30T10:132020-08-04 BB@mRNA-1273-P201SEmRNA-1273-P201-US205-1026US2051026A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-17 B@CPmRNA-1273-P201SEmRNA-1273-P201-US205-1027US2051027ASCREEN Screening ASCREENING 2020-05-28 2020-06-08T13:10Á°AmRNA-1273-P201SEmRNA-1273-P201-US205-1027US2051027A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T13:102020-07-07T11:27ABmRNA-1273-P201SEmRNA-1273-P201-US205-1027US2051027A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T11:272020-07-31 BB6mRNA-1273-P201SEmRNA-1273-P201-US205-1027US2051027A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-02-18 B6CmRNA-1273-P201SEmRNA-1273-P201-US205-1028US2051028ASCREEN Screening ASCREENING 2020-05-28 2020-06-04T14:02ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1028US2051028A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-04T14:022020-06-15 AAÀmRNA-1273-P201SEmRNA-1273-P201-US205-1028US2051028A0FUPA Part A Follow up A@PART A FOLLOW-UP 2020-06-16 2021-02-19 AÐCPmRNA-1273-P201SEmRNA-1273-P201-US205-1029US2051029ASCREEN Screening ASCREENING 2020-05-28 2020-06-04T11:08ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1029US2051029A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-04T11:082020-07-09T12:45AB$mRNA-1273-P201SEmRNA-1273-P201-US205-1029US2051029A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-09T12:452020-07-30 B$B9mRNA-1273-P201SEmRNA-1273-P201-US205-1029US2051029A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-09 B9BûmRNA-1273-P201SEmRNA-1273-P201-US205-1030US2051030ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T09:55Á`AmRNA-1273-P201SEmRNA-1273-P201-US205-1030US2051030A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T09:552020-07-06T13:14AB"mRNA-1273-P201SEmRNA-1273-P201-US205-1030US2051030A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-06T13:142020-08-04 B"B?mRNA-1273-P201SEmRNA-1273-P201-US205-1030US2051030A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-16 B?C0mRNA-1273-P201SEmRNA-1273-P201-US205-1031US2051031ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T15:35ÁPAmRNA-1273-P201SEmRNA-1273-P201-US205-1031US2051031A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T15:352020-06-30T14:53ABmRNA-1273-P201SEmRNA-1273-P201-US205-1031US2051031A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T14:532020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1031US2051031A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-23 B9C°mRNA-1273-P201SEmRNA-1273-P201-US205-1032US2051032ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T11:06ÁPAmRNA-1273-P201SEmRNA-1273-P201-US205-1032US2051032A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T11:062020-06-30T09:21ABmRNA-1273-P201SEmRNA-1273-P201-US205-1032US2051032A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T09:212020-07-27 BB8mRNA-1273-P201SEmRNA-1273-P201-US205-1032US2051032A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-16 B8C@mRNA-1273-P201SEmRNA-1273-P201-US205-1033US2051033ASCREEN Screening ASCREENING 2020-05-28 2020-06-04T15:28ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1033US2051033A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-04T15:282020-07-07T10:16AB"mRNA-1273-P201SEmRNA-1273-P201-US205-1033US2051033A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T10:162020-07-28 B"B7mRNA-1273-P201SEmRNA-1273-P201-US205-1033US2051033A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-16 B7C mRNA-1273-P201SEmRNA-1273-P201-US205-1034US2051034ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T09:35Á`AmRNA-1273-P201SEmRNA-1273-P201-US205-1034US2051034A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T09:352020-07-01T12:41ABmRNA-1273-P201SEmRNA-1273-P201-US205-1034US2051034A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-01T12:412020-07-29 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1034US2051034A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-02-16 B9C0mRNA-1273-P201SEmRNA-1273-P201-US205-1035US2051035ASCREEN Screening ASCREENING 2020-05-28 2020-06-04T10:02ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1035US2051035A PBO Placebo A BLINDED TREATMENT 2020-06-04T10:022020-07-08T14:01AB#mRNA-1273-P201SEmRNA-1273-P201-US205-1035US2051035A0PBO Placebo A0BLINDED TREATMENT 2020-07-08T14:012020-07-30 B#B9mRNA-1273-P201SEmRNA-1273-P201-US205-1035US2051035A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-03-26 B9C€mRNA-1273-P201SEmRNA-1273-P201-US205-1036US2051036ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T15:17ÁPAmRNA-1273-P201SEmRNA-1273-P201-US205-1036US2051036A PBO Placebo A BLINDED TREATMENT 2020-06-02T15:172020-07-02T14:22ABmRNA-1273-P201SEmRNA-1273-P201-US205-1036US2051036A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T14:222020-07-31 BB<mRNA-1273-P201SEmRNA-1273-P201-US205-1036US2051036A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-02-18 B<C`mRNA-1273-P201SEmRNA-1273-P201-US205-1037US2051037ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1038US2051038ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T16:06ÁPAmRNA-1273-P201SEmRNA-1273-P201-US205-1038US2051038A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T16:062020-07-02 ABmRNA-1273-P201SEmRNA-1273-P201-US205-1039US2051039ASCREEN Screening ASCREENING 2020-05-29 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1040US2051040ASCREEN Screening ASCREENING 2020-05-29 2020-06-05T14:28ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1040US2051040A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-05T14:282020-07-07T14:05AB!mRNA-1273-P201SEmRNA-1273-P201-US205-1040US2051040A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T14:052020-08-05 B!B>mRNA-1273-P201SEmRNA-1273-P201-US205-1040US2051040A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-18 B>C0mRNA-1273-P201SEmRNA-1273-P201-US205-1041US2051041ASCREEN Screening ASCREENING 2020-05-29 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1042US2051042ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T11:52Á@AmRNA-1273-P201SEmRNA-1273-P201-US205-1042US2051042A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T11:522020-07-01T13:22ABmRNA-1273-P201SEmRNA-1273-P201-US205-1042US2051042A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-01T13:222020-07-29 BB:mRNA-1273-P201SEmRNA-1273-P201-US205-1042US2051042A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-02-15 B:C0mRNA-1273-P201SEmRNA-1273-P201-US205-1043US2051043ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T13:27ÁPAmRNA-1273-P201SEmRNA-1273-P201-US205-1043US2051043A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T13:272020-07-01T15:32ABmRNA-1273-P201SEmRNA-1273-P201-US205-1043US2051043A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-01T15:322020-07-27 BB7mRNA-1273-P201SEmRNA-1273-P201-US205-1043US2051043A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-16 B7C0mRNA-1273-P201SEmRNA-1273-P201-US205-1044US2051044ASCREEN Screening ASCREENING 2020-06-03 2020-06-05T14:03Á AmRNA-1273-P201SEmRNA-1273-P201-US205-1044US2051044A PBO Placebo A BLINDED TREATMENT 2020-06-05T14:032020-07-06T11:35AB mRNA-1273-P201SEmRNA-1273-P201-US205-1044US2051044A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T11:352020-07-28 B B6mRNA-1273-P201SEmRNA-1273-P201-US205-1044US2051044A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-10 B6BûmRNA-1273-P201SEmRNA-1273-P201-US205-1045US2051045ASCREEN Screening ASCREENING 2020-06-03 2020-06-10T13:11ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1045US2051045A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-10T13:112020-07-08T15:50ABmRNA-1273-P201SEmRNA-1273-P201-US205-1045US2051045A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-08T15:502020-08-04 BB8mRNA-1273-P201SEmRNA-1273-P201-US205-1045US2051045A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-03 B8BïmRNA-1273-P201SEmRNA-1273-P201-US205-1046US2051046ASCREEN Screening ASCREENING 2020-06-03 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1047US2051047ASCREEN Screening ASCREENING 2020-06-03 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1048US2051048ASCREEN Screening ASCREENING 2020-06-03 2020-06-09T13:21Á`AmRNA-1273-P201SEmRNA-1273-P201-US205-1048US2051048A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-09T13:212020-07-10T09:32AB mRNA-1273-P201SEmRNA-1273-P201-US205-1048US2051048A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-10T09:322020-08-05 B B:mRNA-1273-P201SEmRNA-1273-P201-US205-1048US2051048A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-17 B:BþmRNA-1273-P201SEmRNA-1273-P201-US205-1049US2051049ASCREEN Screening ASCREENING 2020-06-04 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1050US2051050ASCREEN Screening ASCREENING 2020-06-04 2020-06-08T15:42Á@AmRNA-1273-P201SEmRNA-1273-P201-US205-1050US2051050A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T15:422020-07-08T09:01ABmRNA-1273-P201SEmRNA-1273-P201-US205-1050US2051050A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-08T09:012020-08-05 BB;mRNA-1273-P201SEmRNA-1273-P201-US205-1050US2051050A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-22 B;C@mRNA-1273-P201SEmRNA-1273-P201-US205-1051US2051051ASCREEN Screening ASCREENING 2020-06-09 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1052US2051052ASCREEN Screening ASCREENING 2020-06-09 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1053US2051053ASCREEN Screening ASCREENING 2020-06-10 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1054US2051054ASCREEN Screening ASCREENING 2020-06-11 2020-06-26T11:13ÁðAmRNA-1273-P201SEmRNA-1273-P201-US205-1054US2051054A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T11:132020-07-24T10:55ABmRNA-1273-P201SEmRNA-1273-P201-US205-1054US2051054A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-24T10:552020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1054US2051054A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-02-18 B9BîmRNA-1273-P201SEmRNA-1273-P201-US205-1055US2051055ASCREEN Screening ASCREENING 2020-06-12 2020-06-26T09:49ÁàAmRNA-1273-P201SEmRNA-1273-P201-US205-1055US2051055A PBO Placebo A BLINDED TREATMENT 2020-06-26T09:492020-07-30T09:30AB#mRNA-1273-P201SEmRNA-1273-P201-US205-1055US2051055A0PBO Placebo A0BLINDED TREATMENT 2020-07-30T09:302020-08-25 B#B=mRNA-1273-P201SEmRNA-1273-P201-US205-1055US2051055A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-25 B=BõmRNA-1273-P201SEmRNA-1273-P201-US205-1056US2051056ASCREEN Screening ASCREENING 2020-06-12 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1057US2051057ASCREEN Screening ASCREENING 2020-06-15 2020-06-26T09:36Á°AmRNA-1273-P201SEmRNA-1273-P201-US205-1057US2051057A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T09:362020-07-24T09:00ABmRNA-1273-P201SEmRNA-1273-P201-US205-1057US2051057A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-24T09:002020-08-24 BB<mRNA-1273-P201SEmRNA-1273-P201-US205-1057US2051057A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-16 B<BìmRNA-1273-P201SEmRNA-1273-P201-US205-1058US2051058ASCREEN Screening ASCREENING 2020-06-15 2020-06-19 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1059US2051059ASCREEN Screening ASCREENING 2020-06-15 2020-06-26T14:33Á°AmRNA-1273-P201SEmRNA-1273-P201-US205-1059US2051059A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T14:332020-07-27T13:25AB mRNA-1273-P201SEmRNA-1273-P201-US205-1059US2051059A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-27T13:252020-08-18 B B6mRNA-1273-P201SEmRNA-1273-P201-US205-1059US2051059A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-18 2021-02-10 B6BæmRNA-1273-P201SEmRNA-1273-P201-US205-1060US2051060ASCREEN Screening ASCREENING 2020-06-16 2020-06-26T10:16Á AmRNA-1273-P201SEmRNA-1273-P201-US205-1060US2051060A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T10:162020-07-28T10:03AB!mRNA-1273-P201SEmRNA-1273-P201-US205-1060US2051060A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-28T10:032020-08-24 B!B<mRNA-1273-P201SEmRNA-1273-P201-US205-1060US2051060A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-23 B<BómRNA-1273-P201SEmRNA-1273-P201-US205-1061US2051061ASCREEN Screening ASCREENING 2020-06-16 2020-06-24 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1062US2051062ASCREEN Screening ASCREENING 2020-06-16 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1063US2051063ASCREEN Screening ASCREENING 2020-06-16 2020-06-30T14:27ÁàAmRNA-1273-P201SEmRNA-1273-P201-US205-1063US2051063A PBO Placebo A BLINDED TREATMENT 2020-06-30T14:272020-07-28T10:41ABmRNA-1273-P201SEmRNA-1273-P201-US205-1063US2051063A0PBO Placebo A0BLINDED TREATMENT 2020-07-28T10:412020-08-25 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1063US2051063A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-18 B9BêmRNA-1273-P201SEmRNA-1273-P201-US205-1064US2051064ASCREEN Screening ASCREENING 2020-06-17 2020-07-01T09:58ÁàAmRNA-1273-P201SEmRNA-1273-P201-US205-1064US2051064A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-01T09:582020-07-29T10:13ABmRNA-1273-P201SEmRNA-1273-P201-US205-1064US2051064A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T10:132020-08-27 BB:mRNA-1273-P201SEmRNA-1273-P201-US205-1064US2051064A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-02-12 B:BãmRNA-1273-P201SEmRNA-1273-P201-US205-1065US2051065ASCREEN Screening ASCREENING 2020-06-17 2020-06-25 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1066US2051066ASCREEN Screening ASCREENING 2020-06-17 2020-06-29T10:19ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US205-1066US2051066A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-29T10:192020-07-27T10:16ABmRNA-1273-P201SEmRNA-1273-P201-US205-1066US2051066A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-27T10:162020-08-21 BB6mRNA-1273-P201SEmRNA-1273-P201-US205-1066US2051066A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-02-09 B6BâmRNA-1273-P201SEmRNA-1273-P201-US205-1067US2051067ASCREEN Screening ASCREENING 2020-06-17 2020-06-17 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1068US2051068ASCREEN Screening ASCREENING 2020-06-17 2020-06-30T13:48ÁÐAmRNA-1273-P201SEmRNA-1273-P201-US205-1068US2051068A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-30T13:482020-07-28T13:08ABmRNA-1273-P201SEmRNA-1273-P201-US205-1068US2051068A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-28T13:082020-08-25 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1068US2051068A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-10 B9BâmRNA-1273-P201SEmRNA-1273-P201-US205-1069US2051069ASCREEN Screening ASCREENING 2020-06-18 2020-06-26T13:49Á€AmRNA-1273-P201SEmRNA-1273-P201-US205-1069US2051069A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T13:492020-07-28T09:17AB!mRNA-1273-P201SEmRNA-1273-P201-US205-1069US2051069A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-28T09:172020-08-26 B!B>mRNA-1273-P201SEmRNA-1273-P201-US205-1069US2051069A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-02-19 B>BïmRNA-1273-P201SEmRNA-1273-P201-US205-1070US2051070ASCREEN Screening ASCREENING 2020-06-18 2020-07-01T09:56ÁÐAmRNA-1273-P201SEmRNA-1273-P201-US205-1070US2051070A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-01T09:562020-08-03T09:23AB"mRNA-1273-P201SEmRNA-1273-P201-US205-1070US2051070A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-03T09:232020-08-28 B"B;mRNA-1273-P201SEmRNA-1273-P201-US205-1070US2051070A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-15 B;BæmRNA-1273-P201SEmRNA-1273-P201-US205-1071US2051071ASCREEN Screening ASCREENING 2020-06-18 2020-06-29T13:22Á°AmRNA-1273-P201SEmRNA-1273-P201-US205-1071US2051071A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-29T13:222020-07-27T14:29ABmRNA-1273-P201SEmRNA-1273-P201-US205-1071US2051071A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-27T14:292020-08-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1071US2051071A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-09 B9BâmRNA-1273-P201SEmRNA-1273-P201-US205-1072US2051072ASCREEN Screening ASCREENING 2020-06-19 2020-07-06T16:17ÂAmRNA-1273-P201SEmRNA-1273-P201-US205-1072US2051072A PBO Placebo A BLINDED TREATMENT 2020-07-06T16:172020-08-03T09:49ABmRNA-1273-P201SEmRNA-1273-P201-US205-1072US2051072A0PBO Placebo A0BLINDED TREATMENT 2020-08-03T09:492020-09-21 BBNmRNA-1273-P201SEmRNA-1273-P201-US205-1072US2051072A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-21 2021-02-08 BNBÚmRNA-1273-P201SEmRNA-1273-P201-US205-1073US2051073ASCREEN Screening ASCREENING 2020-06-19 2020-07-06T13:34ÂAmRNA-1273-P201SEmRNA-1273-P201-US205-1073US2051073A PBO Placebo A BLINDED TREATMENT 2020-07-06T13:342020-08-05T12:08ABmRNA-1273-P201SEmRNA-1273-P201-US205-1073US2051073A0PBO Placebo A0BLINDED TREATMENT 2020-08-05T12:082020-08-31 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1073US2051073A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-08 B9BÚmRNA-1273-P201SEmRNA-1273-P201-US205-1074US2051074ASCREEN Screening ASCREENING 2020-06-19 2020-06-30T10:27Á°AmRNA-1273-P201SEmRNA-1273-P201-US205-1074US2051074A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-30T10:272020-07-28T10:39ABmRNA-1273-P201SEmRNA-1273-P201-US205-1074US2051074A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-28T10:392020-08-25 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1074US2051074A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-12 B9BämRNA-1273-P201SEmRNA-1273-P201-US205-1075US2051075ASCREEN Screening ASCREENING 2020-06-19 2020-06-30T15:32Á°AmRNA-1273-P201SEmRNA-1273-P201-US205-1075US2051075A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-30T15:322020-07-29T13:26ABmRNA-1273-P201SEmRNA-1273-P201-US205-1075US2051075A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T13:262020-08-27 BB;mRNA-1273-P201SEmRNA-1273-P201-US205-1075US2051075A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-01-11 B;BÄmRNA-1273-P201SEmRNA-1273-P201-US205-1076US2051076ASCREEN Screening ASCREENING 2020-06-19 2020-06-19 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1077US2051077ASCREEN Screening ASCREENING 2020-06-22 2020-06-30T11:23Á€AmRNA-1273-P201SEmRNA-1273-P201-US205-1077US2051077A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-30T11:232020-07-29T14:24ABmRNA-1273-P201SEmRNA-1273-P201-US205-1077US2051077A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T14:242020-08-25 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1077US2051077A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-08 B9BàmRNA-1273-P201SEmRNA-1273-P201-US205-1078US2051078ASCREEN Screening ASCREENING 2020-06-22 2020-06-30T15:16Á€AmRNA-1273-P201SEmRNA-1273-P201-US205-1078US2051078A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-30T15:162020-07-29T09:13ABmRNA-1273-P201SEmRNA-1273-P201-US205-1078US2051078A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-29T09:132020-08-24 BB8mRNA-1273-P201SEmRNA-1273-P201-US205-1078US2051078A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-10 B8BâmRNA-1273-P201SEmRNA-1273-P201-US205-1079US2051079ASCREEN Screening ASCREENING 2020-06-22 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1080US2051080ASCREEN Screening ASCREENING 2020-06-22 2020-06-29 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1081US2051081ASCREEN Screening ASCREENING 2020-06-23 2020-06-29T12:49Á`AmRNA-1273-P201SEmRNA-1273-P201-US205-1081US2051081A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-29T12:492020-07-27T10:13ABmRNA-1273-P201SEmRNA-1273-P201-US205-1081US2051081A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-27T10:132020-08-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1081US2051081A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-10 B9BãmRNA-1273-P201SEmRNA-1273-P201-US205-1082US2051082ASCREEN Screening ASCREENING 2020-06-23 2020-06-29 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1083US2051083ASCREEN Screening ASCREENING 2020-06-23 2020-07-01 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1084US2051084ASCREEN Screening ASCREENING 2020-06-23 2020-07-01T12:08Á€AmRNA-1273-P201SEmRNA-1273-P201-US205-1084US2051084A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-01T12:082020-07-29T15:15ABmRNA-1273-P201SEmRNA-1273-P201-US205-1084US2051084A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T15:152020-09-02 BB@mRNA-1273-P201SEmRNA-1273-P201-US205-1084US2051084A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-02 2021-02-09 B@BàmRNA-1273-P201SEmRNA-1273-P201-US205-1085US2051085ASCREEN Screening ASCREENING 2020-06-24 2020-07-02T11:41Á€AmRNA-1273-P201SEmRNA-1273-P201-US205-1085US2051085A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-02T11:412020-07-30T10:24ABmRNA-1273-P201SEmRNA-1273-P201-US205-1085US2051085A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-30T10:242020-09-01 BB>mRNA-1273-P201SEmRNA-1273-P201-US205-1085US2051085A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-01 2021-02-10 B>BàmRNA-1273-P201SEmRNA-1273-P201-US205-1086US2051086ASCREEN Screening ASCREENING 2020-06-24 2020-07-06T15:06ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US205-1086US2051086A PBO Placebo A BLINDED TREATMENT 2020-07-06T15:062020-08-04T12:07ABmRNA-1273-P201SEmRNA-1273-P201-US205-1086US2051086A0PBO Placebo A0BLINDED TREATMENT 2020-08-04T12:072020-09-03 BB<mRNA-1273-P201SEmRNA-1273-P201-US205-1086US2051086A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-03 2021-02-09 B<BÛmRNA-1273-P201SEmRNA-1273-P201-US205-1087US2051087ASCREEN Screening ASCREENING 2020-06-25 2020-07-06T10:40Á°AmRNA-1273-P201SEmRNA-1273-P201-US205-1087US2051087A PBO Placebo A BLINDED TREATMENT 2020-07-06T10:402020-08-04T09:23ABmRNA-1273-P201SEmRNA-1273-P201-US205-1087US2051087A0PBO Placebo A0BLINDED TREATMENT 2020-08-04T09:232020-09-08 BBAmRNA-1273-P201SEmRNA-1273-P201-US205-1087US2051087A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-08 2021-02-08 BABÚmRNA-1273-P201SEmRNA-1273-P201-US205-1088US2051088ASCREEN Screening ASCREENING 2020-06-25 2020-06-30T13:28ÁPAmRNA-1273-P201SEmRNA-1273-P201-US205-1088US2051088A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-30T13:282020-07-28T10:05ABmRNA-1273-P201SEmRNA-1273-P201-US205-1088US2051088A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-28T10:052020-08-25 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1088US2051088A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-12 B9BämRNA-1273-P201SEmRNA-1273-P201-US205-1089US2051089ASCREEN Screening ASCREENING 2020-06-25 2020-07-02T12:33ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1089US2051089A PBO Placebo A BLINDED TREATMENT 2020-07-02T12:332020-07-30T10:48ABmRNA-1273-P201SEmRNA-1273-P201-US205-1089US2051089A0PBO Placebo A0BLINDED TREATMENT 2020-07-30T10:482020-08-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US205-1089US2051089A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-09 B:BßmRNA-1273-P201SEmRNA-1273-P201-US205-1090US2051090ASCREEN Screening ASCREENING 2020-06-25 2020-06-29 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1091US2051091ASCREEN Screening ASCREENING 2020-06-26 2020-07-02 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1092US2051092ASCREEN Screening ASCREENING 2020-06-26 2020-07-07T12:08Á°AmRNA-1273-P201SEmRNA-1273-P201-US205-1092US2051092A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-07T12:082020-08-06T10:22ABmRNA-1273-P201SEmRNA-1273-P201-US205-1092US2051092A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-06T10:222020-09-03 BB;mRNA-1273-P201SEmRNA-1273-P201-US205-1092US2051092A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-03 2021-02-10 B;BÛmRNA-1273-P201SEmRNA-1273-P201-US205-1093US2051093ASCREEN Screening ASCREENING 2020-06-26 2020-07-06T09:42Á AmRNA-1273-P201SEmRNA-1273-P201-US205-1093US2051093A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-06T09:422020-08-04T10:45ABmRNA-1273-P201SEmRNA-1273-P201-US205-1093US2051093A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-04T10:452020-09-01 BB:mRNA-1273-P201SEmRNA-1273-P201-US205-1093US2051093A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-01 2021-02-08 B:BÚmRNA-1273-P201SEmRNA-1273-P201-US205-1094US2051094ASCREEN Screening ASCREENING 2020-06-29 2020-07-07T11:41Á€AmRNA-1273-P201SEmRNA-1273-P201-US205-1094US2051094A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-07T11:412020-08-04T11:43ABmRNA-1273-P201SEmRNA-1273-P201-US205-1094US2051094A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-04T11:432020-09-02 BB:mRNA-1273-P201SEmRNA-1273-P201-US205-1094US2051094A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-02 2021-02-10 B:BÛmRNA-1273-P201SEmRNA-1273-P201-US205-1095US2051095ASCREEN Screening ASCREENING 2020-06-29 2020-07-02T12:15Á0AmRNA-1273-P201SEmRNA-1273-P201-US205-1095US2051095A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-02T12:152020-07-30T12:22ABmRNA-1273-P201SEmRNA-1273-P201-US205-1095US2051095A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-30T12:222020-08-26 BB8mRNA-1273-P201SEmRNA-1273-P201-US205-1095US2051095A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-02-10 B8BàmRNA-1273-P201SEmRNA-1273-P201-US205-1096US2051096ASCREEN Screening ASCREENING 2020-06-29 2020-07-06T10:12ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1096US2051096A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-06T10:122020-08-03T10:12ABmRNA-1273-P201SEmRNA-1273-P201-US205-1096US2051096A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-03T10:122020-08-31 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1096US2051096A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-12 B9BÞmRNA-1273-P201SEmRNA-1273-P201-US205-1097US2051097ASCREEN Screening ASCREENING 2020-06-29 2020-07-06T10:10ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1097US2051097A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-06T10:102020-08-03T10:33ABmRNA-1273-P201SEmRNA-1273-P201-US205-1097US2051097A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-03T10:332020-08-31 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1097US2051097A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-09 B9BÛmRNA-1273-P201SEmRNA-1273-P201-US205-1098US2051098ASCREEN Screening ASCREENING 2020-06-29 2020-07-06T14:19ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1098US2051098A PBO Placebo A BLINDED TREATMENT 2020-07-06T14:192020-08-05T10:09ABmRNA-1273-P201SEmRNA-1273-P201-US205-1098US2051098A0PBO Placebo A0BLINDED TREATMENT 2020-08-05T10:092020-09-08 BBAmRNA-1273-P201SEmRNA-1273-P201-US205-1098US2051098A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-08 2021-02-09 BABÛmRNA-1273-P201SEmRNA-1273-P201-US205-1099US2051099ASCREEN Screening ASCREENING 2020-06-29 2020-07-06T13:03ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1099US2051099A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-06T13:032020-08-03T11:20ABmRNA-1273-P201SEmRNA-1273-P201-US205-1099US2051099A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-03T11:202020-09-02 BB;mRNA-1273-P201SEmRNA-1273-P201-US205-1099US2051099A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-02 2021-02-09 B;BÛmRNA-1273-P201SEmRNA-1273-P201-US205-1100US2051100ASCREEN Screening ASCREENING 2020-06-29 2020-07-02T11:43Á0AmRNA-1273-P201SEmRNA-1273-P201-US205-1100US2051100A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-02T11:432020-08-04T12:31AB"mRNA-1273-P201SEmRNA-1273-P201-US205-1100US2051100A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-04T12:312020-09-08 B"BEmRNA-1273-P201SEmRNA-1273-P201-US205-1100US2051100A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-08 2021-02-10 BEBàmRNA-1273-P201SEmRNA-1273-P201-US205-1101US2051101ASCREEN Screening ASCREENING 2020-06-30 2020-07-06T09:39Á`AmRNA-1273-P201SEmRNA-1273-P201-US205-1101US2051101A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-06T09:392020-08-10T09:19AB$mRNA-1273-P201SEmRNA-1273-P201-US205-1101US2051101A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-10T09:192020-09-10 B$BCmRNA-1273-P201SEmRNA-1273-P201-US205-1101US2051101A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-10 2021-02-17 BCBãmRNA-1273-P201SEmRNA-1273-P201-US205-1102US2051102ASCREEN Screening ASCREENING 2020-06-30 2020-07-06T15:54Á`AmRNA-1273-P201SEmRNA-1273-P201-US205-1102US2051102A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-06T15:542020-08-03T09:25ABmRNA-1273-P201SEmRNA-1273-P201-US205-1102US2051102A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-03T09:252020-08-31 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1102US2051102A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-16 B9BâmRNA-1273-P201SEmRNA-1273-P201-US205-1103US2051103ASCREEN Screening ASCREENING 2020-06-30 2020-07-02T15:41Á AmRNA-1273-P201SEmRNA-1273-P201-US205-1103US2051103A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-02T15:412020-07-30T09:09ABmRNA-1273-P201SEmRNA-1273-P201-US205-1103US2051103A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-30T09:092020-08-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1103US2051103A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-04-30 B9CðmRNA-1273-P201SEmRNA-1273-P201-US205-1104US2051104ASCREEN Screening ASCREENING 2020-06-30 2020-07-07T12:55ÁpAmRNA-1273-P201SEmRNA-1273-P201-US205-1104US2051104A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-07T12:552020-08-11 AB$mRNA-1273-P201SEmRNA-1273-P201-US205-1104US2051104A0FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-12 2020-09-02 B%B:mRNA-1273-P201SEmRNA-1273-P201-US205-1105US2051105ASCREEN Screening ASCREENING 2020-06-30 2020-07-02T14:51Á AmRNA-1273-P201SEmRNA-1273-P201-US205-1105US2051105A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-02T14:512020-07-31T10:27ABmRNA-1273-P201SEmRNA-1273-P201-US205-1105US2051105A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-31T10:272020-08-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1105US2051105A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-02-08 B9BÞmRNA-1273-P201SEmRNA-1273-P201-US205-1106US2051106ASCREEN Screening ASCREENING 2020-06-30 2020-07-06T11:11Á`AmRNA-1273-P201SEmRNA-1273-P201-US205-1106US2051106A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-06T11:112020-08-04T11:15ABmRNA-1273-P201SEmRNA-1273-P201-US205-1106US2051106A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-04T11:152020-09-01 BB:mRNA-1273-P201SEmRNA-1273-P201-US205-1106US2051106A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-01 2021-02-17 B:BãmRNA-1273-P201SEmRNA-1273-P201-US205-1107US2051107ASCREEN Screening ASCREENING 2020-06-30 2020-07-02T14:49Á AmRNA-1273-P201SEmRNA-1273-P201-US205-1107US2051107A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-02T14:492020-07-31T10:21ABmRNA-1273-P201SEmRNA-1273-P201-US205-1107US2051107A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-31T10:212020-08-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US205-1107US2051107A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-09 B:BßmRNA-1273-P201SEmRNA-1273-P201-US205-1108US2051108ASCREEN Screening ASCREENING 2020-06-30 2020-07-06T14:41Á`AmRNA-1273-P201SEmRNA-1273-P201-US205-1108US2051108A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-06T14:412020-08-10T14:31AB$mRNA-1273-P201SEmRNA-1273-P201-US205-1108US2051108A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-10T14:312020-09-08 B$BAmRNA-1273-P201SEmRNA-1273-P201-US205-1108US2051108A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-08 2021-02-16 BABâmRNA-1273-P201SEmRNA-1273-P201-US205-1109US2051109ASCREEN Screening ASCREENING 2020-06-30 2020-07-06T15:22Á`AmRNA-1273-P201SEmRNA-1273-P201-US205-1109US2051109A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-06T15:222020-08-04T13:07ABmRNA-1273-P201SEmRNA-1273-P201-US205-1109US2051109A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-04T13:072020-09-02 BB;mRNA-1273-P201SEmRNA-1273-P201-US205-1109US2051109A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-02 2021-02-18 B;BämRNA-1273-P201SEmRNA-1273-P201-US205-1110US2051110ASCREEN Screening ASCREENING 2020-07-01 2020-07-01 ..mRNA-1273-P201SEmRNA-1273-P201-US205-1111US2051111ASCREEN Screening ASCREENING 2020-07-01 2020-07-06T15:58ÁPAmRNA-1273-P201SEmRNA-1273-P201-US205-1111US2051111A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-06T15:582020-08-04T14:55ABmRNA-1273-P201SEmRNA-1273-P201-US205-1111US2051111A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-04T14:552020-08-31 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1111US2051111A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-10 B9BÜmRNA-1273-P201SEmRNA-1273-P201-US205-1112US2051112ASCREEN Screening ASCREENING 2020-07-01 2020-07-06T11:37ÁPAmRNA-1273-P201SEmRNA-1273-P201-US205-1112US2051112A PBO Placebo A BLINDED TREATMENT 2020-07-06T11:372020-08-03T12:40ABmRNA-1273-P201SEmRNA-1273-P201-US205-1112US2051112A0PBO Placebo A0BLINDED TREATMENT 2020-08-03T12:402020-08-31 BB9mRNA-1273-P201SEmRNA-1273-P201-US205-1112US2051112A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-08 B9BÚmRNA-1273-P201SEmRNA-1273-P201-US206-1001US2061001ASCREEN Screening ASCREENING 2020-05-28 2020-06-04T18:13ÁpAmRNA-1273-P201SEmRNA-1273-P201-US206-1001US2061001A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-04T18:132020-07-10T14:33AB%mRNA-1273-P201SEmRNA-1273-P201-US206-1001US2061001A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-10T14:332020-08-04 B%B>mRNA-1273-P201SEmRNA-1273-P201-US206-1001US2061001A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-03 B>BõmRNA-1273-P201SEmRNA-1273-P201-US206-1002US2061002ASCREEN Screening ASCREENING 2020-05-28 2020-06-04 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1003US2061003ASCREEN Screening ASCREENING 2020-05-28 2020-06-04T14:38ÁpAmRNA-1273-P201SEmRNA-1273-P201-US206-1003US2061003A PBO Placebo A BLINDED TREATMENT 2020-06-04T14:382020-07-06T10:38AB!mRNA-1273-P201SEmRNA-1273-P201-US206-1003US2061003A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T10:382020-08-03 B!B=mRNA-1273-P201SEmRNA-1273-P201-US206-1003US2061003A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-25 B=C°mRNA-1273-P201SEmRNA-1273-P201-US206-1004US2061004ASCREEN Screening ASCREENING 2020-05-28 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1005US2061005ASCREEN Screening ASCREENING 2020-05-28 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1006US2061006ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T10:10Á`AmRNA-1273-P201SEmRNA-1273-P201-US206-1006US2061006A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T10:102020-07-01T12:23ABmRNA-1273-P201SEmRNA-1273-P201-US206-1006US2061006A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-01T12:232020-07-29 BB9mRNA-1273-P201SEmRNA-1273-P201-US206-1006US2061006A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-02-11 B9BþmRNA-1273-P201SEmRNA-1273-P201-US206-1007US2061007ASCREEN Screening ASCREENING 2020-05-28 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1008US2061008ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T14:25Á`AmRNA-1273-P201SEmRNA-1273-P201-US206-1008US2061008A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T14:252020-07-06T09:36AB"mRNA-1273-P201SEmRNA-1273-P201-US206-1008US2061008A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-06T09:362020-08-03 B"B>mRNA-1273-P201SEmRNA-1273-P201-US206-1008US2061008A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-10 B>BýmRNA-1273-P201SEmRNA-1273-P201-US206-1009US2061009ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T18:15Á`AmRNA-1273-P201SEmRNA-1273-P201-US206-1009US2061009A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T18:152020-07-07T14:14AB#mRNA-1273-P201SEmRNA-1273-P201-US206-1009US2061009A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T14:142020-08-04 B#B?mRNA-1273-P201SEmRNA-1273-P201-US206-1009US2061009A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-05 B?BømRNA-1273-P201SEmRNA-1273-P201-US206-1010US2061010ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T09:51Á`AmRNA-1273-P201SEmRNA-1273-P201-US206-1010US2061010A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T09:512020-07-08T09:21AB$mRNA-1273-P201SEmRNA-1273-P201-US206-1010US2061010A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-08T09:212020-08-04 B$B?mRNA-1273-P201SEmRNA-1273-P201-US206-1010US2061010A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-05 B?BømRNA-1273-P201SEmRNA-1273-P201-US206-1011US2061011ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T14:23Á`AmRNA-1273-P201SEmRNA-1273-P201-US206-1011US2061011A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T14:232020-07-06T14:45AB"mRNA-1273-P201SEmRNA-1273-P201-US206-1011US2061011A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-06T14:452020-08-10 B"BEmRNA-1273-P201SEmRNA-1273-P201-US206-1011US2061011A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-03 BEBömRNA-1273-P201SEmRNA-1273-P201-US206-1012US2061012ASCREEN Screening ASCREENING 2020-05-28 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1013US2061013ASCREEN Screening ASCREENING 2020-05-28 2020-06-05T09:05Á€AmRNA-1273-P201SEmRNA-1273-P201-US206-1013US2061013A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-05T09:052020-07-06T14:25AB mRNA-1273-P201SEmRNA-1273-P201-US206-1013US2061013A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-06T14:252020-08-04 B B=mRNA-1273-P201SEmRNA-1273-P201-US206-1013US2061013A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-04 B=BõmRNA-1273-P201SEmRNA-1273-P201-US206-1014US2061014ASCREEN Screening ASCREENING 2020-05-28 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1015US2061015ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T14:57ÁPAmRNA-1273-P201SEmRNA-1273-P201-US206-1015US2061015A PBO Placebo A BLINDED TREATMENT 2020-06-03T14:572020-07-06T14:31AB"mRNA-1273-P201SEmRNA-1273-P201-US206-1015US2061015A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T14:312020-08-05 B"B@mRNA-1273-P201SEmRNA-1273-P201-US206-1015US2061015A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-04 B@B÷mRNA-1273-P201SEmRNA-1273-P201-US206-1016US2061016ASCREEN Screening ASCREENING 2020-05-29 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1017US2061017ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1018US2061018ASCREEN Screening ASCREENING 2020-05-29 2020-06-05T16:52ÁpAmRNA-1273-P201SEmRNA-1273-P201-US206-1018US2061018A PBO Placebo A BLINDED TREATMENT 2020-06-05T16:522020-07-08T09:27AB"mRNA-1273-P201SEmRNA-1273-P201-US206-1018US2061018A0PBO Placebo A0BLINDED TREATMENT 2020-07-08T09:272020-08-12 B"BEmRNA-1273-P201SEmRNA-1273-P201-US206-1018US2061018A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-12 2021-02-05 BEBömRNA-1273-P201SEmRNA-1273-P201-US206-1019US2061019ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T18:25ÁPAmRNA-1273-P201SEmRNA-1273-P201-US206-1019US2061019A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T18:252020-07-01T14:25ABmRNA-1273-P201SEmRNA-1273-P201-US206-1019US2061019A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-01T14:252020-07-29 BB9mRNA-1273-P201SEmRNA-1273-P201-US206-1019US2061019A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-29 2021-02-03 B9BömRNA-1273-P201SEmRNA-1273-P201-US206-1020US2061020ASCREEN Screening ASCREENING 2020-05-29 2020-06-08T18:12Á AmRNA-1273-P201SEmRNA-1273-P201-US206-1020US2061020A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T18:122020-07-07T09:17ABmRNA-1273-P201SEmRNA-1273-P201-US206-1020US2061020A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T09:172020-08-04 BB:mRNA-1273-P201SEmRNA-1273-P201-US206-1020US2061020A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-03 B:BñmRNA-1273-P201SEmRNA-1273-P201-US206-1021US2061021ASCREEN Screening ASCREENING 2020-05-29 2020-06-04T16:21Á`AmRNA-1273-P201SEmRNA-1273-P201-US206-1021US2061021A PBO Placebo A BLINDED TREATMENT 2020-06-04T16:212020-07-02T14:03ABmRNA-1273-P201SEmRNA-1273-P201-US206-1021US2061021A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T14:032020-07-30 BB9mRNA-1273-P201SEmRNA-1273-P201-US206-1021US2061021A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-30 2021-02-04 B9BömRNA-1273-P201SEmRNA-1273-P201-US206-1022US2061022ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T11:52ÁPAmRNA-1273-P201SEmRNA-1273-P201-US206-1022US2061022A PBO Placebo A BLINDED TREATMENT 2020-06-03T11:522020-07-02T09:42ABmRNA-1273-P201SEmRNA-1273-P201-US206-1022US2061022A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T09:422020-07-28 BB8mRNA-1273-P201SEmRNA-1273-P201-US206-1022US2061022A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-03 B8BömRNA-1273-P201SEmRNA-1273-P201-US206-1023US2061023ASCREEN Screening ASCREENING 2020-05-29 2020-06-05T11:36ÁpAmRNA-1273-P201SEmRNA-1273-P201-US206-1023US2061023A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-05T11:362020-07-06T09:40AB mRNA-1273-P201SEmRNA-1273-P201-US206-1023US2061023A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-06T09:402020-08-03 B B<mRNA-1273-P201SEmRNA-1273-P201-US206-1023US2061023A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-05 B<BömRNA-1273-P201SEmRNA-1273-P201-US206-1024US2061024ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T16:47ÁPAmRNA-1273-P201SEmRNA-1273-P201-US206-1024US2061024A UNPLAN Placebo .BLINDED TREATMENT 2020-06-03T16:472020-07-02T16:16ABmRNA-1273-P201SEmRNA-1273-P201-US206-1024US2061024A0UNPLAN Placebo .BLINDED TREATMENT 2020-07-02T16:162020-08-04 BB?mRNA-1273-P201SEmRNA-1273-P201-US206-1024US2061024A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-03 B?BömRNA-1273-P201SEmRNA-1273-P201-US206-1025US2061025ASCREEN Screening ASCREENING 2020-05-29 2020-06-03T17:16ÁPAmRNA-1273-P201SEmRNA-1273-P201-US206-1025US2061025A UNPLAN mRNA-1273 100 ug .BLINDED TREATMENT 2020-06-03T17:162020-07-01T15:19ABmRNA-1273-P201SEmRNA-1273-P201-US206-1025US2061025A0UNPLAN mRNA-1273 100 ug .BLINDED TREATMENT 2020-07-01T15:192020-07-31 BB;mRNA-1273-P201SEmRNA-1273-P201-US206-1025US2061025A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-02-04 B;B÷mRNA-1273-P201SEmRNA-1273-P201-US206-1026US2061026ASCREEN Screening ASCREENING 2020-06-02 2020-06-05T11:26Á0AmRNA-1273-P201SEmRNA-1273-P201-US206-1026US2061026A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-05T11:262020-07-07T11:23AB!mRNA-1273-P201SEmRNA-1273-P201-US206-1026US2061026A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T11:232020-08-04 B!B=mRNA-1273-P201SEmRNA-1273-P201-US206-1026US2061026A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-10 B=BûmRNA-1273-P201SEmRNA-1273-P201-US206-1027US2061027ASCREEN Screening ASCREENING 2020-06-02 2020-06-05T14:57Á0AmRNA-1273-P201SEmRNA-1273-P201-US206-1027US2061027A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-05T14:572020-07-08T14:54AB"mRNA-1273-P201SEmRNA-1273-P201-US206-1027US2061027A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-08T14:542020-08-06 B"B?mRNA-1273-P201SEmRNA-1273-P201-US206-1027US2061027A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-05 B?BömRNA-1273-P201SEmRNA-1273-P201-US206-1028US2061028ASCREEN Screening ASCREENING 2020-06-02 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1029US2061029ASCREEN Screening ASCREENING 2020-06-03 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1030US2061030ASCREEN Screening ASCREENING 2020-06-03 2020-06-04 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1031US2061031ASCREEN Screening ASCREENING 2020-06-03 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1032US2061032ASCREEN Screening ASCREENING 2020-06-03 2020-06-05T10:31Á AmRNA-1273-P201SEmRNA-1273-P201-US206-1032US2061032A PBO Placebo A BLINDED TREATMENT 2020-06-05T10:312020-07-07T15:57AB!mRNA-1273-P201SEmRNA-1273-P201-US206-1032US2061032A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T15:572020-08-05 B!B>mRNA-1273-P201SEmRNA-1273-P201-US206-1032US2061032A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-09 B>BúmRNA-1273-P201SEmRNA-1273-P201-US206-1033US2061033ASCREEN Screening ASCREENING 2020-06-03 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1034US2061034ASCREEN Screening ASCREENING 2020-06-05 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1035US2061035ASCREEN Screening ASCREENING 2020-06-09 2020-06-26T12:34ÂAmRNA-1273-P201SEmRNA-1273-P201-US206-1035US2061035A PBO Placebo A BLINDED TREATMENT 2020-06-26T12:342020-07-20T10:12ABmRNA-1273-P201SEmRNA-1273-P201-US206-1035US2061035A0PBO Placebo A0BLINDED TREATMENT 2020-07-20T10:122020-08-18 BB6mRNA-1273-P201SEmRNA-1273-P201-US206-1035US2061035A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-18 2021-02-04 B6BàmRNA-1273-P201SEmRNA-1273-P201-US206-1036US2061036ASCREEN Screening ASCREENING 2020-06-09 2020-06-26T11:58ÂAmRNA-1273-P201SEmRNA-1273-P201-US206-1036US2061036A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T11:582020-07-27T11:35AB mRNA-1273-P201SEmRNA-1273-P201-US206-1036US2061036A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-27T11:352020-08-24 B B<mRNA-1273-P201SEmRNA-1273-P201-US206-1036US2061036A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-03 B<BßmRNA-1273-P201SEmRNA-1273-P201-US206-1037US2061037ASCREEN Screening ASCREENING 2020-06-09 2020-06-26T09:48ÂAmRNA-1273-P201SEmRNA-1273-P201-US206-1037US2061037A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T09:482020-07-29T09:28AB"mRNA-1273-P201SEmRNA-1273-P201-US206-1037US2061037A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-29T09:282020-08-26 B"B>mRNA-1273-P201SEmRNA-1273-P201-US206-1037US2061037A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-02-03 B>BßmRNA-1273-P201SEmRNA-1273-P201-US206-1038US2061038ASCREEN Screening ASCREENING 2020-06-09 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1039US2061039ASCREEN Screening ASCREENING 2020-06-10 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1040US2061040ASCREEN Screening ASCREENING 2020-06-10 2020-06-19 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1041US2061041ASCREEN Screening ASCREENING 2020-06-10 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1042US2061042ASCREEN Screening ASCREENING 2020-06-10 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1043US2061043ASCREEN Screening ASCREENING 2020-06-10 2020-06-29T15:19ÂAmRNA-1273-P201SEmRNA-1273-P201-US206-1043US2061043A PBO Placebo A BLINDED TREATMENT 2020-06-29T15:192020-07-27T14:46ABmRNA-1273-P201SEmRNA-1273-P201-US206-1043US2061043A0PBO Placebo A0BLINDED TREATMENT 2020-07-27T14:462020-08-21 BB6mRNA-1273-P201SEmRNA-1273-P201-US206-1043US2061043A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-02-04 B6BÝmRNA-1273-P201SEmRNA-1273-P201-US206-1044US2061044ASCREEN Screening ASCREENING 2020-06-10 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1045US2061045ASCREEN Screening ASCREENING 2020-06-10 2020-06-29T16:55ÂAmRNA-1273-P201SEmRNA-1273-P201-US206-1045US2061045A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-29T16:552020-07-27T16:35ABmRNA-1273-P201SEmRNA-1273-P201-US206-1045US2061045A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-27T16:352020-08-20 BB5mRNA-1273-P201SEmRNA-1273-P201-US206-1045US2061045A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-20 2021-02-04 B5BÝmRNA-1273-P201SEmRNA-1273-P201-US206-1046US2061046ASCREEN Screening ASCREENING 2020-06-11 2020-06-29T15:12ÂAmRNA-1273-P201SEmRNA-1273-P201-US206-1046US2061046A PBO Placebo A BLINDED TREATMENT 2020-06-29T15:122020-07-27T09:28ABmRNA-1273-P201SEmRNA-1273-P201-US206-1046US2061046A0PBO Placebo A0BLINDED TREATMENT 2020-07-27T09:282020-08-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US206-1046US2061046A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-04 B9BÝmRNA-1273-P201SEmRNA-1273-P201-US206-1047US2061047ASCREEN Screening ASCREENING 2020-06-11 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1048US2061048ASCREEN Screening ASCREENING 2020-06-11 2020-06-19 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1049US2061049ASCREEN Screening ASCREENING 2020-06-11 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1050US2061050ASCREEN Screening ASCREENING 2020-06-15 2020-06-23 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1051US2061051ASCREEN Screening ASCREENING 2020-06-15 2020-06-30T11:03ÁðAmRNA-1273-P201SEmRNA-1273-P201-US206-1051US2061051A PBO Placebo A BLINDED TREATMENT 2020-06-30T11:032020-07-30T16:18ABmRNA-1273-P201SEmRNA-1273-P201-US206-1051US2061051A0PBO Placebo A0BLINDED TREATMENT 2020-07-30T16:182020-08-24 BB8mRNA-1273-P201SEmRNA-1273-P201-US206-1051US2061051A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-04 B8BÜmRNA-1273-P201SEmRNA-1273-P201-US206-1052US2061052ASCREEN Screening ASCREENING 2020-06-15 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1053US2061053ASCREEN Screening ASCREENING 2020-06-15 2020-07-01T10:29ÂAmRNA-1273-P201SEmRNA-1273-P201-US206-1053US2061053A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-01T10:292020-07-29T12:18ABmRNA-1273-P201SEmRNA-1273-P201-US206-1053US2061053A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-29T12:182020-08-24 BB7mRNA-1273-P201SEmRNA-1273-P201-US206-1053US2061053A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-05 B7BÜmRNA-1273-P201SEmRNA-1273-P201-US206-1054US2061054ASCREEN Screening ASCREENING 2020-06-16 2020-06-24 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1055US2061055ASCREEN Screening ASCREENING 2020-06-16 2020-06-30T09:32ÁàAmRNA-1273-P201SEmRNA-1273-P201-US206-1055US2061055A PBO Placebo A BLINDED TREATMENT 2020-06-30T09:322020-07-28T09:21ABmRNA-1273-P201SEmRNA-1273-P201-US206-1055US2061055A0PBO Placebo A0BLINDED TREATMENT 2020-07-28T09:212020-08-24 BB8mRNA-1273-P201SEmRNA-1273-P201-US206-1055US2061055A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-19 B8BëmRNA-1273-P201SEmRNA-1273-P201-US206-1056US2061056ASCREEN Screening ASCREENING 2020-06-16 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1057US2061057ASCREEN Screening ASCREENING 2020-06-18 2020-07-01T14:50ÁÐAmRNA-1273-P201SEmRNA-1273-P201-US206-1057US2061057A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-01T14:502020-07-29T12:15ABmRNA-1273-P201SEmRNA-1273-P201-US206-1057US2061057A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-29T12:152020-08-24 BB7mRNA-1273-P201SEmRNA-1273-P201-US206-1057US2061057A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-04 B7BÛmRNA-1273-P201SEmRNA-1273-P201-US206-1058US2061058ASCREEN Screening ASCREENING 2020-06-18 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1059US2061059ASCREEN Screening ASCREENING 2020-06-18 2020-06-25 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1060US2061060ASCREEN Screening ASCREENING 2020-06-19 2020-06-24 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1061US2061061ASCREEN Screening ASCREENING 2020-06-19 2020-06-26 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1062US2061062ASCREEN Screening ASCREENING 2020-06-19 2020-06-26 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1063US2061063ASCREEN Screening ASCREENING 2020-06-22 2020-06-30T17:04Á€AmRNA-1273-P201SEmRNA-1273-P201-US206-1063US2061063A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-30T17:042020-07-28T16:19ABmRNA-1273-P201SEmRNA-1273-P201-US206-1063US2061063A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-28T16:192020-08-31 BB?mRNA-1273-P201SEmRNA-1273-P201-US206-1063US2061063A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-11 B?BãmRNA-1273-P201SEmRNA-1273-P201-US206-1064US2061064ASCREEN Screening ASCREENING 2020-06-22 2020-06-30T16:22Á€AmRNA-1273-P201SEmRNA-1273-P201-US206-1064US2061064A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-30T16:222020-07-28T14:57ABmRNA-1273-P201SEmRNA-1273-P201-US206-1064US2061064A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-28T14:572020-08-24 BB8mRNA-1273-P201SEmRNA-1273-P201-US206-1064US2061064A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-05 B8BÝmRNA-1273-P201SEmRNA-1273-P201-US206-1065US2061065ASCREEN Screening ASCREENING 2020-06-23 2020-06-29 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1066US2061066ASCREEN Screening ASCREENING 2020-06-23 2020-06-23 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1067US2061067ASCREEN Screening ASCREENING 2020-06-23 2020-07-23 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1068US2061068ASCREEN Screening ASCREENING 2020-06-24 2020-06-30T09:48Á`AmRNA-1273-P201SEmRNA-1273-P201-US206-1068US2061068A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-30T09:482020-07-31T09:57AB mRNA-1273-P201SEmRNA-1273-P201-US206-1068US2061068A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-31T09:572020-09-02 B BAmRNA-1273-P201SEmRNA-1273-P201-US206-1068US2061068A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-02 2021-02-04 BABÜmRNA-1273-P201SEmRNA-1273-P201-US206-1069US2061069ASCREEN Screening ASCREENING 2020-06-24 2020-06-24 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1070US2061070ASCREEN Screening ASCREENING 2020-06-29 2020-07-06 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1071US2061071ASCREEN Screening ASCREENING 2020-06-30 2020-06-30 ..mRNA-1273-P201SEmRNA-1273-P201-US206-1072US2061072ASCREEN Screening ASCREENING 2020-07-01 2020-07-08 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1001US2071001ASCREEN Screening ASCREENING 2020-05-22 2020-05-29T16:12ÁpAmRNA-1273-P201SEmRNA-1273-P201-US207-1001US2071001A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-05-29T16:122020-06-30T13:38AB!mRNA-1273-P201SEmRNA-1273-P201-US207-1001US2071001A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T13:382020-07-27 B!B<mRNA-1273-P201SEmRNA-1273-P201-US207-1001US2071001A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-22 B<CàmRNA-1273-P201SEmRNA-1273-P201-US207-1002US2071002ASCREEN Screening ASCREENING 2020-05-22 2020-06-01T11:42Á AmRNA-1273-P201SEmRNA-1273-P201-US207-1002US2071002A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T11:422020-06-30T13:48ABmRNA-1273-P201SEmRNA-1273-P201-US207-1002US2071002A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-30T13:482020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US207-1002US2071002A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-05 B9BúmRNA-1273-P201SEmRNA-1273-P201-US207-1003US2071003ASCREEN Screening ASCREENING 2020-05-22 2020-06-01T11:05Á AmRNA-1273-P201SEmRNA-1273-P201-US207-1003US2071003A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T11:052020-06-30T13:44ABmRNA-1273-P201SEmRNA-1273-P201-US207-1003US2071003A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-30T13:442020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US207-1003US2071003A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-03 B9BømRNA-1273-P201SEmRNA-1273-P201-US207-1004US2071004ASCREEN Screening ASCREENING 2020-05-25 2020-06-04T09:26Á AmRNA-1273-P201SEmRNA-1273-P201-US207-1004US2071004A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-04T09:262020-07-08T09:18AB#mRNA-1273-P201SEmRNA-1273-P201-US207-1004US2071004A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-08T09:182020-08-06 B#B@mRNA-1273-P201SEmRNA-1273-P201-US207-1004US2071004A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-04 B@BömRNA-1273-P201SEmRNA-1273-P201-US207-1005US2071005ASCREEN Screening ASCREENING 2020-05-25 2020-06-02T17:17Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1005US2071005A PBO Placebo A BLINDED TREATMENT 2020-06-02T17:172020-07-06T14:46AB#mRNA-1273-P201SEmRNA-1273-P201-US207-1005US2071005A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T14:462020-07-31 B#B<mRNA-1273-P201SEmRNA-1273-P201-US207-1005US2071005A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-02-02 B<BömRNA-1273-P201SEmRNA-1273-P201-US207-1006US2071006ASCREEN Screening ASCREENING 2020-05-25 2020-06-02T10:21Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1006US2071006A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T10:212020-07-01T09:26ABmRNA-1273-P201SEmRNA-1273-P201-US207-1006US2071006A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T09:262020-07-27 BB8mRNA-1273-P201SEmRNA-1273-P201-US207-1006US2071006A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-22 B8C mRNA-1273-P201SEmRNA-1273-P201-US207-1007US2071007ASCREEN Screening ASCREENING 2020-05-25 2020-06-02T11:33Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1007US2071007A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T11:332020-07-07T10:42AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1007US2071007A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T10:422020-08-06 B$BBmRNA-1273-P201SEmRNA-1273-P201-US207-1007US2071007A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-23 BBC°mRNA-1273-P201SEmRNA-1273-P201-US207-1008US2071008ASCREEN Screening ASCREENING 2020-05-25 2020-05-25 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1009US2071009ASCREEN Screening ASCREENING 2020-05-25 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1010US2071010ASCREEN Screening ASCREENING 2020-05-25 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1011US2071011ASCREEN Screening ASCREENING 2020-05-25 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1012US2071012ASCREEN Screening ASCREENING 2020-05-25 2020-06-03T14:15ÁAmRNA-1273-P201SEmRNA-1273-P201-US207-1012US2071012A PBO Placebo A BLINDED TREATMENT 2020-06-03T14:152020-07-07T13:45AB#mRNA-1273-P201SEmRNA-1273-P201-US207-1012US2071012A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T13:452020-08-05 B#B@mRNA-1273-P201SEmRNA-1273-P201-US207-1012US2071012A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-04 B@B÷mRNA-1273-P201SEmRNA-1273-P201-US207-1013US2071013ASCREEN Screening ASCREENING 2020-05-25 2020-06-02T14:30Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1013US2071013A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T14:302020-07-09T15:04AB&mRNA-1273-P201SEmRNA-1273-P201-US207-1013US2071013A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-09T15:042020-08-03 B&B?mRNA-1273-P201SEmRNA-1273-P201-US207-1013US2071013A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-22 B?C mRNA-1273-P201SEmRNA-1273-P201-US207-1014US2071014ASCREEN Screening ASCREENING 2020-05-25 2020-06-03T11:10ÁAmRNA-1273-P201SEmRNA-1273-P201-US207-1014US2071014A PBO Placebo A BLINDED TREATMENT 2020-06-03T11:102020-07-06T13:56AB"mRNA-1273-P201SEmRNA-1273-P201-US207-1014US2071014A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T13:562020-08-04 B"B?mRNA-1273-P201SEmRNA-1273-P201-US207-1014US2071014A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-24 B?C°mRNA-1273-P201SEmRNA-1273-P201-US207-1015US2071015ASCREEN Screening ASCREENING 2020-05-25 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1016US2071016ASCREEN Screening ASCREENING 2020-05-25 2020-06-03T14:05ÁAmRNA-1273-P201SEmRNA-1273-P201-US207-1016US2071016A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T14:052020-07-08T12:54AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1016US2071016A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-08T12:542020-08-03 B$B>mRNA-1273-P201SEmRNA-1273-P201-US207-1016US2071016A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-03 B>BömRNA-1273-P201SEmRNA-1273-P201-US207-1017US2071017ASCREEN Screening ASCREENING 2020-05-25 2020-06-02T17:08Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1017US2071017A PBO Placebo A BLINDED TREATMENT 2020-06-02T17:082020-07-01T14:13ABmRNA-1273-P201SEmRNA-1273-P201-US207-1017US2071017A0PBO Placebo A0BLINDED TREATMENT 2020-07-01T14:132020-08-18 BBNmRNA-1273-P201SEmRNA-1273-P201-US207-1017US2071017A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-18 2021-03-04 BNC@mRNA-1273-P201SEmRNA-1273-P201-US207-1018US2071018ASCREEN Screening ASCREENING 2020-05-25 2020-05-25 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1019US2071019ASCREEN Screening ASCREENING 2020-05-25 2020-05-25 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1020US2071020ASCREEN Screening ASCREENING 2020-05-25 2020-05-25 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1021US2071021ASCREEN Screening ASCREENING 2020-05-25 2020-05-25 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1022US2071022ASCREEN Screening ASCREENING 2020-05-26 2020-06-03T12:19Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1022US2071022A PBO Placebo A BLINDED TREATMENT 2020-06-03T12:192020-07-02T10:57ABmRNA-1273-P201SEmRNA-1273-P201-US207-1022US2071022A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T10:572020-08-06 BBAmRNA-1273-P201SEmRNA-1273-P201-US207-1022US2071022A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-04 BAB÷mRNA-1273-P201SEmRNA-1273-P201-US207-1023US2071023ASCREEN Screening ASCREENING 2020-05-26 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1024US2071024ASCREEN Screening ASCREENING 2020-05-26 2020-06-03T14:57Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1024US2071024A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T14:572020-07-06T10:07AB"mRNA-1273-P201SEmRNA-1273-P201-US207-1024US2071024A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-06T10:072020-08-03 B"B>mRNA-1273-P201SEmRNA-1273-P201-US207-1024US2071024A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-04 B>B÷mRNA-1273-P201SEmRNA-1273-P201-US207-1025US2071025ASCREEN Screening ASCREENING 2020-05-26 2020-06-03T11:56Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1025US2071025A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T11:562020-07-08T11:01AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1025US2071025A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-08T11:012020-08-05 B$B@mRNA-1273-P201SEmRNA-1273-P201-US207-1025US2071025A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-23 B@C mRNA-1273-P201SEmRNA-1273-P201-US207-1026US2071026ASCREEN Screening ASCREENING 2020-05-26 2020-06-08T15:44ÁÐAmRNA-1273-P201SEmRNA-1273-P201-US207-1026US2071026A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T15:442020-07-13T14:47AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1026US2071026A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-13T14:472020-08-12 B$BBmRNA-1273-P201SEmRNA-1273-P201-US207-1026US2071026A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-12 2021-02-25 BBCpmRNA-1273-P201SEmRNA-1273-P201-US207-1027US2071027ASCREEN Screening ASCREENING 2020-05-26 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1028US2071028ASCREEN Screening ASCREENING 2020-05-26 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1029US2071029ASCREEN Screening ASCREENING 2020-05-26 2020-06-05T17:03Á AmRNA-1273-P201SEmRNA-1273-P201-US207-1029US2071029A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-05T17:032020-07-10T16:39AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1029US2071029A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-10T16:392020-08-05 B$B>mRNA-1273-P201SEmRNA-1273-P201-US207-1029US2071029A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2020-09-28 B>BtmRNA-1273-P201SEmRNA-1273-P201-US207-1030US2071030ASCREEN Screening ASCREENING 2020-05-26 2020-06-03T17:16Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1030US2071030A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-03T17:162020-07-06T17:13AB"mRNA-1273-P201SEmRNA-1273-P201-US207-1030US2071030A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-06T17:132020-08-11 B"BFmRNA-1273-P201SEmRNA-1273-P201-US207-1030US2071030A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-11 2021-02-22 BFCmRNA-1273-P201SEmRNA-1273-P201-US207-1032US2071032ASCREEN Screening ASCREENING 2020-05-27 2020-06-08T18:46ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US207-1032US2071032A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T18:462020-07-10T08:46AB!mRNA-1273-P201SEmRNA-1273-P201-US207-1032US2071032A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-10T08:462020-08-12 B!BBmRNA-1273-P201SEmRNA-1273-P201-US207-1032US2071032A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-12 2021-03-05 BBCðmRNA-1273-P201SEmRNA-1273-P201-US207-1033US2071033ASCREEN Screening ASCREENING 2020-05-27 2020-06-08T11:10ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US207-1033US2071033A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T11:102020-07-09T09:47AB mRNA-1273-P201SEmRNA-1273-P201-US207-1033US2071033A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-09T09:472020-08-13 B BCmRNA-1273-P201SEmRNA-1273-P201-US207-1033US2071033A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-13 2021-02-25 BCCpmRNA-1273-P201SEmRNA-1273-P201-US207-1034US2071034ASCREEN Screening ASCREENING 2020-05-27 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1035US2071035ASCREEN Screening ASCREENING 2020-05-27 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1036US2071036ASCREEN Screening ASCREENING 2020-05-27 2020-06-08T15:25ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US207-1036US2071036A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T15:252020-07-13T12:48AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1036US2071036A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-13T12:482020-08-11 B$BAmRNA-1273-P201SEmRNA-1273-P201-US207-1036US2071036A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-11 2021-03-09 BAC0mRNA-1273-P201SEmRNA-1273-P201-US207-1037US2071037ASCREEN Screening ASCREENING 2020-05-27 2020-06-03T11:08ÁpAmRNA-1273-P201SEmRNA-1273-P201-US207-1037US2071037A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T11:082020-07-07T13:57AB#mRNA-1273-P201SEmRNA-1273-P201-US207-1037US2071037A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T13:572020-08-03 B#B>mRNA-1273-P201SEmRNA-1273-P201-US207-1037US2071037A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-23 B>C mRNA-1273-P201SEmRNA-1273-P201-US207-1038US2071038ASCREEN Screening ASCREENING 2020-05-27 2020-06-04T14:02Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1038US2071038A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-04T14:022020-07-13T09:15AB(mRNA-1273-P201SEmRNA-1273-P201-US207-1038US2071038A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-13T09:152020-08-11 B(BEmRNA-1273-P201SEmRNA-1273-P201-US207-1038US2071038A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-11 2021-03-03 BECmRNA-1273-P201SEmRNA-1273-P201-US207-1039US2071039ASCREEN Screening ASCREENING 2020-05-27 2020-06-05T16:53ÁAmRNA-1273-P201SEmRNA-1273-P201-US207-1039US2071039A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-05T16:532020-07-13T15:15AB'mRNA-1273-P201SEmRNA-1273-P201-US207-1039US2071039A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-13T15:152020-08-13 B'BFmRNA-1273-P201SEmRNA-1273-P201-US207-1039US2071039A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-13 2021-02-24 BFCmRNA-1273-P201SEmRNA-1273-P201-US207-1040US2071040ASCREEN Screening ASCREENING 2020-05-28 2020-06-08T13:00Á°AmRNA-1273-P201SEmRNA-1273-P201-US207-1040US2071040A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T13:002020-07-13T12:41AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1040US2071040A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-13T12:412020-08-10 B$B@mRNA-1273-P201SEmRNA-1273-P201-US207-1040US2071040A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-23 B@CPmRNA-1273-P201SEmRNA-1273-P201-US207-1041US2071041ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T09:50ÁPAmRNA-1273-P201SEmRNA-1273-P201-US207-1041US2071041A PBO Placebo A BLINDED TREATMENT 2020-06-02T09:502020-07-02T08:44ABmRNA-1273-P201SEmRNA-1273-P201-US207-1041US2071041A0PBO Placebo A0BLINDED TREATMENT 2020-07-02T08:442020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US207-1041US2071041A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-05 B9BùmRNA-1273-P201SEmRNA-1273-P201-US207-1042US2071042ASCREEN Screening ASCREENING 2020-05-28 2020-06-04T15:05ÁpAmRNA-1273-P201SEmRNA-1273-P201-US207-1042US2071042A PBO Placebo A BLINDED TREATMENT 2020-06-04T15:052020-07-09T12:44AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1042US2071042A0PBO Placebo A0BLINDED TREATMENT 2020-07-09T12:442020-08-07 B$BAmRNA-1273-P201SEmRNA-1273-P201-US207-1042US2071042A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-07 2021-02-03 BABõmRNA-1273-P201SEmRNA-1273-P201-US207-1043US2071043ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T13:06Á`AmRNA-1273-P201SEmRNA-1273-P201-US207-1043US2071043A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T13:062020-07-06T12:01AB"mRNA-1273-P201SEmRNA-1273-P201-US207-1043US2071043A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-06T12:012020-08-03 B"B>mRNA-1273-P201SEmRNA-1273-P201-US207-1043US2071043A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-02-25 B>CÀmRNA-1273-P201SEmRNA-1273-P201-US207-1044US2071044ASCREEN Screening ASCREENING 2020-05-28 2020-06-08T14:41Á°AmRNA-1273-P201SEmRNA-1273-P201-US207-1044US2071044A PBO Placebo A BLINDED TREATMENT 2020-06-08T14:412020-07-09T14:00AB mRNA-1273-P201SEmRNA-1273-P201-US207-1044US2071044A0PBO Placebo A0BLINDED TREATMENT 2020-07-09T14:002020-08-06 B B<mRNA-1273-P201SEmRNA-1273-P201-US207-1044US2071044A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-02 B<BðmRNA-1273-P201SEmRNA-1273-P201-US207-1045US2071045ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1046US2071046ASCREEN Screening ASCREENING 2020-05-28 2020-06-04T11:37ÁpAmRNA-1273-P201SEmRNA-1273-P201-US207-1046US2071046A PBO Placebo A BLINDED TREATMENT 2020-06-04T11:372020-07-07T16:11AB"mRNA-1273-P201SEmRNA-1273-P201-US207-1046US2071046A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T16:112020-08-11 B"BEmRNA-1273-P201SEmRNA-1273-P201-US207-1046US2071046A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-11 2021-03-05 BEC0mRNA-1273-P201SEmRNA-1273-P201-US207-1048US2071048ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1049US2071049ASCREEN Screening ASCREENING 2020-05-29 2020-06-04T10:15Á`AmRNA-1273-P201SEmRNA-1273-P201-US207-1049US2071049A PBO Placebo A BLINDED TREATMENT 2020-06-04T10:152020-07-08T09:30AB#mRNA-1273-P201SEmRNA-1273-P201-US207-1049US2071049A0PBO Placebo A0BLINDED TREATMENT 2020-07-08T09:302020-08-06 B#B@mRNA-1273-P201SEmRNA-1273-P201-US207-1049US2071049A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-05 B@B÷mRNA-1273-P201SEmRNA-1273-P201-US207-1050US2071050ASCREEN Screening ASCREENING 2020-05-29 2020-06-05T13:15ÁpAmRNA-1273-P201SEmRNA-1273-P201-US207-1050US2071050A PBO Placebo A BLINDED TREATMENT 2020-06-05T13:152020-07-07T11:43AB!mRNA-1273-P201SEmRNA-1273-P201-US207-1050US2071050A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T11:432020-08-07 B!B@mRNA-1273-P201SEmRNA-1273-P201-US207-1050US2071050A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-07 2021-02-04 B@BõmRNA-1273-P201SEmRNA-1273-P201-US207-1051US2071051ASCREEN Screening ASCREENING 2020-05-29 2020-06-05T14:54ÁpAmRNA-1273-P201SEmRNA-1273-P201-US207-1051US2071051A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-05T14:542020-07-07T11:16AB!mRNA-1273-P201SEmRNA-1273-P201-US207-1051US2071051A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T11:162020-08-03 B!B<mRNA-1273-P201SEmRNA-1273-P201-US207-1051US2071051A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-04-09 B<CPmRNA-1273-P201SEmRNA-1273-P201-US207-1053US2071053ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1054US2071054ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1055US2071055ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1056US2071056ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1058US2071058ASCREEN Screening ASCREENING 2020-06-01 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1059US2071059ASCREEN Screening ASCREENING 2020-06-01 2020-06-08T16:05ÁpAmRNA-1273-P201SEmRNA-1273-P201-US207-1059US2071059A PBO Placebo A BLINDED TREATMENT 2020-06-08T16:052020-07-07T15:38ABmRNA-1273-P201SEmRNA-1273-P201-US207-1059US2071059A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T15:382020-08-04 BB:mRNA-1273-P201SEmRNA-1273-P201-US207-1059US2071059A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-03-05 B:CðmRNA-1273-P201SEmRNA-1273-P201-US207-1060US2071060ASCREEN Screening ASCREENING 2020-06-01 2020-06-10 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1061US2071061ASCREEN Screening ASCREENING 2020-06-01 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1062US2071062ASCREEN Screening ASCREENING 2020-06-01 2020-06-04T16:40Á0AmRNA-1273-P201SEmRNA-1273-P201-US207-1062US2071062A PBO Placebo A BLINDED TREATMENT 2020-06-04T16:402020-07-07T14:35AB"mRNA-1273-P201SEmRNA-1273-P201-US207-1062US2071062A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T14:352020-08-04 B"B>mRNA-1273-P201SEmRNA-1273-P201-US207-1062US2071062A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-26 B>CÀmRNA-1273-P201SEmRNA-1273-P201-US207-1063US2071063ASCREEN Screening ASCREENING 2020-06-01 2020-06-04T17:10Á0AmRNA-1273-P201SEmRNA-1273-P201-US207-1063US2071063A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-04T17:102020-07-09T16:21AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1063US2071063A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-09T16:212020-08-06 B$B@mRNA-1273-P201SEmRNA-1273-P201-US207-1063US2071063A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-03 B@BõmRNA-1273-P201SEmRNA-1273-P201-US207-1064US2071064ASCREEN Screening ASCREENING 2020-06-01 2020-06-05T15:16Á@AmRNA-1273-P201SEmRNA-1273-P201-US207-1064US2071064A PBO Placebo A BLINDED TREATMENT 2020-06-05T15:162020-07-09T16:48AB#mRNA-1273-P201SEmRNA-1273-P201-US207-1064US2071064A0PBO Placebo A0BLINDED TREATMENT 2020-07-09T16:482020-08-07 B#B@mRNA-1273-P201SEmRNA-1273-P201-US207-1064US2071064A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-07 2021-03-19 B@CmRNA-1273-P201SEmRNA-1273-P201-US207-1065US2071065ASCREEN Screening ASCREENING 2020-06-01 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1066US2071066ASCREEN Screening ASCREENING 2020-06-01 2020-06-09T16:27Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1066US2071066A PBO Placebo A BLINDED TREATMENT 2020-06-09T16:272020-07-08T14:16ABmRNA-1273-P201SEmRNA-1273-P201-US207-1066US2071066A0PBO Placebo A0BLINDED TREATMENT 2020-07-08T14:162020-08-03 BB8mRNA-1273-P201SEmRNA-1273-P201-US207-1066US2071066A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-03-02 B8C°mRNA-1273-P201SEmRNA-1273-P201-US207-1067US2071067ASCREEN Screening ASCREENING 2020-06-01 2020-06-05T12:18Á@AmRNA-1273-P201SEmRNA-1273-P201-US207-1067US2071067A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-05T12:182020-07-08T17:20AB"mRNA-1273-P201SEmRNA-1273-P201-US207-1067US2071067A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-08T17:202020-08-13 B"BFmRNA-1273-P201SEmRNA-1273-P201-US207-1067US2071067A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-13 2021-03-10 BFCpmRNA-1273-P201SEmRNA-1273-P201-US207-1068US2071068ASCREEN Screening ASCREENING 2020-06-01 2020-06-08T16:31ÁpAmRNA-1273-P201SEmRNA-1273-P201-US207-1068US2071068A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T16:312020-07-08T13:58ABmRNA-1273-P201SEmRNA-1273-P201-US207-1068US2071068A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-08T13:582020-08-04 BB:mRNA-1273-P201SEmRNA-1273-P201-US207-1068US2071068A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-24 B:C`mRNA-1273-P201SEmRNA-1273-P201-US207-1069US2071069ASCREEN Screening ASCREENING 2020-06-02 2020-06-08T10:49Á`AmRNA-1273-P201SEmRNA-1273-P201-US207-1069US2071069A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T10:492020-07-13T10:38AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1069US2071069A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-13T10:382020-08-17 B$BGmRNA-1273-P201SEmRNA-1273-P201-US207-1069US2071069A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-17 2021-02-25 BGCpmRNA-1273-P201SEmRNA-1273-P201-US207-1070US2071070ASCREEN Screening ASCREENING 2020-06-02 2020-06-08T11:15Á`AmRNA-1273-P201SEmRNA-1273-P201-US207-1070US2071070A PBO Placebo A BLINDED TREATMENT 2020-06-08T11:152020-07-07T08:49ABmRNA-1273-P201SEmRNA-1273-P201-US207-1070US2071070A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T08:492020-08-04 BB:mRNA-1273-P201SEmRNA-1273-P201-US207-1070US2071070A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-02 B:BðmRNA-1273-P201SEmRNA-1273-P201-US207-1071US2071071ASCREEN Screening ASCREENING 2020-06-02 2020-06-05T12:54Á0AmRNA-1273-P201SEmRNA-1273-P201-US207-1071US2071071A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-05T12:542020-07-07T11:51AB!mRNA-1273-P201SEmRNA-1273-P201-US207-1071US2071071A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T11:512020-08-11 B!BDmRNA-1273-P201SEmRNA-1273-P201-US207-1071US2071071A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-11 2021-02-03 BDBômRNA-1273-P201SEmRNA-1273-P201-US207-1072US2071072ASCREEN Screening ASCREENING 2020-06-02 2020-06-05T13:04Á0AmRNA-1273-P201SEmRNA-1273-P201-US207-1072US2071072A PBO Placebo A BLINDED TREATMENT 2020-06-05T13:042020-07-06T09:07AB mRNA-1273-P201SEmRNA-1273-P201-US207-1072US2071072A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T09:072020-07-31 B B9mRNA-1273-P201SEmRNA-1273-P201-US207-1072US2071072A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-31 2021-02-02 B9BómRNA-1273-P201SEmRNA-1273-P201-US207-1073US2071073ASCREEN Screening ASCREENING 2020-06-02 2020-06-08T12:07Á`AmRNA-1273-P201SEmRNA-1273-P201-US207-1073US2071073A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T12:072020-07-07T10:35ABmRNA-1273-P201SEmRNA-1273-P201-US207-1073US2071073A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T10:352020-08-04 BB:mRNA-1273-P201SEmRNA-1273-P201-US207-1073US2071073A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-26 B:C€mRNA-1273-P201SEmRNA-1273-P201-US207-1074US2071074ASCREEN Screening ASCREENING 2020-06-02 2020-06-08T14:16Á`AmRNA-1273-P201SEmRNA-1273-P201-US207-1074US2071074A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T14:162020-07-09T13:16AB mRNA-1273-P201SEmRNA-1273-P201-US207-1074US2071074A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-09T13:162020-08-04 B B:mRNA-1273-P201SEmRNA-1273-P201-US207-1074US2071074A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-02-26 B:C€mRNA-1273-P201SEmRNA-1273-P201-US207-1075US2071075ASCREEN Screening ASCREENING 2020-06-02 2020-06-08 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1076US2071076ASCREEN Screening ASCREENING 2020-06-03 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1077US2071077ASCREEN Screening ASCREENING 2020-06-03 2020-06-08T13:15ÁPAmRNA-1273-P201SEmRNA-1273-P201-US207-1077US2071077A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T13:152020-07-10T09:54AB!mRNA-1273-P201SEmRNA-1273-P201-US207-1077US2071077A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-10T09:542020-08-04 B!B:mRNA-1273-P201SEmRNA-1273-P201-US207-1077US2071077A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-04 2021-03-12 B:C`mRNA-1273-P201SEmRNA-1273-P201-US207-1078US2071078ASCREEN Screening ASCREENING 2020-06-03 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1079US2071079ASCREEN Screening ASCREENING 2020-06-04 2020-06-04 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1080US2071080ASCREEN Screening ASCREENING 2020-06-05 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1081US2071081ASCREEN Screening ASCREENING 2020-06-05 2020-06-08T16:59Á0AmRNA-1273-P201SEmRNA-1273-P201-US207-1081US2071081A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T16:592020-07-07T15:52ABmRNA-1273-P201SEmRNA-1273-P201-US207-1081US2071081A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T15:522020-08-10 BB@mRNA-1273-P201SEmRNA-1273-P201-US207-1081US2071081A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-26 B@C€mRNA-1273-P201SEmRNA-1273-P201-US207-1082US2071082ASCREEN Screening ASCREENING 2020-06-15 2020-06-26T15:40Á°AmRNA-1273-P201SEmRNA-1273-P201-US207-1082US2071082A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T15:402020-07-28T10:00AB!mRNA-1273-P201SEmRNA-1273-P201-US207-1082US2071082A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-28T10:002020-08-26 B!B>mRNA-1273-P201SEmRNA-1273-P201-US207-1082US2071082A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-02-25 B>BõmRNA-1273-P201SEmRNA-1273-P201-US207-1083US2071057ASCREEN Screening ASCREENING 2020-05-26 2020-06-15 ÂÁ°mRNA-1273-P201SEmRNA-1273-P201-US207-1083US2071083A SCREEN Screening ASCREENING 2020-06-15 2020-06-26T10:30Á°AmRNA-1273-P201SEmRNA-1273-P201-US207-1083US2071083A0V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T10:302020-07-21T09:42ABmRNA-1273-P201SEmRNA-1273-P201-US207-1083US2071083A@V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-21T09:422020-08-24 BB<mRNA-1273-P201SEmRNA-1273-P201-US207-1083US2071083APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-22 B<BòmRNA-1273-P201SEmRNA-1273-P201-US207-1084US2071084ASCREEN Screening ASCREENING 2020-06-05 2020-06-26T10:16ÂAmRNA-1273-P201SEmRNA-1273-P201-US207-1084US2071084A PBO Placebo A BLINDED TREATMENT 2020-06-26T10:162020-07-27T11:09AB mRNA-1273-P201SEmRNA-1273-P201-US207-1084US2071084A0PBO Placebo A0BLINDED TREATMENT 2020-07-27T11:092020-08-24 B B<mRNA-1273-P201SEmRNA-1273-P201-US207-1084US2071084A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-19 B<BïmRNA-1273-P201SEmRNA-1273-P201-US207-1085US2071085ASCREEN Screening ASCREENING 2020-06-17 2020-06-26T14:43ÁAmRNA-1273-P201SEmRNA-1273-P201-US207-1085US2071085A PBO Placebo A BLINDED TREATMENT 2020-06-26T14:432020-07-28T14:11AB!mRNA-1273-P201SEmRNA-1273-P201-US207-1085US2071085A0PBO Placebo A0BLINDED TREATMENT 2020-07-28T14:112020-08-24 B!B<mRNA-1273-P201SEmRNA-1273-P201-US207-1085US2071085A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-04 B<BàmRNA-1273-P201SEmRNA-1273-P201-US207-1086US2071086ASCREEN Screening ASCREENING 2020-06-18 2020-06-26T12:35Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1086US2071086A PBO Placebo A BLINDED TREATMENT 2020-06-26T12:352020-07-29T10:39AB"mRNA-1273-P201SEmRNA-1273-P201-US207-1086US2071086A0PBO Placebo A0BLINDED TREATMENT 2020-07-29T10:392020-08-24 B"B<mRNA-1273-P201SEmRNA-1273-P201-US207-1086US2071086A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-02 B<BÞmRNA-1273-P201SEmRNA-1273-P201-US207-1087US2071087ASCREEN Screening ASCREENING 2020-06-18 2020-06-26T12:17Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1087US2071087A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T12:172020-07-30T10:58AB#mRNA-1273-P201SEmRNA-1273-P201-US207-1087US2071087A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-30T10:582020-08-28 B#B@mRNA-1273-P201SEmRNA-1273-P201-US207-1087US2071087A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-26 B@BömRNA-1273-P201SEmRNA-1273-P201-US207-1088US2071052ASCREEN Screening ASCREENING 2020-05-29 2020-06-18 ÂÁ€mRNA-1273-P201SEmRNA-1273-P201-US207-1088US2071088A SCREEN Screening ASCREENING 2020-06-18 2020-06-26T14:09Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1088US2071088A0PBO Placebo A BLINDED TREATMENT 2020-06-26T14:092020-07-27T12:07AB mRNA-1273-P201SEmRNA-1273-P201-US207-1088US2071088A@PBO Placebo A0BLINDED TREATMENT 2020-07-27T12:072020-08-24 B B<mRNA-1273-P201SEmRNA-1273-P201-US207-1088US2071088APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-24 B<BômRNA-1273-P201SEmRNA-1273-P201-US207-1089US2071031ASCREEN Screening ASCREENING 2020-05-26 2020-06-18 ÂÁ€mRNA-1273-P201SEmRNA-1273-P201-US207-1089US2071089A SCREEN Screening ASCREENING 2020-06-18 2020-06-26T09:40Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1089US2071089A0V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T09:402020-07-29T16:32AB"mRNA-1273-P201SEmRNA-1273-P201-US207-1089US2071089A@V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T16:322020-08-27 B"B?mRNA-1273-P201SEmRNA-1273-P201-US207-1089US2071089APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-02-25 B?BõmRNA-1273-P201SEmRNA-1273-P201-US207-1090US2071090ASCREEN Screening ASCREENING 2020-06-18 2020-06-29T14:11Á°AmRNA-1273-P201SEmRNA-1273-P201-US207-1090US2071090A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-29T14:112020-07-29T15:17ABmRNA-1273-P201SEmRNA-1273-P201-US207-1090US2071090A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-29T15:172020-08-25 BB:mRNA-1273-P201SEmRNA-1273-P201-US207-1090US2071090A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-22 B:BïmRNA-1273-P201SEmRNA-1273-P201-US207-1091US2071091ASCREEN Screening ASCREENING 2020-06-19 2020-06-26T10:53ÁpAmRNA-1273-P201SEmRNA-1273-P201-US207-1091US2071091A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T10:532020-07-27T11:54AB mRNA-1273-P201SEmRNA-1273-P201-US207-1091US2071091A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-27T11:542020-08-21 B B9mRNA-1273-P201SEmRNA-1273-P201-US207-1091US2071091A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-02-26 B9BömRNA-1273-P201SEmRNA-1273-P201-US207-1092US2071092ASCREEN Screening ASCREENING 2020-06-19 2020-06-26T11:12ÁpAmRNA-1273-P201SEmRNA-1273-P201-US207-1092US2071092A PBO Placebo A BLINDED TREATMENT 2020-06-26T11:122020-07-21T10:18ABmRNA-1273-P201SEmRNA-1273-P201-US207-1092US2071092A0PBO Placebo A0BLINDED TREATMENT 2020-07-21T10:182020-08-19 BB7mRNA-1273-P201SEmRNA-1273-P201-US207-1092US2071092A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-19 2021-02-03 B7BßmRNA-1273-P201SEmRNA-1273-P201-US207-1093US2071093ASCREEN Screening ASCREENING 2020-06-22 2020-06-29T10:32ÁpAmRNA-1273-P201SEmRNA-1273-P201-US207-1093US2071093A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-29T10:322020-07-29T10:24ABmRNA-1273-P201SEmRNA-1273-P201-US207-1093US2071093A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T10:242020-09-01 BBAmRNA-1273-P201SEmRNA-1273-P201-US207-1093US2071093A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-01 2021-02-26 BABómRNA-1273-P201SEmRNA-1273-P201-US207-1094US2071094ASCREEN Screening ASCREENING 2020-06-22 2020-07-06T09:28ÁàAmRNA-1273-P201SEmRNA-1273-P201-US207-1094US2071094A PBO Placebo A BLINDED TREATMENT 2020-07-06T09:282020-08-04T12:54ABmRNA-1273-P201SEmRNA-1273-P201-US207-1094US2071094A0PBO Placebo A0BLINDED TREATMENT 2020-08-04T12:542020-08-31 BB9mRNA-1273-P201SEmRNA-1273-P201-US207-1094US2071094A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-01 B9BÓmRNA-1273-P201SEmRNA-1273-P201-US207-1095US2071095ASCREEN Screening ASCREENING 2020-06-23 2020-06-29T11:04Á`AmRNA-1273-P201SEmRNA-1273-P201-US207-1095US2071095A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-29T11:042020-07-28T10:41ABmRNA-1273-P201SEmRNA-1273-P201-US207-1095US2071095A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-28T10:412020-08-25 BB:mRNA-1273-P201SEmRNA-1273-P201-US207-1095US2071095A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-24 B:BñmRNA-1273-P201SEmRNA-1273-P201-US207-1096US2071047ASCREEN Screening ASCREENING 2020-05-28 2020-06-24 Â#Á€mRNA-1273-P201SEmRNA-1273-P201-US207-1096US2071096A SCREEN Screening ASCREENING 2020-06-24 2020-07-02T15:54Á€AmRNA-1273-P201SEmRNA-1273-P201-US207-1096US2071096A0V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-02T15:542020-08-05T15:47AB#mRNA-1273-P201SEmRNA-1273-P201-US207-1096US2071096A@V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-05T15:472020-09-04 B#BAmRNA-1273-P201SEmRNA-1273-P201-US207-1096US2071096APFUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-04 2021-02-05 BABÛmRNA-1273-P201SEmRNA-1273-P201-US207-1097US2071097ASCREEN Screening ASCREENING 2020-06-24 2020-06-24 ..mRNA-1273-P201SEmRNA-1273-P201-US207-1098US2071098ASCREEN Screening ASCREENING 2020-06-24 2020-07-01T10:35ÁpAmRNA-1273-P201SEmRNA-1273-P201-US207-1098US2071098A PBO Placebo A BLINDED TREATMENT 2020-07-01T10:352020-08-05T16:15AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1098US2071098A0PBO Placebo A0BLINDED TREATMENT 2020-08-05T16:152020-08-31 B$B>mRNA-1273-P201SEmRNA-1273-P201-US207-1098US2071098A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-24 B>BïmRNA-1273-P201SEmRNA-1273-P201-US207-1099US2071099ASCREEN Screening ASCREENING 2020-06-24 2020-07-07T13:34ÁÐAmRNA-1273-P201SEmRNA-1273-P201-US207-1099US2071099A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-07T13:342020-08-04T15:12ABmRNA-1273-P201SEmRNA-1273-P201-US207-1099US2071099A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-04T15:122020-09-03 BB;mRNA-1273-P201SEmRNA-1273-P201-US207-1099US2071099A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-03 2021-02-23 B;BèmRNA-1273-P201SEmRNA-1273-P201-US207-1100US2071100ASCREEN Screening ASCREENING 2020-06-25 2020-07-06T16:05Á°AmRNA-1273-P201SEmRNA-1273-P201-US207-1100US2071100A PBO Placebo A BLINDED TREATMENT 2020-07-06T16:052020-08-04T10:47ABmRNA-1273-P201SEmRNA-1273-P201-US207-1100US2071100A0PBO Placebo A0BLINDED TREATMENT 2020-08-04T10:472020-09-03 BB<mRNA-1273-P201SEmRNA-1273-P201-US207-1100US2071100A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-03 2021-03-01 B<BïmRNA-1273-P201SEmRNA-1273-P201-US207-1101US2071101ASCREEN Screening ASCREENING 2020-06-25 2020-06-29T16:40Á@AmRNA-1273-P201SEmRNA-1273-P201-US207-1101US2071101A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-29T16:402020-08-03T14:53AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1101US2071101A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-03T14:532020-09-14 B$BNmRNA-1273-P201SEmRNA-1273-P201-US207-1102US2071102ASCREEN Screening ASCREENING 2020-06-25 2020-06-29T13:04Á@AmRNA-1273-P201SEmRNA-1273-P201-US207-1102US2071102A PBO Placebo A BLINDED TREATMENT 2020-06-29T13:042020-07-28T14:14ABmRNA-1273-P201SEmRNA-1273-P201-US207-1102US2071102A0PBO Placebo A0BLINDED TREATMENT 2020-07-28T14:142020-08-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US207-1102US2071102A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-02 B9BÛmRNA-1273-P201SEmRNA-1273-P201-US207-1103US2071103ASCREEN Screening ASCREENING 2020-06-26 2020-07-02T15:50Á`AmRNA-1273-P201SEmRNA-1273-P201-US207-1103US2071103A PBO Placebo A BLINDED TREATMENT 2020-07-02T15:502020-08-06T10:00AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1103US2071103A0PBO Placebo A0BLINDED TREATMENT 2020-08-06T10:002020-09-11 B$BHmRNA-1273-P201SEmRNA-1273-P201-US207-1103US2071103A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-11 2021-02-19 BHBémRNA-1273-P201SEmRNA-1273-P201-US207-1104US2071104ASCREEN Screening ASCREENING 2020-06-26 2020-07-06T13:13Á AmRNA-1273-P201SEmRNA-1273-P201-US207-1104US2071104A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-06T13:132020-08-10T10:46AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1104US2071104A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-10T10:462020-09-04 B$B=mRNA-1273-P201SEmRNA-1273-P201-US207-1104US2071104A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-04 2021-03-03 B=BñmRNA-1273-P201SEmRNA-1273-P201-US207-1105US2071105ASCREEN Screening ASCREENING 2020-06-30 2020-07-06T13:05Á`AmRNA-1273-P201SEmRNA-1273-P201-US207-1105US2071105A PBO Placebo A BLINDED TREATMENT 2020-07-06T13:052020-08-10T11:35AB$mRNA-1273-P201SEmRNA-1273-P201-US207-1105US2071105A0PBO Placebo A0BLINDED TREATMENT 2020-08-10T11:352020-09-09 B$BBmRNA-1273-P201SEmRNA-1273-P201-US207-1105US2071105A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-09 2021-02-01 BBBÓmRNA-1273-P201SEmRNA-1273-P201-US207-1106US2071106ASCREEN Screening ASCREENING 2020-07-01 2020-07-06T16:51ÁPAmRNA-1273-P201SEmRNA-1273-P201-US207-1106US2071106A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-06T16:512020-07-11 AA`mRNA-1273-P201SEmRNA-1273-P201-US207-1106US2071106A0FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-12 2021-03-17 ApBÿmRNA-1273-P201SEmRNA-1273-P201-US208-1001US2081001ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T11:00Á0AmRNA-1273-P201SEmRNA-1273-P201-US208-1001US2081001A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-05-29T11:002020-06-24T08:24ABmRNA-1273-P201SEmRNA-1273-P201-US208-1001US2081001A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-24T08:242020-07-23 BB8mRNA-1273-P201SEmRNA-1273-P201-US208-1001US2081001A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-23 2021-02-05 B8BýmRNA-1273-P201SEmRNA-1273-P201-US208-1002US2081002ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T10:50Á0AmRNA-1273-P201SEmRNA-1273-P201-US208-1002US2081002A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-05-29T10:502020-06-25T09:07ABmRNA-1273-P201SEmRNA-1273-P201-US208-1002US2081002A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-25T09:072020-07-24 BB9mRNA-1273-P201SEmRNA-1273-P201-US208-1002US2081002A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-24 2021-02-02 B9BúmRNA-1273-P201SEmRNA-1273-P201-US208-1003US2081003ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T14:31Á0AmRNA-1273-P201SEmRNA-1273-P201-US208-1003US2081003A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-05-29T14:312020-06-29T09:42AB mRNA-1273-P201SEmRNA-1273-P201-US208-1003US2081003A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T09:422020-07-27 B B<mRNA-1273-P201SEmRNA-1273-P201-US208-1003US2081003A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-26 B<C mRNA-1273-P201SEmRNA-1273-P201-US208-1004US2081004ASCREEN Screening ASCREENING 2020-05-26 2020-05-29T14:09Á0AmRNA-1273-P201SEmRNA-1273-P201-US208-1004US2081004A PBO Placebo A BLINDED TREATMENT 2020-05-29T14:092020-06-29T12:06AB mRNA-1273-P201SEmRNA-1273-P201-US208-1004US2081004A0PBO Placebo A0BLINDED TREATMENT 2020-06-29T12:062020-07-27 B B<mRNA-1273-P201SEmRNA-1273-P201-US208-1004US2081004A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-05 B<BýmRNA-1273-P201SEmRNA-1273-P201-US208-1005US2081005ASCREEN Screening ASCREENING 2020-05-26 2020-06-01T10:31Á`AmRNA-1273-P201SEmRNA-1273-P201-US208-1005US2081005A PBO Placebo A BLINDED TREATMENT 2020-06-01T10:312020-07-01T14:09ABmRNA-1273-P201SEmRNA-1273-P201-US208-1005US2081005A0PBO Placebo A0BLINDED TREATMENT 2020-07-01T14:092020-07-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US208-1005US2081005A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-15 B:C@mRNA-1273-P201SEmRNA-1273-P201-US208-1006US2081006ASCREEN Screening ASCREENING 2020-05-26 2020-05-26 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1007US2081007ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T08:01ÁPAmRNA-1273-P201SEmRNA-1273-P201-US208-1007US2081007A PBO Placebo A BLINDED TREATMENT 2020-06-01T08:012020-06-30T15:26ABmRNA-1273-P201SEmRNA-1273-P201-US208-1007US2081007A0PBO Placebo A0BLINDED TREATMENT 2020-06-30T15:262020-07-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US208-1007US2081007A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-01-06 B:BÜmRNA-1273-P201SEmRNA-1273-P201-US208-1008US2081008ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1009US2081009ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T10:13ÁPAmRNA-1273-P201SEmRNA-1273-P201-US208-1009US2081009A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-01T10:132020-07-02T13:24AB mRNA-1273-P201SEmRNA-1273-P201-US208-1009US2081009A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-02T13:242020-07-28 B B:mRNA-1273-P201SEmRNA-1273-P201-US208-1009US2081009A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-05 B:BúmRNA-1273-P201SEmRNA-1273-P201-US208-1010US2081010ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1011US2081011ASCREEN Screening ASCREENING 2020-05-27 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1012US2081012ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1013US2081013ASCREEN Screening ASCREENING 2020-05-27 2020-05-27 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1014US2081014ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T14:08ÁPAmRNA-1273-P201SEmRNA-1273-P201-US208-1014US2081014A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T14:082020-06-30T10:15ABmRNA-1273-P201SEmRNA-1273-P201-US208-1014US2081014A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-30T10:152020-07-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US208-1014US2081014A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-08 B:BýmRNA-1273-P201SEmRNA-1273-P201-US208-1015US2081015ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T14:20ÁPAmRNA-1273-P201SEmRNA-1273-P201-US208-1015US2081015A PBO Placebo A BLINDED TREATMENT 2020-06-01T14:202020-07-01T09:40ABmRNA-1273-P201SEmRNA-1273-P201-US208-1015US2081015A0PBO Placebo A0BLINDED TREATMENT 2020-07-01T09:402020-07-27 BB9mRNA-1273-P201SEmRNA-1273-P201-US208-1015US2081015A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-27 2021-02-02 B9B÷mRNA-1273-P201SEmRNA-1273-P201-US208-1016US2081016ASCREEN Screening ASCREENING 2020-05-27 2020-06-01T12:25ÁPAmRNA-1273-P201SEmRNA-1273-P201-US208-1016US2081016A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-01T12:252020-06-29T14:08ABmRNA-1273-P201SEmRNA-1273-P201-US208-1016US2081016A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-29T14:082020-07-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US208-1016US2081016A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-26 B:CðmRNA-1273-P201SEmRNA-1273-P201-US208-1017US2081017ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T08:14ÁPAmRNA-1273-P201SEmRNA-1273-P201-US208-1017US2081017A PBO Placebo A BLINDED TREATMENT 2020-06-02T08:142020-07-06T15:40AB#mRNA-1273-P201SEmRNA-1273-P201-US208-1017US2081017A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T15:402020-08-06 B#BBmRNA-1273-P201SEmRNA-1273-P201-US208-1017US2081017A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-15 BBC0mRNA-1273-P201SEmRNA-1273-P201-US208-1018US2081018ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1019US2081019ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T10:50ÁPAmRNA-1273-P201SEmRNA-1273-P201-US208-1019US2081019A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T10:502020-06-30T10:37ABmRNA-1273-P201SEmRNA-1273-P201-US208-1019US2081019A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-06-30T10:372020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US208-1019US2081019A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-05 B9BùmRNA-1273-P201SEmRNA-1273-P201-US208-1020US2081020ASCREEN Screening ASCREENING 2020-05-28 2020-06-02T10:31ÁPAmRNA-1273-P201SEmRNA-1273-P201-US208-1020US2081020A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-02T10:312020-06-29T11:58ABmRNA-1273-P201SEmRNA-1273-P201-US208-1020US2081020A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-06-29T11:582020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US208-1020US2081020A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-12 B9CmRNA-1273-P201SEmRNA-1273-P201-US208-1021US2081021ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1022US2081022ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1023US2081023ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T13:51Á`AmRNA-1273-P201SEmRNA-1273-P201-US208-1023US2081023A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T13:512020-07-07T09:47AB#mRNA-1273-P201SEmRNA-1273-P201-US208-1023US2081023A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T09:472020-08-05 B#B@mRNA-1273-P201SEmRNA-1273-P201-US208-1023US2081023A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-17 B@C@mRNA-1273-P201SEmRNA-1273-P201-US208-1024US2081024ASCREEN Screening ASCREENING 2020-05-28 2020-05-28 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1025US2081025ASCREEN Screening ASCREENING 2020-05-28 2020-06-03T11:03Á`AmRNA-1273-P201SEmRNA-1273-P201-US208-1025US2081025A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-03T11:032020-07-07T14:04AB#mRNA-1273-P201SEmRNA-1273-P201-US208-1025US2081025A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T14:042020-08-06 B#BAmRNA-1273-P201SEmRNA-1273-P201-US208-1025US2081025A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-03-12 BAC°mRNA-1273-P201SEmRNA-1273-P201-US208-1026US2081026ASCREEN Screening ASCREENING 2020-05-29 2020-06-04T07:52Á`AmRNA-1273-P201SEmRNA-1273-P201-US208-1026US2081026A PBO Placebo A BLINDED TREATMENT 2020-06-04T07:522020-07-07T07:44AB"mRNA-1273-P201SEmRNA-1273-P201-US208-1026US2081026A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T07:442020-08-06 B"B@mRNA-1273-P201SEmRNA-1273-P201-US208-1026US2081026A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-03 B@BõmRNA-1273-P201SEmRNA-1273-P201-US208-1027US2081027ASCREEN Screening ASCREENING 2020-05-29 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1028US2081028ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T14:03Á@AmRNA-1273-P201SEmRNA-1273-P201-US208-1028US2081028A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T14:032020-07-07T09:57AB$mRNA-1273-P201SEmRNA-1273-P201-US208-1028US2081028A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T09:572020-08-06 B$BBmRNA-1273-P201SEmRNA-1273-P201-US208-1028US2081028A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-17 BBCPmRNA-1273-P201SEmRNA-1273-P201-US208-1029US2081029ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T14:18Á@AmRNA-1273-P201SEmRNA-1273-P201-US208-1029US2081029A PBO Placebo A BLINDED TREATMENT 2020-06-02T14:182020-07-07T11:52AB$mRNA-1273-P201SEmRNA-1273-P201-US208-1029US2081029A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T11:522020-08-06 B$BBmRNA-1273-P201SEmRNA-1273-P201-US208-1029US2081029A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-17 BBCPmRNA-1273-P201SEmRNA-1273-P201-US208-1030US2081030ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T12:28Á@AmRNA-1273-P201SEmRNA-1273-P201-US208-1030US2081030A PBO Placebo A BLINDED TREATMENT 2020-06-02T12:282020-07-06T09:23AB#mRNA-1273-P201SEmRNA-1273-P201-US208-1030US2081030A0PBO Placebo A0BLINDED TREATMENT 2020-07-06T09:232020-08-03 B#B?mRNA-1273-P201SEmRNA-1273-P201-US208-1030US2081030A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-03 2021-01-25 B?BîmRNA-1273-P201SEmRNA-1273-P201-US208-1031US2081031ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1032US2081032ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1033US2081033ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T08:00Á@AmRNA-1273-P201SEmRNA-1273-P201-US208-1033US2081033A PBO Placebo A BLINDED TREATMENT 2020-06-02T08:002020-07-07T10:39AB$mRNA-1273-P201SEmRNA-1273-P201-US208-1033US2081033A0PBO Placebo A0BLINDED TREATMENT 2020-07-07T10:392020-08-06 B$BBmRNA-1273-P201SEmRNA-1273-P201-US208-1033US2081033A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-03-15 BBCðmRNA-1273-P201SEmRNA-1273-P201-US208-1034US2081034ASCREEN Screening ASCREENING 2020-05-29 2020-05-29 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1035US2081035ASCREEN Screening ASCREENING 2020-05-29 2020-06-02T12:52Á@AmRNA-1273-P201SEmRNA-1273-P201-US208-1035US2081035A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-02T12:522020-07-01T12:01ABmRNA-1273-P201SEmRNA-1273-P201-US208-1035US2081035A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-01T12:012020-07-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US208-1035US2081035A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-07-28 2021-02-03 B9B÷mRNA-1273-P201SEmRNA-1273-P201-US208-1036US2081036ASCREEN Screening ASCREENING 2020-05-29 2020-06-04T09:40Á`AmRNA-1273-P201SEmRNA-1273-P201-US208-1036US2081036A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-04T09:402020-07-09T13:48AB$mRNA-1273-P201SEmRNA-1273-P201-US208-1036US2081036A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-09T13:482020-08-06 B$B@mRNA-1273-P201SEmRNA-1273-P201-US208-1036US2081036A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-23 B@CmRNA-1273-P201SEmRNA-1273-P201-US208-1037US2081037ASCREEN Screening ASCREENING 2020-05-29 2020-06-12 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1038US2081038ASCREEN Screening ASCREENING 2020-06-01 2020-06-08T08:02ÁpAmRNA-1273-P201SEmRNA-1273-P201-US208-1038US2081038A PBO Placebo A BLINDED TREATMENT 2020-06-08T08:022020-07-09T07:48AB mRNA-1273-P201SEmRNA-1273-P201-US208-1038US2081038A0PBO Placebo A0BLINDED TREATMENT 2020-07-09T07:482020-08-10 B B@mRNA-1273-P201SEmRNA-1273-P201-US208-1038US2081038A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-23 B@CPmRNA-1273-P201SEmRNA-1273-P201-US208-1039US2081039ASCREEN Screening ASCREENING 2020-06-01 2020-06-08T13:44ÁpAmRNA-1273-P201SEmRNA-1273-P201-US208-1039US2081039A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T13:442020-07-08T12:08ABmRNA-1273-P201SEmRNA-1273-P201-US208-1039US2081039A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-08T12:082020-08-06 BB<mRNA-1273-P201SEmRNA-1273-P201-US208-1039US2081039A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-24 B<C`mRNA-1273-P201SEmRNA-1273-P201-US208-1040US2081040ASCREEN Screening ASCREENING 2020-06-01 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1041US2081041ASCREEN Screening ASCREENING 2020-06-01 2020-06-04T12:56Á0AmRNA-1273-P201SEmRNA-1273-P201-US208-1041US2081041A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-04T12:562020-07-07T12:12AB"mRNA-1273-P201SEmRNA-1273-P201-US208-1041US2081041A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-07T12:122020-08-11 B"BEmRNA-1273-P201SEmRNA-1273-P201-US208-1041US2081041A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-11 2021-02-24 BEC mRNA-1273-P201SEmRNA-1273-P201-US208-1042US2081042ASCREEN Screening ASCREENING 2020-06-01 2020-06-10T07:43ÁAmRNA-1273-P201SEmRNA-1273-P201-US208-1042US2081042A PBO Placebo A BLINDED TREATMENT 2020-06-10T07:432020-07-08T08:00ABmRNA-1273-P201SEmRNA-1273-P201-US208-1042US2081042A0PBO Placebo A0BLINDED TREATMENT 2020-07-08T08:002020-08-06 BB:mRNA-1273-P201SEmRNA-1273-P201-US208-1042US2081042A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-15 B:BûmRNA-1273-P201SEmRNA-1273-P201-US208-1043US2081043ASCREEN Screening ASCREENING 2020-06-01 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1044US2081044ASCREEN Screening ASCREENING 2020-06-01 2020-06-01 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1045US2081045ASCREEN Screening ASCREENING 2020-06-01 2020-06-04T10:02Á0AmRNA-1273-P201SEmRNA-1273-P201-US208-1045US2081045A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-04T10:022020-07-07T14:18AB"mRNA-1273-P201SEmRNA-1273-P201-US208-1045US2081045A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-07T14:182020-08-07 B"BAmRNA-1273-P201SEmRNA-1273-P201-US208-1045US2081045A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-07 2021-02-26 BACÀmRNA-1273-P201SEmRNA-1273-P201-US208-1046US2081046ASCREEN Screening ASCREENING 2020-06-02 2020-06-08T15:42Á`AmRNA-1273-P201SEmRNA-1273-P201-US208-1046US2081046A PBO Placebo A BLINDED TREATMENT 2020-06-08T15:422020-07-09T07:58AB mRNA-1273-P201SEmRNA-1273-P201-US208-1046US2081046A0PBO Placebo A0BLINDED TREATMENT 2020-07-09T07:582020-08-07 B B=mRNA-1273-P201SEmRNA-1273-P201-US208-1046US2081046A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-07 2021-02-23 B=CPmRNA-1273-P201SEmRNA-1273-P201-US208-1047US2081047ASCREEN Screening ASCREENING 2020-06-02 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1048US2081048ASCREEN Screening ASCREENING 2020-06-02 2020-06-02 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1049US2081049ASCREEN Screening ASCREENING 2020-06-02 2020-06-09T09:32ÁpAmRNA-1273-P201SEmRNA-1273-P201-US208-1049US2081049A PBO Placebo A BLINDED TREATMENT 2020-06-09T09:322020-07-08T07:51ABmRNA-1273-P201SEmRNA-1273-P201-US208-1049US2081049A0PBO Placebo A0BLINDED TREATMENT 2020-07-08T07:512020-08-06 BB;mRNA-1273-P201SEmRNA-1273-P201-US208-1049US2081049A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-01-06 B;BÔmRNA-1273-P201SEmRNA-1273-P201-US208-1050US2081050ASCREEN Screening ASCREENING 2020-06-02 2020-06-05 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1051US2081051ASCREEN Screening ASCREENING 2020-06-02 2020-06-05T09:47Á0AmRNA-1273-P201SEmRNA-1273-P201-US208-1051US2081051A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-05T09:472020-07-08T10:02AB"mRNA-1273-P201SEmRNA-1273-P201-US208-1051US2081051A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-08T10:022020-08-10 B"BCmRNA-1273-P201SEmRNA-1273-P201-US208-1051US2081051A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-17 BCC mRNA-1273-P201SEmRNA-1273-P201-US208-1052US2081052ASCREEN Screening ASCREENING 2020-06-02 2020-06-05T11:58Á0AmRNA-1273-P201SEmRNA-1273-P201-US208-1052US2081052A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-05T11:582020-07-09T13:55AB#mRNA-1273-P201SEmRNA-1273-P201-US208-1052US2081052A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-09T13:552020-08-06 B#B?mRNA-1273-P201SEmRNA-1273-P201-US208-1052US2081052A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-03-12 B?CmRNA-1273-P201SEmRNA-1273-P201-US208-1053US2081053ASCREEN Screening ASCREENING 2020-06-03 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1054US2081054ASCREEN Screening ASCREENING 2020-06-03 2020-06-05T13:56Á AmRNA-1273-P201SEmRNA-1273-P201-US208-1054US2081054A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-05T13:562020-07-08T13:46AB"mRNA-1273-P201SEmRNA-1273-P201-US208-1054US2081054A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-08T13:462020-08-05 B"B>mRNA-1273-P201SEmRNA-1273-P201-US208-1054US2081054A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-26 B>C°mRNA-1273-P201SEmRNA-1273-P201-US208-1055US2081055ASCREEN Screening ASCREENING 2020-06-03 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1056US2081056ASCREEN Screening ASCREENING 2020-06-03 2020-06-03 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1057US2081057ASCREEN Screening ASCREENING 2020-06-03 2020-06-05T13:45Á AmRNA-1273-P201SEmRNA-1273-P201-US208-1057US2081057A PBO Placebo A BLINDED TREATMENT 2020-06-05T13:452020-07-09T12:43AB#mRNA-1273-P201SEmRNA-1273-P201-US208-1057US2081057A0PBO Placebo A0BLINDED TREATMENT 2020-07-09T12:432020-08-05 B#B>mRNA-1273-P201SEmRNA-1273-P201-US208-1057US2081057A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-05 2021-02-24 B>CmRNA-1273-P201SEmRNA-1273-P201-US208-1058US2081058ASCREEN Screening ASCREENING 2020-06-04 2020-06-08T11:54Á@AmRNA-1273-P201SEmRNA-1273-P201-US208-1058US2081058A PBO Placebo A BLINDED TREATMENT 2020-06-08T11:542020-06-17 AA mRNA-1273-P201SEmRNA-1273-P201-US208-1058US2081058A0FUPA Part A Follow up A@PART A FOLLOW-UP 2020-06-18 2021-02-19 A°CmRNA-1273-P201SEmRNA-1273-P201-US208-1059US2081059ASCREEN Screening ASCREENING 2020-06-04 2020-06-08T14:34Á@AmRNA-1273-P201SEmRNA-1273-P201-US208-1059US2081059A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-08T14:342020-07-13T11:33AB$mRNA-1273-P201SEmRNA-1273-P201-US208-1059US2081059A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-13T11:332020-08-10 B$B@mRNA-1273-P201SEmRNA-1273-P201-US208-1059US2081059A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-10 2021-02-28 B@C mRNA-1273-P201SEmRNA-1273-P201-US208-1060US2081060ASCREEN Screening ASCREENING 2020-06-04 2020-06-04 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1061US2081061ASCREEN Screening ASCREENING 2020-06-04 2020-06-04 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1062US2081062ASCREEN Screening ASCREENING 2020-06-05 2020-06-08T09:17Á0AmRNA-1273-P201SEmRNA-1273-P201-US208-1062US2081062A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T09:172020-07-09T12:54AB mRNA-1273-P201SEmRNA-1273-P201-US208-1062US2081062A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-09T12:542020-08-06 B B<mRNA-1273-P201SEmRNA-1273-P201-US208-1062US2081062A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-24 B<C`mRNA-1273-P201SEmRNA-1273-P201-US208-1063US2081063ASCREEN Screening ASCREENING 2020-06-05 2020-06-08T08:24Á0AmRNA-1273-P201SEmRNA-1273-P201-US208-1063US2081063A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T08:242020-07-08T09:55ABmRNA-1273-P201SEmRNA-1273-P201-US208-1063US2081063A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-08T09:552020-08-06 BB<mRNA-1273-P201SEmRNA-1273-P201-US208-1063US2081063A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-06 2021-02-24 B<C`mRNA-1273-P201SEmRNA-1273-P201-US208-1064US2081064ASCREEN Screening ASCREENING 2020-06-05 2020-06-08T11:40Á0AmRNA-1273-P201SEmRNA-1273-P201-US208-1064US2081064A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-08T11:402020-07-09T09:56AB mRNA-1273-P201SEmRNA-1273-P201-US208-1064US2081064A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-09T09:562020-08-07 B B=mRNA-1273-P201SEmRNA-1273-P201-US208-1064US2081064A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-07 2021-02-26 B=C€mRNA-1273-P201SEmRNA-1273-P201-US208-1065US2081065ASCREEN Screening ASCREENING 2020-06-11 2020-06-26T08:31ÁðAmRNA-1273-P201SEmRNA-1273-P201-US208-1065US2081065A PBO Placebo A BLINDED TREATMENT 2020-06-26T08:312020-07-24T07:46ABmRNA-1273-P201SEmRNA-1273-P201-US208-1065US2081065A0PBO Placebo A0BLINDED TREATMENT 2020-07-24T07:462020-08-24 BB<mRNA-1273-P201SEmRNA-1273-P201-US208-1065US2081065A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-02 B<BÞmRNA-1273-P201SEmRNA-1273-P201-US208-1066US2081066ASCREEN Screening ASCREENING 2020-06-11 2020-06-26T12:07ÁðAmRNA-1273-P201SEmRNA-1273-P201-US208-1066US2081066A PBO Placebo A BLINDED TREATMENT 2020-06-26T12:072020-07-24T09:29ABmRNA-1273-P201SEmRNA-1273-P201-US208-1066US2081066A0PBO Placebo A0BLINDED TREATMENT 2020-07-24T09:292020-08-25 BB=mRNA-1273-P201SEmRNA-1273-P201-US208-1066US2081066A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-25 2021-02-05 B=BámRNA-1273-P201SEmRNA-1273-P201-US208-1067US2081067ASCREEN Screening ASCREENING 2020-06-11 2020-06-11 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1068US2081068ASCREEN Screening ASCREENING 2020-06-11 2020-06-23 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1069US2081069ASCREEN Screening ASCREENING 2020-06-11 2020-06-26T14:54ÁðAmRNA-1273-P201SEmRNA-1273-P201-US208-1069US2081069A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T14:542020-07-24T14:17ABmRNA-1273-P201SEmRNA-1273-P201-US208-1069US2081069A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-24T14:172020-08-24 BB<mRNA-1273-P201SEmRNA-1273-P201-US208-1069US2081069A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-24 2021-02-08 B<BämRNA-1273-P201SEmRNA-1273-P201-US208-1070US2081070ASCREEN Screening ASCREENING 2020-06-12 2020-06-26T11:54ÁàAmRNA-1273-P201SEmRNA-1273-P201-US208-1070US2081070A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-26T11:542020-07-24T14:01ABmRNA-1273-P201SEmRNA-1273-P201-US208-1070US2081070A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-24T14:012020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US208-1070US2081070A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-02-03 B9BßmRNA-1273-P201SEmRNA-1273-P201-US208-1071US2081071ASCREEN Screening ASCREENING 2020-06-12 2020-06-30T12:03ÂAmRNA-1273-P201SEmRNA-1273-P201-US208-1071US2081071A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-30T12:032020-07-29T11:55ABmRNA-1273-P201SEmRNA-1273-P201-US208-1071US2081071A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-29T11:552020-08-26 BB:mRNA-1273-P201SEmRNA-1273-P201-US208-1071US2081071A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-02-12 B:BämRNA-1273-P201SEmRNA-1273-P201-US208-1072US2081072ASCREEN Screening ASCREENING 2020-06-15 2020-06-26T09:50Á°AmRNA-1273-P201SEmRNA-1273-P201-US208-1072US2081072A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T09:502020-07-24T11:44ABmRNA-1273-P201SEmRNA-1273-P201-US208-1072US2081072A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-24T11:442020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US208-1072US2081072A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-02-03 B9BßmRNA-1273-P201SEmRNA-1273-P201-US208-1073US2081073ASCREEN Screening ASCREENING 2020-06-15 2020-06-26T09:57Á°AmRNA-1273-P201SEmRNA-1273-P201-US208-1073US2081073A PBO Placebo A BLINDED TREATMENT 2020-06-26T09:572020-07-24T11:57ABmRNA-1273-P201SEmRNA-1273-P201-US208-1073US2081073A0PBO Placebo A0BLINDED TREATMENT 2020-07-24T11:572020-08-21 BB9mRNA-1273-P201SEmRNA-1273-P201-US208-1073US2081073A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-21 2021-02-03 B9BßmRNA-1273-P201SEmRNA-1273-P201-US208-1074US2081074ASCREEN Screening ASCREENING 2020-06-15 2020-06-15 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1075US2081075ASCREEN Screening ASCREENING 2020-06-15 2020-06-30T14:08ÁðAmRNA-1273-P201SEmRNA-1273-P201-US208-1075US2081075A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-30T14:082020-07-29T09:56ABmRNA-1273-P201SEmRNA-1273-P201-US208-1075US2081075A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T09:562020-08-26 BB:mRNA-1273-P201SEmRNA-1273-P201-US208-1075US2081075A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-02-08 B:BàmRNA-1273-P201SEmRNA-1273-P201-US208-1076US2081076ASCREEN Screening ASCREENING 2020-06-16 2020-07-01T10:00ÁðAmRNA-1273-P201SEmRNA-1273-P201-US208-1076US2081076A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-01T10:002020-08-05T14:22AB$mRNA-1273-P201SEmRNA-1273-P201-US208-1076US2081076A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-05T14:222020-09-03 B$BAmRNA-1273-P201SEmRNA-1273-P201-US208-1076US2081076A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-03 2021-02-24 BABïmRNA-1273-P201SEmRNA-1273-P201-US208-1077US2081077ASCREEN Screening ASCREENING 2020-06-16 2020-06-30T14:24ÁàAmRNA-1273-P201SEmRNA-1273-P201-US208-1077US2081077A PBO Placebo A BLINDED TREATMENT 2020-06-30T14:242020-08-03T11:54AB#mRNA-1273-P201SEmRNA-1273-P201-US208-1077US2081077A0PBO Placebo A0BLINDED TREATMENT 2020-08-03T11:542020-08-31 B#B?mRNA-1273-P201SEmRNA-1273-P201-US208-1077US2081077A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-03 B?BÛmRNA-1273-P201SEmRNA-1273-P201-US208-1078US2081078ASCREEN Screening ASCREENING 2020-06-16 2020-06-23 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1079US2081079ASCREEN Screening ASCREENING 2020-06-17 2020-06-17 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1080US2081080ASCREEN Screening ASCREENING 2020-06-17 2020-07-01T11:49ÁàAmRNA-1273-P201SEmRNA-1273-P201-US208-1080US2081080A PBO Placebo A BLINDED TREATMENT 2020-07-01T11:492020-07-31T09:50ABmRNA-1273-P201SEmRNA-1273-P201-US208-1080US2081080A0PBO Placebo A0BLINDED TREATMENT 2020-07-31T09:502020-08-28 BB;mRNA-1273-P201SEmRNA-1273-P201-US208-1080US2081080A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-17 B;BèmRNA-1273-P201SEmRNA-1273-P201-US208-1081US2081081ASCREEN Screening ASCREENING 2020-06-17 2020-06-29T10:46ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US208-1081US2081081A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-29T10:462020-07-29T10:14ABmRNA-1273-P201SEmRNA-1273-P201-US208-1081US2081081A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T10:142020-08-27 BB<mRNA-1273-P201SEmRNA-1273-P201-US208-1081US2081081A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-05-03 B<CPmRNA-1273-P201SEmRNA-1273-P201-US208-1082US2081082ASCREEN Screening ASCREENING 2020-06-18 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1083US2081083ASCREEN Screening ASCREENING 2020-06-18 2020-07-02 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1084US2081084ASCREEN Screening ASCREENING 2020-06-18 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1085US2081085ASCREEN Screening ASCREENING 2020-06-18 2020-07-03T13:13ÁðAmRNA-1273-P201SEmRNA-1273-P201-US208-1085US2081085A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-03T13:132020-08-11T08:58AB(mRNA-1273-P201SEmRNA-1273-P201-US208-1085US2081085A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-11T08:582020-09-08 B(BDmRNA-1273-P201SEmRNA-1273-P201-US208-1085US2081085A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-08 2021-03-03 BDBômRNA-1273-P201SEmRNA-1273-P201-US208-1086US2081086ASCREEN Screening ASCREENING 2020-06-18 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1087US2081087ASCREEN Screening ASCREENING 2020-06-18 2020-06-30T07:46ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US208-1087US2081087A PBO Placebo A BLINDED TREATMENT 2020-06-30T07:462020-07-29T07:46ABmRNA-1273-P201SEmRNA-1273-P201-US208-1087US2081087A0PBO Placebo A0BLINDED TREATMENT 2020-07-29T07:462020-08-26 BB:mRNA-1273-P201SEmRNA-1273-P201-US208-1087US2081087A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-02-17 B:BémRNA-1273-P201SEmRNA-1273-P201-US208-1088US2081088ASCREEN Screening ASCREENING 2020-06-18 2020-07-02T10:12ÁàAmRNA-1273-P201SEmRNA-1273-P201-US208-1088US2081088A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-02T10:122020-08-03T07:54AB!mRNA-1273-P201SEmRNA-1273-P201-US208-1088US2081088A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-03T07:542020-08-31 B!B=mRNA-1273-P201SEmRNA-1273-P201-US208-1088US2081088A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-15 B=BåmRNA-1273-P201SEmRNA-1273-P201-US208-1089US2081089ASCREEN Screening ASCREENING 2020-06-18 2020-06-18 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1090US2081090ASCREEN Screening ASCREENING 2020-06-19 2020-07-01T08:03ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US208-1090US2081090A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-01T08:032020-08-03T08:13AB"mRNA-1273-P201SEmRNA-1273-P201-US208-1090US2081090A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-03T08:132020-09-02 B"B@mRNA-1273-P201SEmRNA-1273-P201-US208-1090US2081090A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-02 2021-02-26 B@BñmRNA-1273-P201SEmRNA-1273-P201-US208-1091US2081091ASCREEN Screening ASCREENING 2020-06-19 2020-07-03T07:49ÁàAmRNA-1273-P201SEmRNA-1273-P201-US208-1091US2081091A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-03T07:492020-08-03T09:55AB mRNA-1273-P201SEmRNA-1273-P201-US208-1091US2081091A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-03T09:552020-08-31 B B<mRNA-1273-P201SEmRNA-1273-P201-US208-1091US2081091A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-15 B<BämRNA-1273-P201SEmRNA-1273-P201-US208-1092US2081092ASCREEN Screening ASCREENING 2020-06-19 2020-07-02T10:27ÁÐAmRNA-1273-P201SEmRNA-1273-P201-US208-1092US2081092A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-02T10:272020-07-31T14:10ABmRNA-1273-P201SEmRNA-1273-P201-US208-1092US2081092A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-31T14:102020-08-28 BB:mRNA-1273-P201SEmRNA-1273-P201-US208-1092US2081092A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-12 B:BâmRNA-1273-P201SEmRNA-1273-P201-US208-1093US2081093ASCREEN Screening ASCREENING 2020-06-19 2020-07-02T11:50ÁÐAmRNA-1273-P201SEmRNA-1273-P201-US208-1093US2081093A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-02T11:502020-08-03T12:11AB!mRNA-1273-P201SEmRNA-1273-P201-US208-1093US2081093A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-03T12:112020-09-01 B!B>mRNA-1273-P201SEmRNA-1273-P201-US208-1093US2081093A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-01 2021-02-05 B>BÛmRNA-1273-P201SEmRNA-1273-P201-US208-1094US2081094ASCREEN Screening ASCREENING 2020-06-19 2020-06-19 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1095US2081095ASCREEN Screening ASCREENING 2020-06-19 2020-06-29 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1096US2081096ASCREEN Screening ASCREENING 2020-06-19 2020-06-19 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1097US2081097ASCREEN Screening ASCREENING 2020-06-22 2020-07-01T08:13ÁAmRNA-1273-P201SEmRNA-1273-P201-US208-1097US2081097A PBO Placebo A BLINDED TREATMENT 2020-07-01T08:132020-07-31T09:40ABmRNA-1273-P201SEmRNA-1273-P201-US208-1097US2081097A0PBO Placebo A0BLINDED TREATMENT 2020-07-31T09:402020-08-28 BB;mRNA-1273-P201SEmRNA-1273-P201-US208-1097US2081097A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-03 B;BÚmRNA-1273-P201SEmRNA-1273-P201-US208-1098US2081098ASCREEN Screening ASCREENING 2020-06-22 2020-07-01 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1099US2081099ASCREEN Screening ASCREENING 2020-06-22 2020-06-26T08:50Á@AmRNA-1273-P201SEmRNA-1273-P201-US208-1099US2081099A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-26T08:502020-07-29T08:04AB"mRNA-1273-P201SEmRNA-1273-P201-US208-1099US2081099A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T08:042020-08-26 B"B>mRNA-1273-P201SEmRNA-1273-P201-US208-1099US2081099A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-02-17 B>BímRNA-1273-P201SEmRNA-1273-P201-US208-1100US2081100ASCREEN Screening ASCREENING 2020-06-22 2020-07-02T13:51Á AmRNA-1273-P201SEmRNA-1273-P201-US208-1100US2081100A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-02T13:512020-08-03T10:06AB!mRNA-1273-P201SEmRNA-1273-P201-US208-1100US2081100A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-03T10:062020-09-10 B!BGmRNA-1273-P201SEmRNA-1273-P201-US208-1100US2081100A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-10 2021-02-15 BGBåmRNA-1273-P201SEmRNA-1273-P201-US208-1101US2081101ASCREEN Screening ASCREENING 2020-06-22 2020-06-22 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1102US2081102ASCREEN Screening ASCREENING 2020-06-22 2020-06-29 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1103US2081103ASCREEN Screening ASCREENING 2020-06-23 2020-07-02T08:04ÁAmRNA-1273-P201SEmRNA-1273-P201-US208-1103US2081103A PBO Placebo A BLINDED TREATMENT 2020-07-02T08:042020-08-06T12:24AB$mRNA-1273-P201SEmRNA-1273-P201-US208-1103US2081103A0PBO Placebo A0BLINDED TREATMENT 2020-08-06T12:242020-09-01 B$B>mRNA-1273-P201SEmRNA-1273-P201-US208-1103US2081103A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-01 2021-02-02 B>BØmRNA-1273-P201SEmRNA-1273-P201-US208-1104US2081104ASCREEN Screening ASCREENING 2020-06-23 2020-07-02T08:16ÁAmRNA-1273-P201SEmRNA-1273-P201-US208-1104US2081104A PBO Placebo A BLINDED TREATMENT 2020-07-02T08:162020-08-06T12:04AB$mRNA-1273-P201SEmRNA-1273-P201-US208-1104US2081104A0PBO Placebo A0BLINDED TREATMENT 2020-08-06T12:042020-09-01 B$B>mRNA-1273-P201SEmRNA-1273-P201-US208-1104US2081104A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-01 2021-02-02 B>BØmRNA-1273-P201SEmRNA-1273-P201-US208-1105US2081105ASCREEN Screening ASCREENING 2020-06-23 2020-06-23 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1106US2081106ASCREEN Screening ASCREENING 2020-06-23 2020-06-23 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1107US2081107ASCREEN Screening ASCREENING 2020-06-23 2020-06-23 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1108US2081108ASCREEN Screening ASCREENING 2020-06-23 2020-07-03T09:21Á AmRNA-1273-P201SEmRNA-1273-P201-US208-1108US2081108A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-03T09:212020-07-31T12:08ABmRNA-1273-P201SEmRNA-1273-P201-US208-1108US2081108A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-31T12:082020-08-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US208-1108US2081108A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-08 B9BÝmRNA-1273-P201SEmRNA-1273-P201-US208-1109US2081109ASCREEN Screening ASCREENING 2020-06-23 2020-06-29 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1110US2081110ASCREEN Screening ASCREENING 2020-06-23 2020-07-03T09:32Á AmRNA-1273-P201SEmRNA-1273-P201-US208-1110US2081110A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-03T09:322020-07-31T11:50ABmRNA-1273-P201SEmRNA-1273-P201-US208-1110US2081110A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-31T11:502020-08-28 BB9mRNA-1273-P201SEmRNA-1273-P201-US208-1110US2081110A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-12 B9BámRNA-1273-P201SEmRNA-1273-P201-US208-1111US2081111ASCREEN Screening ASCREENING 2020-06-24 2020-06-24 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1112US2081112ASCREEN Screening ASCREENING 2020-06-24 2020-07-03T11:51ÁAmRNA-1273-P201SEmRNA-1273-P201-US208-1112US2081112A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-03T11:512020-08-11T10:11AB(mRNA-1273-P201SEmRNA-1273-P201-US208-1112US2081112A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-08-11T10:112020-09-14 B(BJmRNA-1273-P201SEmRNA-1273-P201-US208-1112US2081112A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-14 2021-02-15 BJBämRNA-1273-P201SEmRNA-1273-P201-US208-1113US2081113ASCREEN Screening ASCREENING 2020-06-24 2020-07-08T08:52ÁàAmRNA-1273-P201SEmRNA-1273-P201-US208-1113US2081113A PBO Placebo A BLINDED TREATMENT 2020-07-08T08:522020-08-10T10:01AB"mRNA-1273-P201SEmRNA-1273-P201-US208-1113US2081113A0PBO Placebo A0BLINDED TREATMENT 2020-08-10T10:012020-09-08 B"B?mRNA-1273-P201SEmRNA-1273-P201-US208-1113US2081113A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-08 2021-02-17 B?BámRNA-1273-P201SEmRNA-1273-P201-US208-1114US2081114ASCREEN Screening ASCREENING 2020-06-24 2020-07-02 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1115US2081115ASCREEN Screening ASCREENING 2020-06-24 2020-06-24 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1116US2081116ASCREEN Screening ASCREENING 2020-06-24 2020-06-29T15:04ÁPAmRNA-1273-P201SEmRNA-1273-P201-US208-1116US2081116A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-06-29T15:042020-07-29T12:10ABmRNA-1273-P201SEmRNA-1273-P201-US208-1116US2081116A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T12:102020-08-27 BB<mRNA-1273-P201SEmRNA-1273-P201-US208-1116US2081116A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-27 2021-02-05 B<BÞmRNA-1273-P201SEmRNA-1273-P201-US208-1117US2081117ASCREEN Screening ASCREENING 2020-06-24 2020-07-06T13:45ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US208-1117US2081117A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-06T13:452020-08-11T15:30AB%mRNA-1273-P201SEmRNA-1273-P201-US208-1117US2081117A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-11T15:302020-09-08 B%BAmRNA-1273-P201SEmRNA-1273-P201-US208-1117US2081117A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-08 2021-02-05 BAB×mRNA-1273-P201SEmRNA-1273-P201-US208-1118US2081118ASCREEN Screening ASCREENING 2020-06-24 2020-07-01T14:01ÁpAmRNA-1273-P201SEmRNA-1273-P201-US208-1118US2081118A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-07-01T14:012020-07-31T13:50ABmRNA-1273-P201SEmRNA-1273-P201-US208-1118US2081118A0V-50 mRNA-1273 50 ug A0BLINDED TREATMENT 2020-07-31T13:502020-08-28 BB;mRNA-1273-P201SEmRNA-1273-P201-US208-1118US2081118A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-28 2021-02-15 B;BæmRNA-1273-P201SEmRNA-1273-P201-US208-1119US2081119ASCREEN Screening ASCREENING 2020-06-24 2020-07-06T07:58ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US208-1119US2081119A PBO Placebo A BLINDED TREATMENT 2020-07-06T07:582020-08-11T07:48AB%mRNA-1273-P201SEmRNA-1273-P201-US208-1119US2081119A0PBO Placebo A0BLINDED TREATMENT 2020-08-11T07:482020-09-08 B%BAmRNA-1273-P201SEmRNA-1273-P201-US208-1119US2081119A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-08 2021-02-02 BABÔmRNA-1273-P201SEmRNA-1273-P201-US208-1120US2081120ASCREEN Screening ASCREENING 2020-06-24 2020-07-01T15:45ÁpAmRNA-1273-P201SEmRNA-1273-P201-US208-1120US2081120A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-01T15:452020-07-29T14:00ABmRNA-1273-P201SEmRNA-1273-P201-US208-1120US2081120A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-07-29T14:002020-08-26 BB9mRNA-1273-P201SEmRNA-1273-P201-US208-1120US2081120A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-26 2021-02-02 B9BÙmRNA-1273-P201SEmRNA-1273-P201-US208-1121US2081121ASCREEN Screening ASCREENING 2020-06-24 2020-07-06T09:50ÁÀAmRNA-1273-P201SEmRNA-1273-P201-US208-1121US2081121A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-06T09:502020-08-10T12:59AB$mRNA-1273-P201SEmRNA-1273-P201-US208-1121US2081121A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-10T12:592020-09-04 B$B=mRNA-1273-P201SEmRNA-1273-P201-US208-1121US2081121A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-09-04 2021-02-03 B=BÕmRNA-1273-P201SEmRNA-1273-P201-US208-1122US2081122ASCREEN Screening ASCREENING 2020-06-25 2020-06-30 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1123US2081123ASCREEN Screening ASCREENING 2020-06-25 2020-06-30T12:18ÁPAmRNA-1273-P201SEmRNA-1273-P201-US208-1123US2081123A V-50 mRNA-1273 50 ug A BLINDED TREATMENT 2020-06-30T12:182020-08-11 AB+mRNA-1273-P201SEmRNA-1273-P201-US208-1123US2081123A0FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-12 2021-02-17 B,BémRNA-1273-P201SEmRNA-1273-P201-US208-1124US2081124ASCREEN Screening ASCREENING 2020-06-25 2020-06-29 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1125US2081125ASCREEN Screening ASCREENING 2020-06-25 2020-07-02T15:29ÁpAmRNA-1273-P201SEmRNA-1273-P201-US208-1125US2081125A PBO Placebo A BLINDED TREATMENT 2020-07-02T15:292020-08-03T13:49AB!mRNA-1273-P201SEmRNA-1273-P201-US208-1125US2081125A0PBO Placebo A0BLINDED TREATMENT 2020-08-03T13:492020-08-31 B!B=mRNA-1273-P201SEmRNA-1273-P201-US208-1125US2081125A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-02 B=BØmRNA-1273-P201SEmRNA-1273-P201-US208-1126US2081126ASCREEN Screening ASCREENING 2020-06-25 2020-06-25 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1127US2081127ASCREEN Screening ASCREENING 2020-06-25 2020-06-25 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1128US2081128ASCREEN Screening ASCREENING 2020-06-25 2020-06-25 ..mRNA-1273-P201SEmRNA-1273-P201-US208-1129US2081129ASCREEN Screening ASCREENING 2020-06-25 2020-07-02T15:50ÁpAmRNA-1273-P201SEmRNA-1273-P201-US208-1129US2081129A V-100 mRNA-1273 100 ug A BLINDED TREATMENT 2020-07-02T15:502020-08-03T13:59AB!mRNA-1273-P201SEmRNA-1273-P201-US208-1129US2081129A0V-100 mRNA-1273 100 ug A0BLINDED TREATMENT 2020-08-03T13:592020-08-31 B!B=mRNA-1273-P201SEmRNA-1273-P201-US208-1129US2081129A@FUPA Part A Follow up A@PART A FOLLOW-UP 2020-08-31 2021-02-15 B=BåmRNA-1273-P201SEmRNA-1273-P201-US208-1130US2081130ASCREEN Screening ASCREENING 2020-06-25 2020-06-29 ..